Document:

Document

EXECUTION VERSION

 

DENTSPLY SIRONA INC.
¥12,552,500,000 0.99% SERIES W SENIOR NOTES DUE SEPTEMBER 25, 2031

________________
NOTE PURCHASE AGREEMENT
________________
DATED AS OF JUNE 24, 2019

TABLE OF CONTENTS

Page

												
	1.	AUTHORIZATION OF NOTES		1

				
	2.	SALE AND PURCHASE OF NOTES		1

				
	3.	CLOSING		2

				
	4.	CONDITIONS TO CLOSING		2

				
		4.1	Representations and Warranties	2

		4.2	Performance; No Default	3

		4.3	Compliance Certificates	3

		4.4	Opinions of Counsel	3

		4.5	Purchase Permitted By Applicable Law, Etc	3

		4.6	Sale of Other Notes	4

		4.7	Payment of Special Counsel Fees	4

		4.8	Private Placement Number	4

		4.9	Changes in Corporate Structure	4

		4.10	Funding Instructions	4

		4.11	Proceedings and Documents	5

				
	5.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY		5

				
		5.1	Organization; Power and Authority	5

		5.2	Authorization, Etc	5

		5.3	Disclosure	5

		5.4	Organization and Ownership of Shares of Subsidiaries; Affiliates	6

		5.5	Financial Statements	7

		5.6	Compliance with Laws, Other Instruments, Etc	7

		5.7	Governmental Authorizations, Etc	7

		5.8	Litigation; Observance of Agreements, Statutes and Orders	7

		5.9	Taxes	8

		5.10	Title to Property; Leases	8

		5.11	Licenses, Permits, Etc	8

		5.12	Compliance with ERISA	9

		5.13	Private Offering by the Company	10

		5.14	Use of Proceeds; Margin Regulations	10

		5.15	Existing Debt; Future Liens	11

		5.16	Foreign Assets Control Regulations, Etc	11

		5.17	Status under Certain Statutes	13

		5.18	Environmental Matters	14

		5.19	Notes Rank Pari Passu	14

	6.	REPRESENTATIONS OF THE PURCHASER		14

		6.1	Purchase for Investment	14

		6.2	Accredited Investor	15

		6.3	Source of Funds	15

	7.	INFORMATION AS TO COMPANY		18

									
		i
	

TABLE OF CONTENTS
(continued)
Page

												
		7.1	Financial and Business Information	18

		7.2	Officer’s Certificate	21

		7.3	Visitation	21

		7.4	Electronic Delivery	22

	8.	PAYMENT OF THE NOTES		22

		8.1	Required Prepayments	23

		8.2	Optional Prepayments with Make-Whole Amount	23

		8.3	Prepayment of Notes Upon Change of Control	23

		8.4	Prepayment of Notes Upon Sale of Assets	25

		8.5	Allocation of Partial Prepayments	25

		8.6	Maturity; Surrender, Etc	25

		8.7	Purchase of Notes	25

		8.8	Prepayment in Connection with a Noteholder Sanctions Event	26

		8.9	[Reserved]	27

		8.10	Make-Whole Amount	27

		8.11	Swap Breakage	33

	9.	AFFIRMATIVE COVENANTS		35

		9.1	Compliance with Law	35

		9.2	Insurance	35

		9.3	Maintenance of Properties	35

		9.4	Payment of Taxes and Claims	36

		9.5	Corporate Existence, Etc	36

		9.6	[Reserved]	36

		9.7	Notes to Rank Pari Passu	36

		9.8	Subsidiary Guarantors	36

		9.9	Books and Records	37

	10.	NEGATIVE COVENANTS		38

		10.1	Financial Covenants	38

		10.2	[Reserved]	38

		10.3	Limitation on Liens	38

		10.4	Sales of Assets	39

		10.5	Merger and Consolidation	41

		10.6	Transactions with Affiliates	42

		10.7	Terrorism Sanctions Regulations	43

		10.8	Line of Business	43

		10.9	Subsidiary Debt	43

	11.	EVENTS OF DEFAULT		44

	12.	REMEDIES ON DEFAULT, ETC		47

		12.1	Acceleration	47

		12.2	Other Remedies	48

		12.3	Rescission	48

		12.4	No Waivers or Election of Remedies, Expenses, Etc	48

	13.	[RESERVED]		49

									
		ii
	

TABLE OF CONTENTS
(continued)
Page

												
	14.	REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES		49

		14.1	Registration of Notes	49

		14.2	Transfer and Exchange of Notes	49

		14.3	Replacement of Notes	50

	15.	PAYMENTS ON NOTES		50

		15.1	Place of Payment	50

		15.2	Home Office Payment	51

	16.	EXPENSES, ETC		51

		16.1	Transaction Expenses	51

		16.2	Survival	52

	17.	SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT		52

	18.	AMENDMENT AND WAIVER		52

		18.1	Requirements	52

		18.2	Solicitation of Holders of Notes	53

		18.3	Binding Effect, Etc	54

		18.4	Notes Held by Company, Etc	54

	19.	NOTICES		54

	20.	REPRODUCTION OF DOCUMENTS		55

	21.	CONFIDENTIAL INFORMATION		55

	22.	SUBSTITUTION OF PURCHASER		56

	23.	[RESERVED]		57

	24.	MISCELLANEOUS		57

		24.1	Successors and Assigns	57

		24.2	Payments Due on Non-Business Days	57

		24.3	Accounting Terms; GAAP; Pro Forma Calculations	57

		24.4	Severability	58

		24.5	Construction	58

		24.6	Counterparts	59

		24.7	Governing Law	59

		24.8	Jurisdiction and Process; Waiver of Jury Trial	59

		24.9	Obligation to Make Payment in Yen	60

		24.10	Change of Currency	60

									
		iii
	

Schedules & Exhibits
Schedule A — Information Relating to Purchasers
Schedule B — Defined Terms
Schedule 5.3 — Disclosure Materials
Schedule 5.4 — Subsidiaries of the Company, Ownership of Subsidiary Stock, Affiliates
Schedule 5.5 — Financial Statements
Schedule 5.15 — Existing Debt; Consignment Agreements; Unfunded Pension     Obligations
Schedule 5.16 — Anti-Money Laundering/Anti-Terrorism Disclosure
Schedule 8.10 — Swapped Notes
Schedule 10.3 — Existing Liens
Schedule 10.9 — Existing Subsidiary Debt
Exhibit 1 — Form of 0.99% Series W Senior Note
Exhibit 4.4(a) — Form of Opinion of General Counsel to the Company 
Exhibit 4.4(b) — Form of Opinion of Special Counsel to the Purchasers

									
		iv
	

DENTSPLY SIRONA Inc.
World Headquarters
Susquehanna Commerce Center, Suite 60W
221 West Philadelphia Street
York, Pennsylvania 17401

Dated as of June 24, 2019
To the Purchasers listed in
the attached Schedule A:

Ladies and Gentlemen:
DENTSPLY SIRONA INC., a Delaware corporation (together with any successor thereto that becomes a party hereto pursuant to Section 10.5, the “Company”), agrees with each of the Purchasers as follows:
1.AUTHORIZATION OF NOTES.  
The Company will authorize the issue and sale of the following Senior Notes:
															
	Issue	Series	Aggregate Principal Amount	Interest Rate	Maturity Date
	Senior Notes	Series W	¥12,552,500,000 	0.99% 	 	September 25, 2031

The Senior Notes described in this Section 1 above are collectively referred to as the “Notes” and each individually, a “Note” (such term shall also include any such notes as amended, restated or otherwise modified from time to time and any such notes issued in substitution therefor pursuant to Section 14 of this Agreement).  The Notes shall be substantially in the form set out in Exhibit 1 with such changes therefrom, if any, as may be approved by the Purchasers and the Company.    
Certain capitalized terms used in this Agreement are defined in Schedule B; references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

2. SALE AND PURCHASE OF NOTES.
Subject to the terms and conditions of this Agreement, the Company will issue and sell to each Purchaser and each Purchaser will purchase from the Company, at the Closing provided for in Section 3, the Notes in the principal amount specified opposite such Purchaser’s name in 

Schedule A at the purchase price of 100% of the principal amount thereof.  The obligations of each Purchaser hereunder are several and not joint obligations and each Purchaser shall have no obligation and no liability to any Person for the performance or nonperformance by any other Purchaser hereunder.

3. CLOSING.
The sale and purchase of the Notes to be purchased by the Purchasers shall occur at the offices of Morgan, Lewis & Bockius LLP, 101 Park Avenue, New York, New York 10178 at 10:00 a.m. Eastern time, at a closing (the “Closing”) on September 25, 2019 or on such other date as may be agreed upon by the Company and the Purchasers (such date, the “Closing Date”).  On the Closing Date, the Company will deliver to each Purchaser such Notes to be purchased by such Purchaser in the form of a single Note (or such greater number of Notes in denominations of at least ¥100,000,000 as such Purchaser may request) dated the Closing Date and registered in such Purchaser’s name (or in the name of such Purchaser’s nominee), against delivery by such Purchaser to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for the account of the Company at Citibank London, Citigroup Centre, Canary Wharf, 25 Canada Square, London E14 5LB, United Kingdom, IBAN GB55CITI18500810806188, SWIFT Code CITIGB2L, Beneficiary/Account Name: DENTSPLY SIRONA Inc..  If, on the Closing Date, the Company shall fail to tender such Notes to any Purchaser as provided above in this Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to such Purchaser’s satisfaction, such Purchaser shall, at its election, be relieved of all further obligations under this Agreement, without thereby waiving any rights such Purchaser may have by reason of such failure or such nonfulfillment.

4. CONDITIONS TO CLOSING.
Each Purchaser’s obligation to purchase and pay for the Notes to be sold to such Purchaser at the Closing is subject to the fulfillment to such Purchaser’s satisfaction, prior to or at the Closing, of the following conditions:

4.1. Representations and Warranties.
The representations and warranties of the Company in this Agreement shall be correct when made and at the time of the Closing.  Notwithstanding the foregoing, at any time during the period commencing with the date hereof and ending on the date of the Closing, the Company may deliver to the Purchasers updates to Schedules 5.3, 5.4 and 5.5 as a result of changes occurring after the date hereof, in which case the existing Schedules 5.3, 5.4 and 5.5 shall be deemed to include the information set forth in such updated Schedules as of the date of such updated Schedules for purposes of the representations and warranties in this Agreement that are required to be made at the time of the Closing; provided, however, that updates to Schedules 5.3 
2

and 5.5 shall be limited to information contained in reports filed by the Company after the date hereof with the SEC under the Exchange Act.

4.2. Performance; No Default.
The Company shall have performed and complied with all agreements and conditions contained in this Agreement required to be performed or complied with by the Company prior to or at the Closing, and before and after giving effect to the issue and sale of the Notes to be issued at the Closing (and the application of the proceeds thereof as contemplated by Section 5.14), no Default or Event of Default shall have occurred and be continuing.  Neither the Company nor any Subsidiary shall have entered into any transaction since May 30, 2019 that would have been prohibited by Section 10 hereof had such Section applied since such date.

4.3. Compliance Certificates.
(a) Officer’s Certificate of the Company.  The Company shall have delivered to such Purchaser an Officer’s Certificate, dated the date of the Closing, certifying that the conditions specified in Sections 4.1, 4.2 and 4.9 have been fulfilled.
(b) Secretary’s Certificate of the Company.  The Company shall have delivered to such Purchaser a certificate of its Secretary, an Assistant Secretary or another appropriate person, dated the date of the Closing, certifying as to (i) the resolutions attached thereto and other corporate proceedings relating to the authorization, execution and delivery of the Notes to be issued by it at the Closing and this Agreement and (ii) the Company’s organizational documents as then in effect.

4.4. Opinions of Counsel.
Such Purchaser shall have received opinions in form and substance satisfactory to such Purchaser, dated the date of the Closing (a) from the General Counsel of the Company, covering the matters set forth in Exhibit 4.4(a) and such other matters incident to the transactions contemplated hereby as such Purchaser or its counsel may reasonably request, and (b) from Morgan, Lewis & Bockius LLP, the Purchasers’ special counsel in connection with such transactions, substantially in the form set forth in Exhibit 4.4(b) and covering such other matters incident to such transactions as such Purchaser may reasonably request.

4.5. Purchase Permitted By Applicable Law, Etc.
On the date of the Closing, such Purchaser’s purchase of Notes shall (a) be permitted by the laws and regulations of each jurisdiction to which such Purchaser is subject, without recourse to provisions (such as section 1405(a)(8) of the New York Insurance Law) permitting limited investments by insurance companies without restriction as to the character of the particular 
3

investment, (b) not violate any applicable law or regulation (including, without limitation, Regulation T, U or X of the Board of Governors of the Federal Reserve System) and (c) not subject such Purchaser to any tax, penalty or liability under or pursuant to any applicable law or regulation, which law or regulation was not in effect on the date hereof.  If requested by such Purchaser, such Purchaser shall have received an Officer’s Certificate certifying as to such matters of fact as such Purchaser may reasonably specify to enable such Purchaser to determine whether such purchase is so permitted.

4.6. Sale of Other Notes.
Contemporaneously with the Closing, the Company shall sell to each other Purchaser and each other Purchaser shall purchase the Notes to be purchased by it at the Closing as specified in Schedule A.

4.7. Payment of Special Counsel Fees.
Without limiting the provisions of Section 16.1, the Company shall have paid on or before the Closing, the reasonable fees, reasonable charges and reasonable disbursements of the Purchasers’ special counsel referred to in Section 4.4 to the extent reflected in a statement of such counsel rendered to the Company at least one Business Day prior to the date of the Closing.

4.8. Private Placement Number.
A Private Placement Number issued by Standard & Poor’s CUSIP Service Bureau (in cooperation with the SVO) shall have been obtained for the Notes to be issued at the Closing.

4.9. Changes in Corporate Structure.
Prior to the Closing Date, the Company shall not have changed its jurisdiction of organization, been a party to any merger or consolidation, or shall have succeeded to all or any substantial part of the liabilities of any other entity, at any time following the date of the most recent financial statements referred to in Section 5.5.

4.10. Funding Instructions.
At least three Business Days prior to the date of the Closing, each Purchaser shall have received written instructions signed by a Responsible Officer on letterhead of the Company including (a) the name and address of the transferee bank, (b) such transferee bank’s ABA number/Swift Code/IBAN and (c) the account name and number into which the purchase price for such Purchaser’s Notes is to be deposited.

4

4.11. Proceedings and Documents.
All corporate and other proceedings in connection with the transactions contemplated by this Agreement and all documents and instruments incident to such transactions shall be reasonably satisfactory to such Purchaser and its special counsel, and such Purchaser and its special counsel shall have received all such counterpart originals or certified or other copies of such documents as such Purchaser or such special counsel may reasonably request.

5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
The Company represents and warrants to each Purchaser that:

5.1. Organization; Power and Authority.
The Company is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation, and is duly qualified as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  The Company has the corporate power and authority to own or hold under lease the properties it purports to own or hold under lease, to transact the business it transacts and proposes to transact, to execute and deliver this Agreement, the Notes, and to perform the provisions hereof and thereof.

5.2. Authorization, Etc.
This Agreement and the Notes have been duly authorized by all necessary corporate action on the part of the Company, and this Agreement constitutes, and upon execution and delivery thereof each Note will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

5.3. Disclosure.
  This Agreement, the financial statements listed in Schedule 5.5 and the documents, certificates or other writings delivered to the Purchasers by or on behalf of the Company prior to May 30, 2019 in connection with the transactions contemplated hereby and identified in Schedule 5.3 (this Agreement and such documents, certificates or other writings and such financial statements delivered to each Purchaser being referred to, collectively, as the “Disclosure Documents”), taken as a whole, do not contain any untrue statement of a material 
5

fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made.  Except as disclosed in the Disclosure Documents, since December 31, 2018, there has been no change in the financial condition, operations, business or properties of the Company or any of its Subsidiaries except changes that individually or in the aggregate would not reasonably be expected to have a Material Adverse Effect.  There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the Disclosure Documents.  Notwithstanding anything to the contrary herein, the Company is not making any representation with respect to any projections included in the Disclosure Documents other than that such projections are based on the information that the Company believes to be accurate and were calculated in a manner the Company believes to be reasonable. 

5.4. Organization and Ownership of Shares of Subsidiaries; Affiliates.
(a) Schedule 5.4 contains (except as noted therein) complete and correct lists of (i)  the Company’s Subsidiaries, showing, as to each Subsidiary, the correct name thereof, the jurisdiction of its organization, and the percentage of shares of each class of its capital stock or similar equity interests outstanding owned by the Company and its Subsidiaries, (ii)  the Company’s Affiliates, other than Subsidiaries, and (iii) the Company’s directors and senior officers.
(b) All of the outstanding shares of capital stock or similar equity interests of each Subsidiary shown in Schedule 5.4 as being owned by the Company and its Subsidiaries have been validly issued, are fully paid and nonassessable and are owned by the Company or another Subsidiary free and clear of any Lien (other than Liens permitted by Section 10.3).
(c) Each Subsidiary identified in Schedule 5.4 is a corporation or other legal entity duly organized, validly existing and, where applicable, in good standing under the laws of its jurisdiction of organization, and is duly qualified as a foreign corporation or other legal entity and, where applicable, is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, each such Subsidiary has the corporate or other power and authority to own or hold under lease the properties it purports to own or hold under lease and to transact the business it transacts and proposes to transact.
(d) No Subsidiary is a party to, or otherwise subject to, any legal restriction or any agreement (other than this Agreement, the agreements listed on Schedule 5.4 and customary limitations imposed by corporate law or similar statutes) restricting the ability of such Subsidiary to pay dividends out of profits or make any other similar distributions of profits to the Company or any of its Subsidiaries that owns outstanding shares of capital stock or similar equity interests of such Subsidiary.

6

5.5. Financial Statements.
The Company has delivered to each Purchaser copies of the consolidated financial statements of the Company and its Subsidiaries listed on Schedule 5.5.  All of said financial statements (including in each case the related schedules and notes) fairly present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the respective dates specified in such Schedule and the consolidated results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP consistently applied throughout the periods involved except as set forth in the notes thereto (subject, in the case of any interim financial statements, to normal year-end adjustments).  The Company and its Subsidiaries do not have any Material liabilities that are not disclosed in the Disclosure Documents.

5.6. Compliance with Laws, Other Instruments, Etc.
The execution, delivery and performance by the Company of this Agreement and the Notes will not (a) contravene, result in any breach of, or constitute a default under, or result in the creation of any Lien in respect of any property of the Company or any Subsidiary under, any indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter, memorandum of association, articles of association, or by-laws, or any other agreement or instrument to which the Company or any Subsidiary is bound or by which the Company or any Subsidiary or any of their respective properties may be bound or affected, (b) conflict with or result in a breach of any of the terms, conditions or provisions of any order, judgment, decree, or ruling of any court, arbitrator or Governmental Authority applicable to the Company or any Subsidiary, or (c) violate any provision of any statute or other rule or regulation of any Governmental Authority applicable to the Company or any Subsidiary, except for such contraventions, breaches, defaults, conflicts, violations or Liens as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

5.7. Governmental Authorizations, Etc.
No consent, approval or authorization of, or registration, filing or declaration with, any Governmental Authority is required in connection with the execution, delivery or performance by the Company of this Agreement and the Notes, including any thereof required in connection with the obtaining of Yen to make payments under this Agreement or the Notes and the payment of such Yen to Persons resident in the United States of America.

5.8. Litigation; Observance of Agreements, Statutes and Orders.
(a) There are no actions, suits, investigations or proceedings pending or, to the knowledge of the Company, threatened against or affecting the Company or any Subsidiary or any property of the Company or any Subsidiary in any court or before any 
7

arbitrator of any kind or before or by any Governmental Authority that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.
(b) Neither the Company nor any Subsidiary is in default under any term of any agreement or instrument to which it is a party or by which it is bound, or any order, judgment, decree or ruling of any court, arbitrator or Governmental Authority or is in violation of any applicable law, ordinance, rule or regulation of any Governmental Authority (including, without limitation, Environmental Laws, the USA PATRIOT Act or any of the other laws and regulations that are referred to in Section 5.16), which default or violation, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.

5.9. Taxes.
The Company and its Subsidiaries have filed all tax returns that are required to have been filed in any jurisdiction, and have paid all taxes shown to be due and payable on such returns and all other taxes and assessments levied upon them or their properties, assets, income or franchises, to the extent such taxes and assessments have become due and payable and before they have become delinquent, except in each case for any taxes and assessments (a) the amount of which is not individually or in the aggregate Material or (b) the amount, applicability or validity of which is currently being contested in good faith by appropriate proceedings and with respect to which the Company or a Subsidiary, as the case may be, has established adequate reserves in accordance with GAAP.  The Company knows of no basis for any other tax or assessment that would reasonably be expected to have a Material Adverse Effect.  The charges, accruals and reserves on the books of the Company and its Subsidiaries in respect of federal, state or other taxes for all fiscal periods are adequate.  As of the date of this Agreement, the U.S. federal income tax liabilities of the Company and its Subsidiaries have been finally determined (whether by reason of completed audits or the statute of limitations having run) for all fiscal years up to and including the fiscal year ended 2011. 

5.10. Title to Property; Leases.
The Company and its Subsidiaries have good and sufficient title to their respective properties which the Company and its Subsidiaries own or purport to own, in each case free and clear of Liens prohibited by this Agreement, except where the failure to have such title would not reasonably be expected to have a Material Adverse Effect.  All Material leases of the Company and its Subsidiaries are valid and subsisting and are in full force and effect in all material respects.

5.11. Licenses, Permits, Etc.
(a) The Company and its Subsidiaries own or possess all licenses, permits, franchises, authorizations, patents, copyrights, proprietary software, service marks, 
8

trademarks and trade names, or rights thereto, without known conflict with the rights of others, except to the extent that the failure to own or possess the same, or the existence of any such conflict, would not reasonably be expected to have a Material Adverse Effect.
(b) No product of the Company or any of its Subsidiaries infringes in any respect any license, permit, franchise, authorization, patent, copyright, proprietary software, service mark, trademark, trade name or other right owned by any other Person, except where any such infringement would not reasonably be expected to have a Material Adverse Effect.
(c) There is no violation by any Person of any right of the Company or any of its Subsidiaries with respect to any patent, copyright, proprietary software, service mark, trademark, trade name or other right owned or used by the Company or any of its Subsidiaries, except where any such violation would not reasonably be expected to have a Material Adverse Effect.

5.12. Compliance with Employee Benefit Plans.
(a) The Company and each ERISA Affiliate have operated and administered each Plan in compliance with all applicable laws except for such instances of noncompliance as have not resulted in and could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.  Neither the Company nor any ERISA Affiliate has incurred any liability pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans (as defined in section 3 of ERISA), and no event, transaction or condition has occurred or exists that could, individually or in the aggregate, reasonably be expected to result in the incurrence of any such liability by the Company or any ERISA Affiliate, or in the imposition of any Lien on any of the rights, properties or assets of the Company or any ERISA Affiliate, in either case pursuant to Title I or IV of ERISA or to section 430(k) of the Code or to any such penalty or excise tax provisions under the Code or federal law or section 4068 of ERISA or by the granting of a security interest in connection with the amendment of a Plan, other than such liabilities or Liens as would not be individually or in the aggregate Material.
(b) The present value of the aggregate benefit liabilities under each of the Plans (other than Multiemployer Plans), determined as of the end of such Plan’s most recently ended plan year on the basis of the actuarial assumptions specified for funding purposes in such Plan’s most recent actuarial valuation report, did not exceed the aggregate current value of the assets of such Plan allocable to such benefit liabilities, in the case of any single Plan or in the aggregate for all Plans, by an amount that would reasonably be expected to have a Material Adverse Effect.  The term “benefit liabilities” has the meaning specified in section 4001 of ERISA and the terms “current value” and “present value” have the meaning specified in section 3 of ERISA.

9

(c) The Company and its ERISA Affiliates have not incurred withdrawal liabilities (and are not subject to contingent withdrawal liabilities) under section 4201 or 4204 of ERISA in respect of Multiemployer Plans that individually or in the aggregate are Material.
(d) The expected postretirement benefit obligation (determined as of the last day of the Company’s most recently ended fiscal year in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 715-60, without regard to liabilities attributable to continuation coverage mandated by section 4980B of the Code) of the Company and its Subsidiaries is not Material.
(e) The execution and delivery of this Agreement and the issuance and sale of the Notes hereunder will not involve any transaction that is subject to the prohibitions of section 406 of ERISA or in connection with which a tax could be imposed pursuant to section 4975(c)(1)(A)-(D) of the Code.  The representation by the Company to each Purchaser in the first sentence of this Section 5.12(e) is made in reliance upon and subject to the accuracy of such Purchaser’s representation in Section 6.3 as to the sources of the funds to be used to pay the purchase price of the Notes to be purchased by such Purchaser.
(f) All Non-U.S. Plans have been established, operated, administered and maintained in compliance with all laws, regulations and orders applicable thereto, except where failure so to comply could not be reasonably expected to have a Material Adverse Effect.  All premiums, contributions and any other amounts required by applicable Non-U.S. Plan documents or applicable laws to be paid or accrued by the Company and its Subsidiaries have been paid or accrued as required, except where failure so to pay or accrue could not be reasonably expected to have a Material Adverse Effect.

5.13. Private Offering by the Company.
Neither the Company nor anyone acting on its behalf has offered the Notes or any similar Securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any Person other than the Purchasers and not more than 22 other Institutional Investors, each of which has been offered the Notes in connection with a private sale for investment.  Neither the Company nor anyone acting on its behalf has taken, or will take, any action that would subject the issuance or sale of the Notes to the registration requirements of Section 5 of the Securities Act or to the registration requirements of any securities or blue sky laws of any applicable jurisdiction, including the jurisdiction of organization of the Company, or of the Financial Instruments and Exchange Act.

5.14. Use of Proceeds; Margin Regulations.
The Company will apply the proceeds of the sale of the Notes to the repayment in full of the September 2014 Loan and other general corporate purposes. No part of the proceeds from the 
10

sale of the Notes hereunder will be used, directly or indirectly, for the purpose of buying or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for the purpose of buying or carrying or trading in any securities under such circumstances as to involve the Company in a violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220).  Margin stock does not constitute more than 5% of the value of the consolidated assets of the Company and its Subsidiaries and the Company does not have any present intention that margin stock will constitute more than 5% of the value of such assets.  As used in this Section, the terms “margin stock” and “purpose of buying or carrying” shall have the meanings assigned to them in said Regulation U.

5.15. Existing Debt; Future Liens.
(a) Except as described therein, Schedule 5.15 sets forth a complete and correct list of (i) all outstanding Debt of the Company and its Subsidiaries, (ii) all Debt incurred in connection with the Consignment Agreements relating to the consignment of precious metals between the Company and certain counterparties, in each case under sub-items (i) and (ii) above as of March 31, 2019, and (iii) all unfunded pension obligations of the Company and its Subsidiaries as of December 31, 2018.  Neither the Company nor any Subsidiary is in default and no waiver of default is currently in effect, in the payment of any principal or interest on any Debt of the Company or such Subsidiary, and no event or condition exists with respect to any Debt of the Company or any Subsidiary, that would permit (or that with notice or the lapse of time, or both, would permit) one or more Persons to cause such Debt to become due and payable before its stated maturity or before its regularly scheduled dates of payment.
(b) Neither the Company nor any Subsidiary has agreed or consented to cause or permit in the future (upon the happening of a contingency or otherwise) any of its property, whether now owned or hereafter acquired, to be subject to a Lien not permitted by Section 10.3.
(c) Neither the Company nor any Subsidiary is a party to, or otherwise subject to any provision contained in, any instrument evidencing Debt of the Company or such Subsidiary, any agreement relating thereto or any other agreement (including, but not limited to, its charter or other organizational document) which limits the amount of, or otherwise imposes restrictions on the incurring of, Debt of the Company, except as specifically indicated in Schedule 5.15.

5.16. Foreign Assets Control Regulations, Etc.
(a) Neither the Company nor any Controlled Entity is (i) a Person whose name appears on the list of Specially Designated Nationals and Blocked Persons published by the Office of Foreign Assets Control, United States Department of the Treasury (“OFAC”) (an “OFAC Listed Person”) (ii) an agent, department, or 
11

instrumentality of, or is otherwise beneficially owned by, controlled by or acting on behalf of, directly or indirectly, (x) any OFAC Listed Person or (y) any Person, entity, organization, foreign country or regime that is the target of any OFAC Sanctions Program, or (iii) otherwise blocked, the target of sanctions under or engaged in any activity in violation of other United States economic sanctions, including but not limited to, the Trading with the Enemy Act, the International Emergency Economic Powers Act, the Iran Sanctions Act or any similar law or regulation with respect to Iran or any other country, the Sudan Accountability and Divestment Act, any OFAC Sanctions Program, or any economic sanctions regulations administered and enforced by the United States or any enabling legislation or executive order relating to any of the foregoing (collectively, “U.S. Economic Sanctions”) or sanctions imposed by the United Nations or the European Union (each OFAC Listed Person and each other Person, entity, organization and government of a country described in clause (i), clause (ii) or clause (iii), a “Blocked Person”).  Neither the Company nor any Controlled Entity has been notified that its name appears or may in the future appear on a state list of Persons that engage in investment or other commercial activities in Iran or any other country that is the target of U.S. Economic Sanctions.
(b) No part of the proceeds from the sale of the Notes hereunder constitutes or will constitute funds obtained on behalf of any Blocked Person or will otherwise be used by the Company or any Controlled Entity, directly or, to the knowledge of the Company, indirectly, (i) in connection with any investment in, or any transactions or dealings with, any Blocked Person or (ii) otherwise in violation of U.S. Economic Sanctions.
(c) Neither the Company nor any Controlled Entity (i) except as disclosed on Schedule 5.16, has been found in violation of, charged with, or convicted of, money laundering, drug trafficking, terrorist-related activities or other money laundering predicate crimes under the Currency and Foreign Transactions Reporting Act of 1970 (otherwise known as the Bank Secrecy Act), the USA PATRIOT Act, any U.S. Economic Sanctions, any other United States law or regulation governing such activities or under any other similar laws of any other jurisdiction governing such activities as of the Closing Date (collectively, “Anti-Money Laundering/Anti-Terrorism Laws”) and is not reasonably likely to be found in violation of, charged with, or convicted of, any Anti-Money Laundering/Anti-Terrorism Laws, (ii) except as disclosed on Schedule 5.16, to the Company’s knowledge, is under investigation by any Governmental Authority for possible violation of Anti-Money Laundering/Anti-Terrorism Laws, (iii) except as disclosed on Schedule 5.16, has been assessed civil penalties under any Anti-Money Laundering/Anti-Terrorism Laws as of the Closing Date and is not reasonably likely to be assessed civil penalties under any Anti-Money Laundering/Anti-Terrorism Laws, or (iv) has had any of its funds seized or forfeited in an action under any Anti-Money Laundering/Anti-Terrorism Laws.  The Company has established procedures and controls which it reasonably believes are adequate (and otherwise comply with applicable law) to ensure that the Company and each Controlled Entity is and will continue to be in compliance in all material respects with applicable Anti-Money Laundering/Anti-Terrorism Laws.

12

(d) (1) Neither the Company nor any Controlled Entity (i) has been charged with, or convicted of bribery or any other anti-corruption related activity under any applicable law or regulation in a U.S. or any non-U.S. country or jurisdiction, including but not limited to, the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act 2010 (collectively, “Anti-Corruption Laws”), (ii) to the Company’s knowledge, is under investigation by any U.S. or non-U.S. Governmental Authority for possible violation of Anti-Corruption Laws, (iii) has been assessed civil or criminal penalties under any Anti-Corruption Laws or (iv) has been or is the target of sanctions imposed by the United Nations or the European Union;
(2) To the Company’s knowledge, neither the Company nor any Controlled Entity has, within the last five years, directly or indirectly offered, promised, given, paid or authorized the offer, promise, giving or payment of anything of value to a Governmental Official or a commercial counterparty for the purposes of: (i) influencing any act, decision or failure to act by such Governmental Official in his or her official capacity or such commercial counterparty, (ii) inducing a Governmental Official to do or omit to do any act in violation of the Governmental Official’s lawful duty, or (iii) inducing a Governmental Official or a commercial counterparty to use his or her influence with a government or governmental instrumentality to affect any act or decision of such government or entity; in each case in order to obtain, retain or direct business or to otherwise secure an improper advantage in violation of any applicable law or regulation or which would cause any holder to be in violation of any law or regulation applicable to such holder; and
(3) No part of the proceeds from the sale of the Notes hereunder will be used by the Company, any Controlled Entity or any of their respective officers, employees or authorized representatives, directly or, to the knowledge of the Company, indirectly, for any illegal payments, including bribes, to any Governmental Official or commercial counterparty in order to obtain, retain or direct business or obtain any improper advantage in violation of law.  The Company has established procedures and controls which it reasonably believes are adequate (and otherwise comply with applicable law) to ensure that the Company and each Controlled Entity is and will continue to be in compliance in all material respects with applicable Anti-Corruption Laws.

5.17. Status under Certain Statutes.
Neither the Company nor any Subsidiary is an “investment company” registered or required to be registered under the Investment Company Act of 1940, as amended, or is subject to regulation under the Public Utility Holding Company Act of 2005, as amended, the ICC Termination Act of 1995, as amended, or the Federal Power Act, as amended.

13

5.18. Environmental Matters.
(a) Neither the Company nor any Subsidiary has knowledge of any liability or has received any notice of any liability, and no proceeding has been instituted raising any liability against the Company or any of its Subsidiaries or any of their respective real properties now or formerly owned, leased or operated by any of them, or other assets, alleging any damage to the environment or violation of any Environmental Laws, except, in each case, such as would not reasonably be expected to result in a Material Adverse Effect.
(b) Neither the Company nor any Subsidiary has knowledge of any facts which would give rise to any liability, public or private, of violation of Environmental Laws or damage to the environment emanating from, occurring on or in any way related to real properties now or formerly owned, leased or operated by any of them or to other assets or their use, except, in each case, such as would not reasonably be expected to result in a Material Adverse Effect.
(c) Neither the Company nor any of its Subsidiaries has stored any Hazardous Materials on real properties now or formerly owned, leased or operated by any of them or has disposed of any Hazardous Materials in each case in a manner contrary to any Environmental Laws in each case in any manner that would reasonably be expected to result in a Material Adverse Effect.
(d) All buildings on all real properties now owned, leased or operated by the Company or any of its Subsidiaries are in compliance with applicable Environmental Laws, except where failure to comply would not reasonably be expected to result in a Material Adverse Effect.

5.19. Notes Rank Pari Passu.
The obligations of the Company in respect of the Notes rank at least pari passu in right of payment with all other Senior Debt (actual or contingent) of the Company, including, without limitation, all Senior Debt of the Company described in Schedule 5.15 hereto.

6. REPRESENTATIONS OF THE PURCHASER.

6.1. Purchase for Investment.
Each Purchaser severally represents that it is purchasing the Notes for its own account or for one or more separate accounts maintained by it or for the account of one or more pension or trust funds and not with a view to the distribution thereof, provided that the disposition of such Purchaser’s or such pension or trust funds’ property shall at all times be within such Purchaser’s or such pension or trust funds’ control.  Each Purchaser understands that the Notes have not been 
14

registered under the Securities Act (or, to the extent applicable, the Financial Instruments and Exchange Act) and may be resold only if registered pursuant to the provisions of the Securities Act (or, to the extent applicable, the Financial Instruments and Exchange Act), or if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption is required by law, and that the Company is not required to, and the Company has no intent to, register the Notes.  Each Purchaser further represents and warrants that such Purchaser will not sell, transfer or otherwise dispose of the Notes or any interest therein except in a transaction exempt from or not subject to the registration requirements of the Securities Act and in accordance with the restrictions set forth in Section 14.2 and the legend set forth on the certificates evidencing the Notes.  

6.2. Accredited Investor.
Each Purchaser represents that it is an “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act) acting for its own account (and not for the account of others) or as a fiduciary or agent for others (which others are also “accredited investors”).  Each Purchaser further represents that such Purchaser has had the opportunity to ask questions of the Company and received answers to its satisfaction concerning the terms and conditions of the sale of the Notes.

6.3. Source of Funds.
Each Purchaser severally represents that at least one of the following statements is an accurate representation as to each source of funds (a “Source”) to be used by such Purchaser to pay the purchase price of the Notes to be purchased by such Purchaser hereunder:
(a) the Source is an “insurance company general account” (as the term is defined in the United States Department of Labor’s Prohibited Transaction Exemption (“PTE”) 95-60) in respect of which the reserves and liabilities (as defined by the annual statement for life insurance companies approved by the NAIC (the “NAIC Annual Statement”)) for the general account contract(s) held by or on behalf of any employee benefit plan together with the amount of the reserves and liabilities for the general account contract(s) held by or on behalf of any other employee benefit plans maintained by the same employer (or affiliate thereof as defined in PTE 95-60) or by the same employee organization in the general account do not exceed 10% of the total reserves and liabilities of the general account (exclusive of separate account liabilities) plus surplus as set forth in the NAIC Annual Statement filed with such Purchaser’s state of domicile; or
(b) the Source is a separate account that is maintained solely in connection with such Purchaser’s fixed contractual obligations under which the amounts payable, or credited, to any employee benefit plan (or its related trust) that has any interest in such separate account (or to any participant or beneficiary of such plan (including any annuitant)) are not affected in any manner by the investment performance of the separate account; or

15

(c) the Source is either (i) an insurance company pooled separate account, within the meaning of PTE 90-1 or (ii) a bank collective investment fund, within the meaning of the PTE 91-38 and, except as disclosed by such Purchaser to the Company in writing pursuant to this clause (c), no employee benefit plan or group of plans maintained by the same employer or employee organization beneficially owns more than 10% of all assets allocated to such pooled separate account or collective investment fund; or
(d) the Source constitutes assets of an “investment fund” (within the meaning of Part VI of PTE 84-14 (the “QPAM Exemption”)) managed by a “qualified professional asset manager” or “QPAM” (within the meaning of Part VI of the QPAM Exemption), no employee benefit plan’s assets that are managed by the QPAM in such investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an affiliate (within the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization and managed by such QPAM, represent more than 20% of the total client assets managed by such QPAM, the conditions of Part I(c) and (g) of the QPAM Exemption are satisfied, neither the QPAM nor a person controlling or controlled by the QPAM maintains an ownership interest in the Company that would cause the QPAM and the Company to be “related” within the meaning of Part VI(h) of the QPAM Exemption and (i) the identity of such QPAM and (ii) the names of any employee benefit plans whose assets in the investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an affiliate (within the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization, represent 10% or more of the assets of such investment fund, have been disclosed to the Company in writing pursuant to this clause (d);or
(e) the Source constitutes assets of a “plan(s)” (within the meaning of Part IV(h) of PTE 96-23 (the “INHAM Exemption”)) managed by an “in-house asset manager” or “INHAM” (within the meaning of Part IV(a) of the INHAM Exemption), the conditions of Part I(a), (g) and (h) of the INHAM Exemption are satisfied, neither the INHAM nor a person controlling or controlled by the INHAM (applying the definition of “control” in Part IV(d)(3) of the INHAM Exemption) owns a 10% or more interest in the Company and (i) the identity of such INHAM and (ii) the name(s) of the employee benefit plan(s) whose assets constitute the Source have been disclosed to the Company in writing pursuant to this clause (e); or
(f) the Source is a governmental plan; or
(g) the Source is one or more employee benefit plans, or a separate account or trust fund comprised of one or more employee benefit plans, each of which has been identified to the Company in writing pursuant to this clause (g); or
(h) the Source does not include assets of any employee benefit plan, other than a plan exempt from the coverage of ERISA.

16

As used in this Section 6.3, the terms “employee benefit plan,” “governmental plan,” and “separate account” shall have the respective meanings assigned to such terms in section 3 of ERISA.

6.4. Denomination of Notes.
Each Purchaser resident in Japan or who was solicited to subscribe for the Notes in Japan or subscribed for the Notes in Japan (a “Japan Purchaser”) hereby acknowledges and confirms that:
(a) the Company has notified such Japan Purchaser that no securities registration statement for a public offering has been filed or will be filed under the provisions of Article 4, Paragraph 1 of the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as amended) (the “Financial Instruments and Exchange Act” or the “FIEA”);
(b) the Notes will be offered in Japan as a “Small Number Private Placement” (Shouninzu Shibo) pursuant to Article 2, Paragraph 3, Item 2(c) of the FIEA and Article 1-7 of the Order for Enforcement of the Financial Instruments and Exchange Act (“Order for Enforcement of FIEA”); provided, however, that if a Japan Purchaser is a “Qualified Institutional Investor” (Tekikaku Kikan Toushika) as defined under Article 2, Paragraph 3, Item 1 of the FIEA and Article 10, Paragraph 1 of the Cabinet Office Ordinance regarding Definitions under Article 2 of the FIEA (Ministry of Finance Ordinance No. 14 of 1993, as amended) (a “Qualified Institutional Investor”) and such solicitation for Notes is conducted in the manner whereby such Japan Purchaser has agreed not to transfer its Notes to anyone other than a Qualified Institutional Investor pursuant to Article 1-4, Item 3 of the Order for Enforcement of FIEA, then such Japan Purchaser is excluded from being counted within the number of offerees permitted under the Small Number Private Placement;
(c) if such Japan Purchaser (x) is a Qualified Institutional Investor at the time that it subscribed for or acquired Notes and (y) is excluded from being counted within the number of investors and offerees permitted under the Small Number Private Placement, such Japan Purchaser agrees to (i) maintain its status as a Qualified Institutional Investor during the time it holds Notes, and (ii) directly or indirectly, not sell, exchange, assign, mortgage, hypothecate, pledge or otherwise transfer its Notes (or any interest therein), in whole or in part, to any person other than a Qualified Institutional Investor;
(d) if such Japan Purchaser is not a Qualified Institutional Investor or is a Qualified Institutional Investor that elects to be counted as a non-Qualified Institutional Investor within the Small Number Private Placement, such Japan Purchaser acknowledges and agrees that such Japan Purchaser (x) will not transfer the Notes held by it to anyone except in the case such Japan Purchaser transfers such Notes to a single party in a block transfer and (y) will not transfer such Notes if such transfer will result in 
17

the limitation on the number of investors and offerees being exceeded or the requirements otherwise specified in the applicable FIEA regulations governing a Small Number Private Placement being violated; and
(e) any transferees of Notes from such Japan Purchaser will be required to agree to comply with the foregoing transfer restrictions and at the time of the transfer of such Notes, the transferor must provide written notification to the transferee of the foregoing transfer restrictions and of the fact that no securities registration statement has been filed or will be filed under Article 4, Paragraph 1 of the FIEA.

7. INFORMATION AS TO COMPANY.

7.1. Financial and Business Information.
The Company shall deliver to each Purchaser (until the Closing) and each holder of Notes that is an Institutional Investor:
(a) Quarterly Statements — within the earlier of (x) 60 days after the end of each quarterly fiscal period in each fiscal year of the Company (other than the last quarterly fiscal period of each such fiscal year) and (y) the date by which such financial statements are required to be delivered under the RCF or the date on which such corresponding financial statements are delivered under the RCF if such delivery occurs earlier than such required delivery date,
(i) a consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarter, and
(ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its Subsidiaries, for such quarter and (in the case of the second and third quarters) for the portion of the fiscal year ending with such quarter,
setting forth in each case in comparative form the figures for the corresponding periods in the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP applicable to quarterly financial statements generally, and certified by a Senior Financial Officer as fairly presenting, in all material respects, the financial position of the companies being reported on and their results of operations and cash flows, subject to changes resulting from year-end adjustments, provided that filing (and providing each holder of Notes that is an Institutional Investor written notice of such filing) with the SEC within the time period specified above of the Company’s Quarterly Report on Form 10‐Q prepared in compliance with the requirements therefor shall be deemed to satisfy the requirements of this Section 7.1(a);
(b) Annual Statements — within the earlier of (x) 105 days after the end of each fiscal year of the Company and (y) the date by which such financial statements are 
18

required to be delivered under the RCF or the date on which such corresponding financial statements are delivered under the RCF if such delivery occurs earlier than such required delivery date,
(i) a consolidated balance sheet of the Company and its Subsidiaries, as at the end of such year, and
(ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its Subsidiaries, for such year,
setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP, and accompanied by an opinion thereon (without a “going concern” or similar qualification or exception and without any qualification or exception as to the scope of the audit on which such opinion is based) of independent certified public accountants of recognized national standing, which opinion shall state that such financial statements present fairly, in all material respects, the financial position of the companies being reported upon and their results of operations and cash flows and have been prepared in conformity with GAAP, and that the examination of such accountants in connection with such financial statements has been made in accordance with generally accepted auditing standards, and that such audit provides a reasonable basis for such opinion in the circumstances, provided that filing (and providing each holder of Notes that is an Institutional Investor written notice of such filing) with the SEC within the time period specified above of the Company’s Annual Report on Form 10‐K for such fiscal year (together with the Company’s annual report to shareholders, if any, prepared pursuant to Rule 14a‐3 under the Exchange Act) prepared in accordance with the requirements therefor shall be deemed to satisfy the requirements of this Section 7.1(b);
(c) [Reserved;]
(d) SEC and Other Reports — except for filings referred to in Sections 7.1(a) and 7.1(b) above, promptly after the sending or filing thereof, one copy of each report that the Company sends to any of its securityholders, and one copy of each report and registration statement that the Company or any Subsidiary publicly files with the SEC or any national securities exchange, provided that filing (and providing written notice of such filing) with the SEC such report shall be deemed to satisfy the requirements of this Section 7.1(d);
(e) Notice of Default or Event of Default — promptly, and in any event within five Business Days after a Responsible Officer becomes aware of the existence of any Default or Event of Default or that any Person has given any notice or taken any action with respect to a claimed default hereunder or that any Person has given any notice or taken any action with respect to a claimed default of the type referred to in Section 11(g), 
19

a written notice specifying the nature and period of existence thereof and what action the Company is taking or proposes to take with respect thereto;
(f) ERISA Matters — promptly, and in any event within five Business Days after a Responsible Officer becomes aware of any of the following, a written notice setting forth the nature thereof and the action, if any, that the Company or an ERISA Affiliate proposes to take with respect thereto:
(i) with respect to any Plan, any reportable event, as defined in Section 4043(c) of ERISA and the regulations thereunder, for which notice thereof has not been waived pursuant to such regulations as in effect on the date thereof; or
(ii) the taking by the PBGC of steps to institute, or the threatening by the PBGC of the institution of, proceedings under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Plan, or the receipt by the Company or any ERISA Affiliate of a notice from a Multiemployer Plan that such action has been taken by the PBGC with respect to such Multiemployer Plan; or
(iii) any event, transaction or condition that would result in the incurrence of any liability by the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or the imposition of a penalty or excise tax under the provisions of the Code relating to employee benefit plans, or the imposition of any Lien on any of the rights, properties or assets of the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or such penalty or excise tax provisions, if such liability or Lien, taken together with any other such liabilities or Liens then existing, would reasonably be expected to have a Material Adverse Effect;
(g) Notices from Governmental Authority — promptly, and in any event within 30 days of receipt thereof, copies of any notice to the Company or any Subsidiary from any federal or state Governmental Authority relating to any order, ruling, statute or other law or regulation that would reasonably be expected to have a Material Adverse Effect; and
(h) Requested Information — with reasonable promptness, such other data and information relating to the business, operations, affairs, financial condition, assets or properties of the Company or any of its Subsidiaries or relating to the ability of the Company to perform its obligations hereunder and under the Notes as from time to time may be reasonably requested by any Purchaser (prior to the Closing) or holder of Notes that is an Institutional Investor and if provided by the Company, would not violate any applicable laws, regulations or rules.

20

7.2. Officer’s Certificate.
At the time each set of financial statements is required to be delivered (or deemed to have been delivered) to a Purchaser (prior to the Closing) or a holder of Notes that is an Institutional Investor pursuant to Section 7.1(a) or Section 7.1(b) hereof, the Company shall deliver to such Purchaser or holder a certificate of a Senior Financial Officer setting forth:
(a) Covenant Compliance — the information required in order to establish whether the Company was in compliance with the requirements of Section 10.1 through Section 10.6 and Section 10.9 hereof, inclusive, during (or, with respect to Section 10.1, as of the end of) the quarterly or annual period covered by the financial statements then being furnished (including with respect to each such Section, where applicable, the calculations of the maximum or minimum amount, ratio or percentage, as the case may be, permissible under the terms of such Sections, and the calculation of the amount, ratio or percentage then in existence); and
(b) Event of Default — a statement that such officer has reviewed the relevant terms hereof and such review shall not have disclosed the existence during the quarterly or annual period covered by the statements then being furnished of any condition or event that constitutes a Default or an Event of Default or, if any such condition or event existed or exists, specifying the nature and period of existence thereof and what action the Company shall have taken or proposes to take with respect thereto.

7.3. Visitation.  
The Company shall permit the representatives of each Purchaser (prior to the Closing) and each holder of Notes that is an Institutional Investor:
(a) No Default — if no Default or Event of Default then exists, at the expense of such Purchaser or such holder and upon reasonable prior notice to the Company, to visit the principal executive office of the Company, to discuss the affairs, finances and accounts of the Company and its Subsidiaries with the Company’s officers, and (with the consent of the Company, which consent will not be unreasonably withheld) its independent public accountants, and (with the consent of the Company, which consent will not be unreasonably withheld) to visit the other offices and properties of the Company and each Subsidiary, all at such reasonable times and as often as may be reasonably requested in writing; and
(b) Default — if a Default or Event of Default then exists, at the expense of the Company, to visit and inspect any of the offices or properties of the Company or any Subsidiary, to examine all their respective books of account, records, reports and other papers, to make copies and extracts therefrom, and to discuss their respective affairs, finances and accounts with their respective officers and independent public accountants (and by this provision the Company authorizes said accountants to discuss the affairs, finances and accounts of the Company and its Subsidiaries), all at such times and as often as may be requested.

21

For the avoidance of doubt, it is understood that Section 21 applies to Confidential Information obtained in connection with the exercise by any holder of Notes of the rights set forth in this Section 7.3.

7.4. Electronic Delivery.
Financial statements, opinions of independent certified public accountants, other information and Officer’s Certificates that are required to be delivered by the Company pursuant to Sections 7.1(a), (b) or (d) and Section 7.2 shall be deemed to have been delivered upon the satisfaction of any of the following requirements with respect thereto:
(a) such financial statements satisfying the requirements of Section 7.1(a) or Section 7.1(b) and related Officer’s Certificate satisfying the requirements of Section 7.2 are delivered to each Purchaser (prior to the Closing) or each holder of Notes by e-mail at the e-mail address set forth in such holder’s Purchaser Schedule or as communicated from time to time in a separate writing delivered to the Company;
(b) the Company shall have timely filed such Form 10–Q or Form 10–K, satisfying the requirements of Section 7.1(a) or Section 7.1(b), as the case may be, with the SEC on EDGAR and shall have made such form and the related Officer’s Certificate satisfying the requirements of Section 7.2 available on its website on the internet, which is located at http://www.dentsplysirona.com as of the date of this Agreement;
(c) such financial statements satisfying the requirements of Section 7.1(a) or Section 7.1(b) and related Officer’s Certificate satisfying the requirements of Section 7.2 are timely posted by or on behalf of the Company on IntraLinks or on any other similar website to which each holder of Notes has free access; or
(d) the Company shall have filed any of the items referred to in Section 7.1(d) with the SEC on EDGAR and shall have made such items available on its website on the internet or on IntraLinks or on any other similar website to which each holder of Notes has free access;
provided however, that in the case of clauses (b) or (c), the Company shall have given each holder of Notes prior or concurrent written notice, which may be by e-mail or in accordance with Section 19, of such posting or filing in connection with each delivery, provided further, that upon request of any holder to receive paper copies of such forms, financial statements and Officer’s Certificates or to receive them by e-mail, the Company will promptly e-mail them or deliver such paper copies, as the case may be, to such holder.

8. PAYMENT OF THE NOTES.

22

8.1. Required Prepayments.
As provided therein, the entire unpaid principal balance of each Note shall be due and payable on the Maturity Date thereof.

8.2. Optional Prepayments with Make-Whole Amount.
The Company may, at its option, upon notice as provided below, prepay at any time all, or from time to time any part of, the Notes that are Swapped Notes or the Notes that are Non-Swapped Notes, in an amount not less than 10% of the original aggregate principal amount of such Notes in the case of a partial prepayment, at 100% of the principal amount so prepaid, together with interest accrued thereon to, but not including, the date of such prepayment, plus the applicable Make-Whole Amount determined for the prepayment date with respect to such principal amount, plus any Net Loss with respect to any Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any Swapped Note.  The Company will give each holder of Notes written notice of each optional prepayment under this Section 8.2 not less than 30 days and not more than 60 days prior to the date fixed for such prepayment.  Each such notice shall specify such date (which shall be a Business Day), the aggregate principal amount of the Notes to be prepaid on such date, the principal amount of each Note held by such holder to be prepaid (determined in accordance with Section 8.5), and the interest to be paid on the prepayment date with respect to such principal amount being prepaid, and shall be accompanied by a certificate of a Senior Financial Officer as to the estimated Make-Whole Amount due in connection with such prepayment (calculated as if the date of such notice were the date of the prepayment), setting forth the details of such computation.  Two Business Days prior to such prepayment, the Company shall deliver to each holder of Notes a certificate of a Senior Financial Officer specifying the calculation of such Make-Whole Amount as of the specified prepayment date.  

8.3. Prepayment of Notes Upon Change of Control.
(a) Notice of Change of Control.  The Company will, within 5 Business Days after any Senior Financial Officer has knowledge of the occurrence of any Change of Control, give written notice of such Change of Control to each holder of Notes.  If a Change of Control has occurred, such notice shall contain and constitute an offer by the Company to prepay Notes as described in subparagraph (c) of this Section 8.3 and shall be accompanied by the certificate described in subparagraph (g) of this Section 8.3.
(b) [Reserved.]
(c) Offer to Prepay Notes.  The offer to prepay Notes contemplated by subparagraph (a) of this Section 8.3 shall be an offer to prepay, in accordance with and subject to this Section 8.3, all, but not less than all, the Notes held by each holder of Notes (in this case only, “holder of Notes” in respect of any Note registered in the name of a nominee for a disclosed beneficial owner shall mean such beneficial owner) on a date specified in such offer (the “Proposed Prepayment Date”), which date shall be not less than thirty (30) days and not more than one hundred twenty (120) days after the date of 
23

such offer (if the Proposed Prepayment Date shall not be specified in such offer, the Proposed Prepayment Date shall be the first Business Day after the 60th day after the date of such offer).
(d) Acceptance/Rejection.  A holder of Notes may accept the offer to prepay made pursuant to this Section 8.3 by causing a notice of such acceptance to be delivered to the Company not later than fifteen (15) days after receipt by such holder of the most recent offer of prepayment.  A failure by a holder of Notes to respond to an offer to prepay made pursuant to this Section 8.3 shall be deemed to constitute a rejection of such offer by such holder of Notes.
(e) Prepayment.  Prepayment of the Notes to be prepaid pursuant to this Section 8.3 shall be at 100% of the principal amount of such Notes, together with interest on such Notes accrued to, but not including, the date of prepayment, plus any Net Loss with respect to any Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any Swapped Note, but without any Make-Whole Amount or penalty or premium of any kind.  The prepayment shall be made on the Proposed Prepayment Date except as provided in subparagraph (f) of this Section 8.3.
(f) Deferral Pending Change of Control.  The obligation of the Company to prepay Notes pursuant to the offers required by subparagraph (c) and accepted in accordance with subparagraph (d) of this Section 8.3 is subject to the occurrence of the Change of Control in respect of which such offers and acceptances shall have been made.  In the event that such Change of Control has not occurred on the Proposed Prepayment Date in respect thereof, the prepayment shall be deferred until, and shall be made on, the date on which such Change of Control occurs; provided, however, that if the Change of Control has not occurred within 45 days after the original Proposed Prepayment Date, any holder of Notes may withdraw its acceptance and the Company shall again comply with this Section 8.3 as to such Change of Control with respect to such withdrawing holder.  The Company shall keep each holder of Notes reasonably and timely informed of (i) any such deferral of the date of prepayment, (ii) the date on which such Change of Control and the prepayment are expected to occur, and (iii) any determination by the Company that efforts to effect such Change of Control have ceased or been abandoned (in which case the offers and acceptances made pursuant to this Section 8.3 in respect of such Change of Control shall be deemed rescinded).
(g) Officer’s Certificate.  Each offer to prepay the Notes pursuant to this Section 8.3 shall be accompanied by a certificate, executed by a Senior Financial Officer of the Company and dated the date of such offer, specifying: (i) the Proposed Prepayment Date; (ii) that such offer is made pursuant to this Section 8.3; (iii) the principal amount of each Note offered to be prepaid; (iv) the interest that would be due on each Note offered to be prepaid, accrued to, but not including, the Proposed Prepayment Date (including the per diem accrual on interest for each day after the Proposed Prepayment Date, in the event of a deferral of the prepayment date pursuant to Section 8.3(f) above); (v) that the 
24

conditions to the giving of such notices in this Section 8.3 have been fulfilled; and (vi) in reasonable detail, the nature and date or proposed date of the Change of Control.

8.4. Prepayment of Notes Upon Sale of Assets.
The Company may prepay the Notes in accordance with Section 10.4.

8.5. Allocation of Partial Prepayments.
In the case of any partial prepayment of Notes pursuant to Section 8.2, the principal amount of Notes to be prepaid shall be allocated among all of the Notes that are Swapped Notes or the Notes that are Non-Swapped Notes, as applicable, being prepaid at the time outstanding in proportion, as nearly as practicable, to the respective unpaid principal amounts thereof not theretofore called for prepayment.

8.6. Maturity; Surrender, Etc.
In the case of each prepayment of Notes pursuant to this Section 8, the principal amount of each Note to be prepaid shall mature and become due and payable on the date fixed for such prepayment (which shall be a Business Day), together with interest on such principal amount accrued to, but not including, such date, plus any Net Loss with respect to any Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any Swapped Note and, in the case of any prepayment pursuant to Section 8.2, the applicable Make-Whole Amount, if any.  From and after such date, unless the Company shall fail to pay such principal amount when so due and payable, together with the interest and Make-Whole Amount, if any, plus any Net Loss with respect to any Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any Swapped Note, as aforesaid, interest on such principal amount shall cease to accrue.  Any Note paid or prepaid in full shall be surrendered to the Company and cancelled and shall not be reissued, and no Note shall be issued in lieu of any prepaid principal amount of any Note.

8.7. Purchase of Notes.
The Company will not and will not permit any controlled Affiliate to purchase, redeem, prepay or otherwise acquire, directly or indirectly, any of the outstanding Notes except (a) upon the payment or prepayment of the Notes in accordance with the terms of this Agreement and the Notes or (b)  pursuant to a written offer to purchase any outstanding Notes made by the Company or an Affiliate pro rata to the holders of all Notes at the time outstanding upon the same terms and conditions.  The Company will promptly cancel all Notes acquired by it or any controlled Affiliate, pursuant to any payment, prepayment or purchase of such Notes pursuant to any provision of this Agreement and no Notes may be issued in substitution or exchange for any such Notes.

25

8.8. Prepayment in Connection with a Noteholder Sanctions Event.
(a) Upon the Company’s receipt of notice from any Affected Noteholder that a Noteholder Sanctions Event has occurred (which notice shall refer specifically to this Section 8.8 and describe in reasonable detail such Noteholder Sanctions Event), the Company shall promptly, and in any event within 10 Business Days, make an offer (the “Sanctions Prepayment Offer”) to prepay the entire unpaid principal amount of Notes issued by the Company and held by such Affected Noteholder (the “Affected Notes”), together with interest thereon to, but not including, the prepayment date selected by the Company with respect to each Affected Note, plus any Net Loss with respect to any Affected Note that is a Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any such Swapped Note, but without payment of any Make-Whole Amount with respect thereto, which prepayment shall be on a Business Day not less than 30 days and not more than 60 days after the date of the Sanctions Prepayment Offer (the “Sanctions Prepayment Date”).  Such Sanctions Prepayment Offer shall provide that such Affected Noteholder notify the Company in writing by a stated date (the “Sanctions Prepayment Response Date”), which date is not later than 10 Business Days prior to the stated Sanctions Prepayment Date, of its acceptance or rejection of such prepayment offer.  If such Affected Noteholder does not notify the Company as provided above, then the holder shall be deemed to have accepted such offer.
(b) Subject to the provisions of subparagraphs (c) and (d) of this Section 8.8, the Company shall prepay on the Sanctions Prepayment Date the entire unpaid principal amount of the Affected Notes held by such Affected Noteholder who has accepted (or has been deemed to have accepted) such prepayment offer (in accordance with subparagraph (a)), together with interest thereon to, but not including, the Sanctions Prepayment Date with respect to each such Affected Note, but without payment of any Make-Whole Amount with respect thereto.
(c) If a Noteholder Sanctions Event has occurred but the Company and/or its Controlled Entities have taken such action(s) in relation to their activities so as to remedy such Noteholder Sanctions Event (with the effect that a Noteholder Sanctions Event no longer exists, as reasonably determined by such Affected Noteholder) prior to the Sanctions Prepayment Date, then the Company shall no longer be obliged or permitted to prepay such Affected Notes in relation to such Noteholder Sanctions Event.  If the Company and/or its Controlled Entities shall undertake any actions to remedy any such Noteholder Sanctions Event, the Company shall keep the holders of Notes reasonably and timely informed of such actions and the results thereof.
(d) If any Affected Noteholder that has given written notice to the Company of its acceptance of (or has been deemed to have accepted) the Company’s prepayment offer in accordance with subparagraph (a) also gives notice to the Company prior to the relevant Sanctions Prepayment Date that it has determined (in its sole discretion) that it requires clearance from any Governmental Authority in order to receive a prepayment pursuant to this Section 8.8, the principal amount of each Affected Note issued by the 
26

Company and held by such Affected Noteholder, together with interest accrued thereon to, but not including, the date of prepayment, shall become due and payable on the later to occur of (but in no event later than the Maturity Date of the relevant Note) (i) such Sanctions Prepayment Date and (ii) the date that is 10 Business Days after such Affected Noteholder gives notice to the Company that it is entitled to receive a prepayment pursuant to this Section 8.8 (which may include payment to an escrow account designated by such Affected Noteholder to be held in escrow for the benefit of such Affected Noteholder until such Affected Noteholder obtains such clearance from such Governmental Authority), and in any event, any such delay in accordance with the foregoing clause (ii) shall not be deemed to give rise to any Default or Event of Default.
(e) Promptly, and in any event within 5 Business Days, after the Company’s receipt of notice from any Affected Noteholder that a Noteholder Sanctions Event shall have occurred with respect to such Affected Noteholder, the Company shall forward a copy of such notice to each other holder of Notes.
(f) The Company shall promptly, and in any event within 10 Business Days, give written notice to the holders of Notes after the Company or any Controlled Entity having been notified that (i) its name appears or is reasonably likely in the future to appear on a State Sanctions List or (ii) it is in violation of, or is the target of, any U.S. Economic Sanctions, in each case which notice shall describe the facts and circumstances thereof and set forth the action, if any, that the Company or a Controlled Entity proposes to take with respect thereto.
(g) The foregoing provisions of this Section 8.8 shall be in addition to any rights or remedies available to any holder of Notes that may arise under this Agreement as a result of the occurrence of a Noteholder Sanctions Event; provided, that, if the Notes shall have been declared due and payable pursuant to Section 12.1 as a result of the events, conditions or actions of either the Company or any of its Controlled Entities that gave rise to a Noteholder Sanctions Event, the remedies set forth in Section 12 shall control.

8.9. [Reserved.]

8.10. Make-Whole Amount.
(a) Make-Whole Amount with respect to Non-Swapped Notes.  The term “Make-Whole Amount” means, with respect to any Non-Swapped Note, an amount equal to the excess, if any, of the Discounted Value of the Remaining Scheduled Payments with respect to the Called Principal of such Non-Swapped Note over the amount of such Called Principal, provided that the Make-Whole Amount may in no event be less than zero. For the purposes of determining the Make-Whole Amount with respect to any Non-Swapped Note, the following terms have the following meanings:

27

“Called Principal” means, with respect to any Non-Swapped Note, the principal of such Non-Swapped Note that is to be prepaid pursuant to Section 8.2 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires.
“Discounted Value” means, with respect to the Called Principal of any Non-Swapped Note, the amount obtained by discounting all Remaining Scheduled Payments with respect to such Called Principal from their respective scheduled due dates to the Settlement Date with respect to such Called Principal, in accordance with accepted financial practice and at a discount factor (applied on the same periodic basis as that on which interest on such Non-Swapped Note is payable) equal to the Reinvestment Yield with respect to such Called Principal.
“Implied Rate Yen Yield” means, with respect to the Called Principal of any Non-Swapped Note, the yield to maturity implied by (i) the ask-side yields reported as of 10:00 a.m. (New York City time) on the second Business Day preceding the Settlement Date with respect to such Called Principal, on the display designated as Bloomberg Financial Markets News Screen BTMM-JN (or such other display as may replace such Bloomberg Financial Markets News Screen) for the most recently issued actively traded Japanese government bonds (“Reported”) having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date, or (ii) if such yields are not Reported as of such time or the yields reported are not ascertainable, the average of the ask-side yields for the most recently issued actively traded Japanese government bonds having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date, as determined by Recognized Yen Market Makers. Such implied yield to maturity will be determined, if necessary, by (a) converting Japanese government bond quotations to bond equivalent yields in accordance with accepted financial practice and (b) interpolating linearly between the ask-side yields Reported for the applicable most recently issued actively traded Japanese government bonds with the maturities (1) closest to and greater than the Remaining Average Life and (2) closest to and less than the Remaining Average Life. The Implied Rate Yen Yield shall be rounded to the number of decimal places as appears in the interest rate of the applicable Non-Swapped Note.
“Non-Swapped Note” means any Note other than a Swapped Note.
“Recognized Yen Market Makers” means internationally recognized dealers of Japanese government bonds selected by the holders of at least a majority in principal amount of the Notes at the time outstanding (exclusive of Notes then owned by the Company or any of its Affiliates and any Notes held by parties who are contractually required to abstain from voting with respect to matters affecting the holders of the Notes).

28

“Reinvestment Yield” means, with respect to the Called Principal of any Non-Swapped Note, the sum of (x) 0.50% plus (y) the Implied Rate Yen Yield. The Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of the applicable Non-Swapped Note.
 “Remaining Average Life” means, with respect to any Called Principal, the number of years obtained by dividing (i) such Called Principal into (ii) the sum of the products obtained by multiplying (a) the principal component of each Remaining Scheduled Payment with respect to such Called Principal by (b) the number of years, computed on the basis of a 360-day year comprised of twelve 30-day months and calculated to two decimal places, that will elapse between the Settlement Date with respect to such Called Principal and the scheduled due date of such Remaining Scheduled Payment.
“Remaining Scheduled Payments” means, with respect to the Called Principal of any Non-Swapped Note, all payments of such Called Principal and interest thereon that would be due after the Settlement Date with respect to such Called Principal if no payment of such Called Principal were made prior to its scheduled due date, provided that if such Settlement Date is not a date on which interest payments are due to be made under such Non-Swapped Note, then the amount of the next succeeding scheduled interest payment will be reduced by the amount of interest accrued to such Settlement Date and required to be paid on such Settlement Date pursuant to Section 8.2 or Section 12.1.
“Settlement Date” means, with respect to the Called Principal of any Non-Swapped Note, the date on which such Called Principal is to be prepaid pursuant to Section 8.2 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires.
(b) Make-Whole Amount with respect to Swapped Notes.  The terms “Make-Whole Amount” means, with respect to any Swapped Note, an amount equal to the excess, if any, of the Swapped Note Discounted Value with respect to the Swapped Note Called Notional Amount related to such Swapped Note over such Swapped Note Called Notional Amount, provided that the Make-Whole Amount may in no event be less than zero. All payments of Make-Whole Amount in respect of any Swapped Note shall be made in Dollars. For the purposes of determining the Make-Whole Amount, Net Loss, Net Gain or Swap Breakage Amount with respect to any Swapped Note, the following terms have the following meanings:
“New Swap Agreement” means any cross-currency swap agreement  pursuant to which the holder of a Swapped Note is to receive payment in Dollars and which is entered into in full or partial replacement of an Original Swap Agreement as a result of such Original Swap Agreement having terminated for any reason other than a non-scheduled prepayment or a repayment of such Swapped Note prior to its scheduled maturity. The terms of a New Swap 
29

Agreement with respect to any Swapped Note do not have to be identical to those of the Original Swap Agreement with respect to such Swapped Note. 
“Original Swap Agreement” means, with respect to any Swapped Note, (x) a cross-currency swap agreement and annexes and schedules thereto (an “Initial Swap Agreement”) that is entered into on an arm's length basis by the original purchaser of such Swapped Note (or any affiliate thereof) in connection with the execution of this Agreement and the purchase of such Swapped Note and relates to the scheduled payments by the Company of interest and principal on such Swapped Note, under which the holder of such Swapped Note is to receive payments from the counterparty thereunder in Dollars and which is more particularly described on Schedule 8.10 or in a side letter delivered by the original purchaser of such Swapped Note to the Company on or prior to the Closing Date, (y) any Initial Swap Agreement that has been assumed by or novated to (without any waiver, amendment, deletion or replacement of any material economic term or provision thereof) a holder of a Swapped Note in connection with a transfer of such Swapped Note and (z) any Replacement Swap Agreement; and a “Replacement Swap Agreement” means, with respect to any Swapped Note, a cross-currency swap agreement and annexes and schedules thereto with payment terms and provisions (other than a reduction in notional amount, if applicable) identical to those of the Initial Swap Agreement with respect to such Swapped Note that is entered into on an arm's length basis by the holder of such Swapped Note in full or partial replacement (by amendment, modification or otherwise) of such Initial Swap Agreement (or any subsequent Replacement Swap Agreement) in a notional amount not exceeding the outstanding principal amount of such Swapped Note following a non-scheduled prepayment or a repayment of such Swapped Note prior to its scheduled maturity. Any holder of a Swapped Note that enters into, assumes or terminates an Initial Swap Agreement or Replacement Swap Agreement shall within a reasonable period of time thereafter deliver to the Company a copy of the confirmation, assumption, novation or termination related thereto.
“Swap Note Agreement” means, with respect to any Swapped Note, an Original Swap Agreement or a New Swap Agreement, as the case may be.
“Swapped Note” means any Note that as of the date of the Closing for such Note is subject to a Swap Note Agreement. A “Swapped Note” shall no longer be deemed a “Swapped Note” at such time as the related Swap Note Agreement ceases to be in force in respect thereof. 
“Swapped Note Called Accrued Interest Amount” means, with respect to a Swapped Note, the accrued interest of such Swapped Note to the Swapped Note Settlement Date that is to be prepaid or has become immediately due and payable, as the context requires.

30

“Swapped Note Called Notional Accrued Interest Amount” means, with respect to any Swapped Note Called Notional Amount, the payment due to the holder of the related Swapped Note under the terms of the Swap Note Agreement to which such holder is a party attributable to and in exchange for the Swapped Note Called Accrued Interest Amount.
“Swapped Note Called Notional Amount” means, with respect to any Swapped Note Called Principal of any Swapped Note, the payment in Dollars due to the holder of such Swapped Note under the terms of the Swap Note Agreement to which such holder is a party, attributable to and in exchange for such Swapped Note Called Principal and assuming that such Swapped Note Called Principal is paid on its scheduled maturity date, provided that if such Swap Note Agreement is not an Initial Swap Agreement, then the “Swapped Note Called Notional Amount” in respect of such Swapped Note shall not exceed the amount in Dollars which would have been due to the holder of such Swapped Note under the terms of the Initial Swap Agreement to which such holder was a party (or if such holder was never party to an Initial Swap Agreement, then the last Initial Swap Agreement to which the most recent predecessor in interest to such holder as a holder of such Swapped Note was a party), attributable to and in exchange for such Swapped Note Called Principal and assuming that such Swapped Note Called Principal is paid on its scheduled maturity date.
“Swapped Note Called Principal” means, with respect to any Swapped Note, the principal of such Swapped Note that is to be prepaid pursuant to Section 8 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires.
“Swapped Note Discounted Value” means, with respect to the Swapped Note Called Notional Amount of any Swapped Note that is to be prepaid pursuant to Section 8 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires, the amount obtained by discounting all Swapped Note Remaining Scheduled Swap Payments corresponding to the Swapped Note Called Notional Amount of such Swapped Note from their respective scheduled due dates to the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount, in accordance with accepted financial practice and at a discount factor (applied on the same periodic basis as that on which interest on such Swapped Note is payable) equal to the Swapped Note Reinvestment Yield with respect to such Swapped Note Called Notional Amount.
“Swapped Note Reinvestment Yield” means, with respect to the Swapped Note Called Notional Amount of any Swapped Note, the sum of (x) 0.50% plus (y) the yield to maturity implied by the “Ask Yield(s)” reported as of 10.00 a.m. (New York City time) on the second Business Day preceding the Swapped Note Settlement Date with respect to such Swapped Note Called 
31

Notional Amount, on the display designated as “Page PX1” (or such other display as may replace Page PX1) on Bloomberg Financial Markets for the most recently issued actively traded on-the-run U.S. Treasury securities (“Reported”) having a maturity equal to the Swapped Note Remaining Average Life of such Swapped Note Called Notional Amount as of such Swapped Note Settlement Date. If there are no such U.S. Treasury securities Reported having a maturity equal to such Swapped Note Remaining Average Life, then such implied yield to maturity will be determined by (a) converting U.S. Treasury bill quotations to bond equivalent yields in accordance with accepted financial practice and (b) interpolating linearly between the “Ask Yields” Reported for the applicable most recently issued actively traded on-the-run U.S. Treasury securities with the maturities (1) closest to and greater than such Swapped Note Remaining Average Life and (2) closest to and less than such Swapped Note Remaining Average Life.
If such yields are not Reported or the yields Reported as of such time are not ascertainable (including by way of interpolation), then “Swapped Note Reinvestment Yield” means, with respect to the Swapped Note Called Notional Amount of any Swapped Note, the sum of (x) 0.50% plus (y) the yield to maturity implied by the U.S. Treasury constant maturity yields reported for the latest day for which such yields have been so reported as of the second Business Day preceding the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount, in Federal Reserve Statistical Release H.15 (or any comparable successor publication) for the U.S. Treasury constant maturity having a term equal to the Swapped Note Remaining Average Life of such Swapped Note Called Notional Amount as of such Swapped Note Settlement Date. If there is no such U.S. Treasury constant maturity having a term equal to such Swapped Note Remaining Average Life, such implied yield to maturity will be determined by interpolating linearly between (1) the U.S. Treasury constant maturity so reported with the term closest to and greater than such Swapped Note Remaining Average Life and (2) the U.S. Treasury constant maturity so reported with the term closest to and less than such Swapped Note Remaining Average Life. The Swapped Note Reinvestment Yield shall be rounded to the number of decimal places as appears in the interest rate of the applicable Swapped Note.
“Swapped Note Remaining Average Life” means, with respect to any Swapped Note Called Notional Amount, the number of years (calculated to the nearest one-twelfth year) obtained by dividing (a) such Swapped Note Called Notional Amount into (b) the sum of the products obtained by multiplying (i) the principal component of each Swapped Note Remaining Scheduled Swap Payment with respect to such Swapped Note Called Notional Amount by (ii) the number of years, computed on the basis of a 360-day year comprised of twelve 30-day months and calculated to two decimal places, that will elapse between the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount and the scheduled due date of such Swapped Note Remaining Scheduled Swap Payment.

32

“Swapped Note Remaining Scheduled Swap Payments” means, with respect to the Swapped Note Called Notional Amount relating to any Swapped Note, the payments due to the holder of such Swapped Note in Dollars under the terms of the Swap Note Agreement to which such holder is a party which correspond to all payments of the Swapped Note Called Principal of such Swapped Note corresponding to such Swapped Note Called Notional Amount and interest on such Swapped Note Called Principal (other than that portion of the payment due under such Swap Note Agreement corresponding to the interest accrued on the Swapped Note Called Principal to the Swapped Note Settlement Date) that would be due after the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount assuming that no payment of such Swapped Note Called Principal is made prior to its originally scheduled payment date, provided that if such Swapped Note Settlement Date is not a date on which an interest payment is due to be made under the terms of such Swapped Note, then the amount of the next succeeding scheduled interest payment will be reduced by the amount of interest accrued to such Swapped Note Settlement Date and required to be paid on such Swapped Note Settlement Date pursuant to Section 8 or Section 12.1.
“Swapped Note Settlement Date” means, with respect to the Swapped Note Called Notional Amount of any Swapped Note Called Principal of any Swapped Note, the date on which such Swapped Note Called Principal is to be prepaid pursuant to Section 8 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires.

8.11. Swap Breakage.
If any Swapped Note is prepaid pursuant to Section 8.2, Section 8.3, Section 8.4 or Section 8.8 or purchased pursuant to Section 8.7, or has become or is declared to be immediately due and payable pursuant to Section 12.1, then (a) any resulting Net Loss in connection therewith shall be reimbursed to the holder of such Swapped Note by the Company in Dollars upon any such prepayment or repayment of such Swapped Note and (b) any resulting Net Gain in connection therewith shall be deducted (i) from the Make-Whole Amount, if any, or any principal or interest to be paid to the holder of such Swapped Note by the Company upon any such prepayment of such Swapped Note pursuant to Section 8.2, Section 8.3, Section 8.4 or Section 8.8 or purchased pursuant to Section 8.7 or (ii) from the Make-Whole Amount, if any, to be paid to the holder of such Swapped Note by the Company upon any such repayment of such Swapped Note pursuant to Section 12.1, provided that the Make-Whole Amount in respect of such Swapped Note may in no event be less than zero. Each holder of a Swapped Note shall be responsible for calculating its own Net Loss or Net Gain, as the case may be, and Swap Breakage Amount in Dollars upon the prepayment or repayment of all or any portion of such Swapped Note, and such calculations as reported to the Company in reasonable detail shall be binding on the Company absent demonstrable error.

33

As used in this Agreement with respect to any Swapped Note that is prepaid or accelerated: “Net Loss” means the amount, if any, by which the total of the Swapped Note Called Notional Amount and the Swapped Note Called Notional Accrued Interest Amount exceeds the sum of (x) the total of the Swapped Note Called Principal and the Swapped Note Called Accrued Interest Amount plus (or minus in the case of an amount paid) (y) the Swap Breakage Amount received (or paid) by the holder of such Swapped Note; and “Net Gain” means the amount, if any, by which the total of the Swapped Note Called Notional Amount and the Swapped Note Called Notional Accrued Interest Amount is exceeded by the sum of (x) the total of the Swapped Note Called Principal and the Swapped Note Called Accrued Interest Amount plus (or minus in the case of an amount paid) (y) the Swap Breakage Amount received (or paid) by such holder. For purposes of any determination of any “Net Loss” or “Net Gain,” the Swapped Note Called Principal and the Swapped Note Called Accrued Interest Amount shall be determined by the holder of the affected Swapped Note by converting Yen into Dollars at the current Yen/Dollar exchange rate as determined as of 10:00 a.m. (New York City time) on the day such Swapped Note is prepaid or accelerated as indicated on the applicable screen of Bloomberg Financial Markets or the Reuters Screen, respectively, and any such calculation shall be reported to the Company in reasonable detail and shall be binding on the Company absent demonstrable error.
As used in this Agreement, “Swap Breakage Amount” means, with respect to the Swap Note Agreement associated with any Swapped Note, in determining the Net Loss or Net Gain, the Dollar amount that would be received (in which case the Swap Breakage Amount shall be positive) or paid (in which case the Swap Breakage Amount shall be negative) by the holder of such Swapped Note as if such Swap Note Agreement had terminated due to the occurrence of an event of default or an early termination under the ISDA 1992 Multi-Currency Cross Border Master Agreement or ISDA 2002 Master Agreement, as applicable (the “ISDA Master Agreement”); provided, however, that if such holder (or its predecessor in interest with respect to such Swapped Note) was, but is not at the time, a party to an Original Swap Agreement but is a party to a New Swap Agreement, then the Swap Breakage Amount shall mean the lesser of (x) the gain or loss (if any) which would have been received or incurred (by payment, through offset or netting or otherwise) by the holder of such Swapped Note under the terms of the Original Swap Agreement (if any) in respect of such Swapped Note to which such holder (or any affiliate thereof) was a party (or if such holder was never a party to an Original Swap Agreement, then the last Original Swap Agreement to which the most recent predecessor in interest to such holder as a holder of a Swapped Note was a party) and which would have arisen as a result of the payment of the Swapped Note Called Principal on the Swapped Note Settlement Date and (y) the gain or loss (if any) actually received or incurred by the holder of such Swapped Note, in connection with the payment of such Swapped Note Called Principal on the Swapped Note Settlement Date, under the terms of the New Swap Agreement to which such holder (or any affiliate thereof) is a party. The holder of such Swapped Note will make all calculations related to the Swap Breakage Amount in good faith and in accordance with its customary practices for calculating such amounts under the ISDA Master Agreement pursuant to which such Swap Note Agreement shall have been entered into and assuming for the purpose of such calculation that there are no other transactions entered into pursuant to such ISDA Master Agreement (other than such Swap Note Agreement).

34

The Swap Breakage Amount shall be payable in Dollars. 

9. AFFIRMATIVE COVENANTS.
From the date of this Agreement until the Closing and thereafter, the Company covenants that so long as any of the Notes are outstanding:

9.1. Compliance with Law.
Without limiting Section 10.7, the Company will, and will cause each of its Subsidiaries to, comply with all laws, ordinances or governmental rules or regulations to which each of them is subject, including, without limitation, ERISA, Environmental Laws, the USA PATRIOT Act and the other laws and regulations that are referred to in Section 5.16, and will obtain and maintain in effect all licenses, certificates, permits, franchises and other governmental authorizations necessary to the ownership of their respective properties or to the conduct of their respective businesses, in each case to the extent necessary to ensure that non-compliance with such laws, ordinances or governmental rules or regulations or failures to obtain or maintain in effect such licenses, certificates, permits, franchises and other governmental authorizations would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

9.2. Insurance.
The Company will, and will cause each of its Subsidiaries to, maintain, with financially sound and reputable insurers, insurance with respect to their respective properties and businesses against such casualties and contingencies, of such types, on such terms and in such amounts (including deductibles, co-insurance and self-insurance, if adequate reserves are maintained with respect thereto) as is customary in the case of entities of established reputations engaged in the same or a similar business and similarly situated, except for any non-maintenance that would not reasonably be expected to have a Material Adverse Effect.

9.3. Maintenance of Properties.
The Company will, and will cause each of its Subsidiaries to, maintain and keep, or cause to be maintained and kept, their respective properties in good repair, working order and condition (other than ordinary wear and tear), so that the business carried on in connection therewith may be conducted in the ordinary course at all times, provided that this Section shall not prevent the Company or any Subsidiary from discontinuing the operation and the maintenance of or disposing of any of its properties if such discontinuance or disposal is desirable in the conduct of its business and the Company has concluded that such discontinuance or disposal would not, individually or in the aggregate, (i) reasonably be expected to have a Material Adverse Effect or (ii) would not violate the limitations set forth in Sections 10.4 and 10.5 hereof.

35

9.4. Payment of Taxes and Claims.
The Company will, and will cause each of its Subsidiaries to, file all tax returns required to be filed in any jurisdiction and to pay and discharge all taxes shown to be due and payable on such returns and all other taxes, assessments, governmental charges, or levies imposed on them or any of their properties, assets, income or franchises, to the extent such taxes and assessments have become due and payable and before they have become delinquent and all claims for which sums have become due and payable that have or might become a Lien on properties or assets of the Company or any Subsidiary not permitted by Section 10.3, provided that neither the Company nor any Subsidiary need pay any such tax or assessment or claims if (i) the amount, applicability or validity thereof is contested by the Company or such Subsidiary on a timely basis in good faith and in appropriate proceedings, and the Company or a Subsidiary has established adequate reserves therefor in accordance with GAAP on the books of the Company or such Subsidiary or (ii) the non-filing or nonpayment, as the case may be, of any such taxes and assessments in the aggregate would not reasonably be expected to have a Material Adverse Effect.

9.5. Corporate Existence, Etc.
Subject to Sections 10.4 and 10.5, the Company will at all times preserve and keep in full force and effect its corporate existence, and will at all times preserve and keep in full force and effect the corporate existence of each of its Subsidiaries unless, in the good faith judgment of the Company, the termination of or failure to preserve and keep in full force and effect such corporate existence would not, individually or in the aggregate, have a Material Adverse Effect.

9.6. [Reserved.]

9.7. Notes to Rank Pari Passu.
The Notes and all other obligations under this Agreement of the Company are and at all times shall remain direct obligations of the Company ranking at least pari passu in right of payment with all other Notes from time to time issued by the Company and outstanding hereunder without any preference among themselves and at least pari passu in right of payment with all Debt outstanding under the Principal Credit Facilities and all other present and future Debt (actual or contingent) of the Company which is not expressed to be subordinate or junior in rank to any other Debt of the Company.  

9.8. Subsidiary Guarantors.
(a) The Company will cause each of its Domestic Subsidiaries that guarantees, or otherwise becomes liable at any time as a borrower or an additional 
36

borrower or co-borrower for or in respect of, any Debt under any Principal Credit Facility, to deliver to each of the holders of Notes (concurrently therewith) the following items:
(i) a duly executed Subsidiary Guaranty in scope, form and substance reasonably satisfactory to the Required Holders;
(ii) a certificate signed by an authorized Responsible Officer of the Company making representations and warranties to the effect of those contained in Sections 5.4, 5.6 and 5.7, with respect to such Domestic Subsidiary and the Subsidiary Guaranty, as applicable; and
(iii) an opinion of counsel (who may be in-house counsel for the Company) addressed to each of the holders of the Notes reasonably satisfactory to the Required Holders, to the effect that the Subsidiary Guaranty by such Person has been duly authorized, executed and delivered and that the Subsidiary Guaranty constitutes the legal, valid and binding contract and agreement of such Person enforceable in accordance with its terms, except as an enforcement of such terms may be limited by bankruptcy, insolvency, fraudulent conveyance and similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles.
(b) At the election of the Company and by written notice to each holder of Notes, any Subsidiary Guarantor may be discharged from all of its obligations and liabilities under its Subsidiary Guaranty and shall be automatically released from its obligations thereunder without the need for the execution or delivery of any document by the holders, provided that (i) if such Subsidiary Guarantor is a guarantor in respect of any Principal Credit Facility, such Subsidiary Guarantor has been released and discharged (or will be released and discharged concurrently with the release of such Subsidiary Guarantor under its Subsidiary Guaranty) under all such Principal Credit Facilities, (ii) at the time of, and after giving effect to, such release and discharge, no Default or Event of Default shall be existing, (iii) no amount is then due and payable under such Subsidiary Guaranty, (iv) if in connection with such Subsidiary Guarantor being released and discharged under any Principal Credit Facility, any fee or other form of consideration is given to any holder of Debt under such Principal Credit Facility for such release or discharge, the holders of Notes shall receive equivalent consideration substantially concurrently therewith and (v) each holder shall have received a certificate of a Responsible Officer certifying as to the matters set forth in clauses (i) through (iv).  In the event of any such release, for purposes of Section 10.9, all Debt of such Subsidiary shall be deemed to have been incurred concurrently with such release.

9.9. Books and Records.
The Company will, and will cause each of its Subsidiaries to, maintain in all material respects proper books of record and account in conformity with GAAP (or with respect to any 
37

Subsidiary organized and operating in a jurisdiction other than the United States of America, in conformity to such jurisdiction’s generally accepted accounting principles) and all applicable requirements of any Governmental Authority having legal or regulatory jurisdiction over the Company or such Subsidiary, as the case may be.
If the Company fails to comply with any provision of Section 9 on or after the date of this Agreement and prior to the Closing and such a failure is continuing at the time of the Closing, then any of the Purchasers may elect not to purchase the Notes on the date of Closing that is specified in Section 3.

10. NEGATIVE COVENANTS.
From the date of this Agreement until the Closing and thereafter, the Company covenants that so long as any of the Notes are outstanding:

10.1. Financial Covenants.
(a) Leverage Ratio.  The Company will not, as of the last day of any fiscal quarter, permit the ratio of (i) Consolidated Debt of the Company and its Subsidiaries as of such date to (ii) the sum of (A) Consolidated Debt of the Company and its Subsidiaries as of such date plus (B) Consolidated Net Worth as of such date to exceed 0.60 to 1.00.
(b) Interest Coverage Ratio.  The Company will not permit the ratio of (i) Consolidated EBITDA of the Company and its Subsidiaries for the consecutive four fiscal quarter period ended as of the last day of any fiscal quarter of the Company to (ii) the sum of interest payable on, and amortization of debt discount in respect of, Debt of the Company and its Subsidiaries during such period (calculated on a Pro Forma Basis to the extent a Material Acquisition or Material Disposition occurred during such period), to be less than 3.00 to 1.00. 

10.2. [Reserved.]

10.3. Limitation on Liens
The Company will not create or suffer to exist, or permit any of its Subsidiaries to create or suffer to exist, any Lien on or with respect to any of its properties, whether now owned or hereafter acquired, other than:

(a)            Permitted Liens;

(b)           Liens securing purchase money Debt or Debt with respect to Capital Leases incurred to finance the acquisition, repair, construction, improvement or lease of capital 
38

assets in an aggregate principal amount not to exceed $300,000,000 outstanding at any one time; provided that (i) such Liens shall be created within 365 days of the acquisition, repair, construction, improvement or lease, as applicable, of the related property and (ii) such Liens do not at any time encumber any property other than the property being financed or improved by such Debt;
(c)            Liens existing on the date hereof and disclosed on Schedule 10.3 hereof;

(d)           Liens on property of a Person existing at the time such Person is merged into or consolidated with the Company or any Subsidiary of the Company or becomes a Subsidiary of the Company or Liens assumed by the Company or a Subsidiary in connection with an acquisition of assets by the Company or such Subsidiary in an acquisition permitted hereunder; provided that such Liens were not created in contemplation of such merger, consolidation, acquisition or such Person becoming a Subsidiary and do not extend to any assets other than those of the Person so merged into or consolidated with the Company or which becomes a Subsidiary or is acquired by the Company or a Subsidiary;

(e)            any replacement, extension or renewal of any Lien permitted by clauses (b), (c) or (d) of this Section 10.3, provided that (i) no additional property shall be encumbered by such Liens and (ii) the principal amount of Debt secured by such Lien immediately prior to such replacement, extension or renewal shall not be increased; and 

(f)            other Liens securing Debt of the Company or any Subsidiary, provided that the sum (without duplication) of (i) the aggregate outstanding principal amount of Debt secured by all such Liens pursuant to this clause (f) plus (ii) the aggregate outstanding principal amount of Debt pursuant to Section 10.9(k) shall not at any time exceed 15% of Consolidated Net Worth (determined as of the end of the then most recently ended fiscal quarter of the Company for which financial statements have been delivered pursuant to Section 7.1(a) or Section 7.1(b)), provided further, that notwithstanding the foregoing, the Company shall not, and shall not permit any of its Subsidiaries to, secure pursuant to this Section 10.3(f) any Debt outstanding under or pursuant to any Principal Credit Facility unless and until the Notes (and any guaranty delivered in connection therewith) shall concurrently be secured equally and ratably with such Debt pursuant to documentation reasonably acceptable to the Required Holders in substance and in form, including, without limitation, an intercreditor agreement and opinions of counsel to the Company and/or any such Subsidiary, as the case may be, from counsel that is reasonably acceptable to the Required Holders.

10.4. Sales of Assets.
The Company will not, and will not permit any Subsidiary to, sell, lease or otherwise dispose of any substantial part (as defined below) of the assets of the Company and its Subsidiaries; provided, however, that the Company or any Subsidiary may sell, lease or otherwise dispose of assets constituting a substantial part of the assets of the Company and its Subsidiaries if, at such time and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing and an amount equal to the net proceeds received from such sale, lease or other disposition (but only with respect to that portion of such assets that exceeds 
39

the definition of “substantial part” set forth below) shall be used within 365 days of such sale, lease or disposition, in any combination:
(1) to acquire operating assets used or useful in carrying on the business of the Company and its Subsidiaries and having a value at least equal to the value of such assets sold, leased or otherwise disposed of (but only with respect to that portion of such assets that exceeds the definition of “substantial part” set forth below); and/or
(2) to prepay or retire Senior Debt of the Company and/or its Subsidiaries, provided that (i) the Company shall offer to prepay each outstanding Note in a principal amount which equals the Ratable Portion for such Note, and (ii) any such prepayment of the Notes shall be made at par, together with accrued interest thereon to, but not including, the date of such prepayment, plus any Net Loss with respect to any Swapped Note and, subject to Section 8.11, less any Net Gain with respect to any Swapped Note, but without the payment of the Make-Whole Amount, if any.  Any offer of prepayment of the Notes pursuant to this Section 10.4 shall be given to each holder of the Notes by written notice that shall be delivered not less than fifteen (15) days and not more than sixty (60) days prior to the proposed prepayment date.  Each such notice shall state that it is given pursuant to this Section and Section 8.4 of this Agreement, that the offer set forth in such notice must be accepted by such holder in writing and shall also set forth (i) the prepayment date, (ii) a description of the circumstances which give rise to the proposed prepayment and (iii) a calculation of the Ratable Portion for such holder’s Notes.  Each holder of the Notes which desires to have its Notes prepaid shall notify the Company in writing delivered not less than five (5) Business Days prior to the proposed prepayment date of its acceptance of such offer of prepayment.  The Company shall prepay on the prepayment date the Ratable Portion of Notes held by each holder of Notes that has accepted such offer, together with accrued interest thereon.
As used in this Section 10.4, a sale, lease or other disposition of assets shall be deemed to be a “substantial part” of the assets of the Company and its Subsidiaries if the book value of such assets, when added to the book value of all other assets sold, leased or otherwise disposed of by the Company and its Subsidiaries during the period beginning on the first day of the 12th complete calendar month preceding the date of such sale, lease or other disposition and ending on such date, exceeds 15% of the book value of Consolidated Total Assets, determined as of the end of the fiscal quarter immediately preceding such sale, lease or other disposition; provided that there shall be excluded from any determination of a “substantial part” (i) any sale or disposition of assets in the ordinary course of business of the Company and its Subsidiaries, (ii) any transfer of assets from the Company to any Subsidiary or from any Subsidiary to the Company or a Subsidiary, (iii) any sale or transfer of property acquired by the Company or any Subsidiary after the date of this Agreement to any Person within 365 days following the acquisition or construction of such property by the Company or any Subsidiary if the Company or a Subsidiary shall concurrently with such sale or transfer, lease such property, as lessee, (iv) 
40

any sale or disposition of obsolete, worn-out, uneconomical or surplus assets and (v) foreclosures on, or condemnations of, assets.

10.5. Merger and Consolidation.
The Company will not, and will not permit any of its Subsidiary Guarantors to, consolidate with or merge with any other Person or convey, transfer or lease all or substantially all of its assets as an entirety in a single transaction or series of transactions to any Person, unless:
(a) in the case of any such transaction involving the Company, either the Company is the surviving Person or the successor formed by such consolidation or the survivor of such merger or the Person that acquires by conveyance, transfer or lease all or substantially all of the assets of the Company as an entirety, as the case may be, (i) shall be a solvent corporation or limited liability company organized and existing under the laws of the United States or any state thereof (including the District of Columbia), (ii) shall have executed and delivered to each holder of any Notes its assumption of the due and punctual performance and observance of each covenant and condition of this Agreement and the Notes and (iii) shall have caused to be delivered to each holder of any Notes an opinion of nationally recognized independent counsel, or other independent counsel reasonably satisfactory to the Required Holders, to the effect that all agreements or instruments effecting such assumption hereunder are enforceable in accordance with their terms and comply with the terms hereof;
(b) in the case of any such transaction involving a Subsidiary Guarantor, the successor formed by such consolidation or the survivor of such merger or the Person that acquires by conveyance, transfer or lease all or substantially all of the assets of such Subsidiary Guarantor as an entirety, as the case may be, shall be (i) the Company, such Subsidiary Guarantor or another Subsidiary Guarantor; (ii) a solvent corporation or limited liability company (other than the Company or another Subsidiary Guarantor) that is organized and existing under the laws of the United States or any state thereof (including the District of Columbia) or the jurisdiction of organization of such Subsidiary Guarantor, provided that such corporation or limited liability company, to the extent not the Subsidiary Guarantor, shall have executed and delivered to each holder of Notes its assumption of the due and punctual performance and observance of each covenant and condition of the Subsidiary Guaranty of such Subsidiary Guarantor, and (B) the Company shall have caused to be delivered to each holder of Notes an opinion of nationally recognized independent counsel in the appropriate jurisdiction(s), or other independent counsel reasonably satisfactory to the Required Holders, to the effect that all agreements or instruments effecting such assumption hereunder are enforceable in accordance with their terms and comply with the terms hereof; or (iii) any other Person so long as the transaction is treated as a disposition of all of the assets of such Subsidiary Guarantor for purposes of Section 10.4 and, based on such characterization, would be permitted pursuant to Section 10.4; 

41

(c) each Subsidiary Guarantor under any Subsidiary Guaranty that is outstanding at the time such transaction or each transaction in such a series of transactions occurs reaffirms its obligations under such Subsidiary Guaranty in writing at such time pursuant to documentation that is reasonably acceptable to the Required Holders; and
(d) immediately before and immediately after giving effect to such transaction or each transaction in any such series of transactions, no Default or Event of Default shall have occurred and be continuing.
No such conveyance, transfer or lease of substantially all of the assets of the Company or any Subsidiary Guarantor shall have the effect of releasing the Company or such Subsidiary Guarantor, as the case may be, or any successor corporation or limited liability company that shall theretofore have become such in the manner prescribed in this Section 10.5, from its liability under (x) this Agreement or the Notes (in the case of the Company) or (z) the Subsidiary Guaranty (in the case of any Subsidiary Guarantor), unless, in the case of the conveyance, transfer or lease of substantially all of the assets of a Subsidiary Guarantor, such Subsidiary Guarantor is released from its Subsidiary Guaranty in accordance with Section 9.8(b) in connection with or immediately following such conveyance, transfer or lease.

10.6. Transactions with Affiliates.
The Company will not and will not permit any Subsidiary to enter into directly or indirectly any Material transaction or Material group of related transactions (including, without limitation, to the extent Material, the purchase, lease, sale or exchange of properties of any kind or the rendering of any service) with any Affiliate (other than the Company or another Subsidiary), except upon fair and reasonable terms that are not materially less favorable, taken as a whole, to the Company or such Subsidiary than would be obtainable in a comparable arm’s-length transaction with a Person not an Affiliate; provided, that the foregoing restriction shall not apply to any of the following: (a) reasonable and customary fees paid to members of the board of directors (or similar governing body) of the Company and its Subsidiaries; (b) compensation arrangements (including severance arrangements to the extent approved by a majority of the disinterested members of the Company’s or the applicable Subsidiary’s board of directors (or similar governing body) or the applicable committee thereof) for present or former officers and other employees entered into in the ordinary course of business; (c) indemnities provided for the benefit of directors, officers or employees of the Company and its Subsidiaries in the ordinary course of business; and (d) loans and advances to employees of the Company and its Subsidiaries permitted hereunder, in each case under this clause (d), solely to the extent consistent with past practices and in the ordinary course of business.  As used herein, “Material” shall mean an amount equal to at least 5% of book value of the consolidated assets of the Company and its Subsidiaries.

42

10.7. Terrorism Sanctions Regulations.
Neither the Company will nor will it permit any Controlled Entity to (a) become (including by virtue of being owned or controlled by a Blocked Person), own or control a Blocked Person or (b) directly or indirectly have any investment in or engage in any dealing or transaction (including any investment, dealing or transaction involving the proceeds of the Notes) with any Person if such investment, dealing or transaction (i) would be in violation of any U.S. Economic Sanctions applicable to the Company or such Controlled Entity, or (ii) would result in the imposition of any U.S. Economic Sanctions against the Company or such Controlled Entity, except, in the case of this clause (b), to the extent that such violation or sanctions, if imposed, could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

10.8. Line of Business.
The Company will not and will not permit any Subsidiary to engage in any business if, as a result, the general nature of the business in which the Company and its Subsidiaries, taken as a whole, would then be engaged would be substantially changed from the general nature of the business in which the Company and its Subsidiaries, taken as a whole, are engaged on the date of this Agreement.

10.9. Subsidiary Debt.
The Company will not permit any of its Subsidiaries to create or suffer to exist any Debt other than:
(a) Debt owed to the Company or any other Subsidiary of the Company;
(b) Debt existing on the date hereof and disclosed on Schedule 10.9 hereof;
(c) purchase money Debt or Debt with respect to Capital Leases incurred to finance the acquisition, repair, construction, improvement or lease of capital assets in an aggregate principal amount not to exceed $300,000,000 outstanding at any one time;
(d) Debt of any Subsidiary Guarantor (so long as the requirements of Section 9.8 shall have been met);
(e) endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;
(f) Debt of a Person existing at the time such Person is merged into or consolidated with the Company or any Subsidiary of the Company or becomes a Subsidiary of the Company or Debt of any Person that is assumed by a Subsidiary in connection with an acquisition of assets by such Subsidiary in an acquisition permitted hereunder, provided that such Debt shall not have been incurred in contemplation of such 
43

merger, consolidation or acquisition or such Person becoming a Subsidiary of the Company;
(g) Debt with respect to Swap Agreements incurred in the ordinary course of business and not for speculative purposes;
(h) Debt under bid bonds, performance bonds, surety bonds, bonds to secure statutory obligations (including obligations under workers compensation, unemployment insurance and other social security legislation) and similar obligations, in each case, incurred by such Subsidiaries in the ordinary course of business, including guarantees or obligations with respect to letters of credit supporting such bid bonds, performance bonds, surety bonds and similar obligations;
(i) Debt deemed to exist in connection with agreements providing for indemnification, adjustment of purchase price, deferred purchase price, escrow arrangements, earn-outs or similar obligations, or from guaranties, surety bonds or performance bonds securing the performance of the Company or any of its Subsidiaries pursuant to such agreements, in connection with acquisitions or dispositions permitted hereunder;
(j) Debt which serves to extend, replace, refund, renew, defease or refinance any Debt incurred under clause (b) or clause (f) of this Section 10.9 that does not increase the outstanding principal amount thereof (other than with respect to unpaid accrued interest and premiums (including tender premiums) thereon, any committed or undrawn amounts, defeasance costs, underwriting discounts, fees, commissions and expenses associated with such Debt); and
(k) additional Debt, provided that the sum (without duplication) of (i) the aggregate outstanding principal amount of Debt pursuant to this clause (k) plus (ii) the aggregate outstanding principal amount of Debt secured by Liens pursuant to Section 10.3(f) shall not at any time exceed 15% of Consolidated Net Worth (determined as of the end of the then most recently ended fiscal quarter of the Company for which financial statements have been provided pursuant to Section 7.1(a) or Section 7.1(b)).
Prior to the Closing, if the Company fails to comply with any provision of Section 10 before or after giving effect to the issuance of the Notes on a pro forma basis, and if such a failure is continuing at the time of the Closing, then any of the Purchasers may elect not to purchase its Notes on the date of Closing that is specified in Section 3.

11. EVENTS OF DEFAULT.
An “Event of Default” shall exist if any of the following conditions or events shall occur and be continuing:

44

(a) the Company defaults in the payment of any principal or Make-Whole Amount or Net Loss, if any, on any Note when the same becomes due and payable, whether at maturity or at a date fixed for prepayment or by declaration or otherwise; or
(b) the Company defaults in the payment of any interest on any Note for more than five Business Days after the same becomes due and payable; or
(c) (i) the Company defaults in the performance of or compliance with any term contained in Section 10 or (ii) any Subsidiary Guarantor defaults in the performance of or compliance with any term of the Subsidiary Guaranty beyond any period of grace or cure period provided with respect thereto; or
(d) the Company defaults in the performance of or compliance with any term contained herein (other than those referred to in paragraphs (a), (b) and (c) of this Section 11) and such default is not remedied within 30 days after the earlier of (i) a Responsible Officer obtaining actual knowledge of such default and (ii) the Company receiving written notice of such default from any holder of a Note (any such written notice to be identified as a “notice of default” and to refer specifically to this paragraph (d) of Section 11); or
(e) any Subsidiary Guaranty ceases to be a legally valid, binding and enforceable obligation or contract of a Subsidiary Guarantor, or any Subsidiary Guarantor challenges the validity, binding nature or enforceability of any such Subsidiary Guaranty; or
(f) any representation or warranty made in writing by or on behalf of the Company or any Subsidiary Guarantor in this Agreement or any Subsidiary Guaranty or by any officer of the Company or any Subsidiary Guarantor in any writing furnished in connection with the transactions contemplated hereby or by any Subsidiary Guaranty proves to have been false or incorrect in any material respect on the date as of which made; or
(g) (i) the Company, any Material Subsidiary or any Subsidiary Guarantor is in default (as principal or as guarantor or other surety) in the payment of any principal of or premium or make-whole amount or interest (in the payment amount of at least $100,000) on any Debt other than the Notes that is outstanding in an aggregate principal amount of at least $100,000,000 beyond any period of grace provided with respect thereto, or (ii) the Company, any Material Subsidiary or any Subsidiary Guarantor is in default in the performance of or compliance with any term of any instrument, mortgage, indenture or other agreement relating to any Debt other than the Notes in an aggregate principal amount of at least $100,000,000 or any other condition exists, and as a consequence of such default or condition such Debt has become, or has been declared (or, after any applicable grace period, one or more Persons are entitled to declare such Debt to be), due and payable, or (iii) as a consequence of the occurrence or continuation of any event or condition (other than the passage of time or the right of the holder of Debt to convert such Debt into equity interests or a prepayment or redemption required solely as 
45

a result of the proceeds of such Debt not having been applied to consummate a transaction or toward any other purpose for which such Debt was incurred), (x) the Company, any Material Subsidiary or any Subsidiary Guarantor has become obligated to purchase or repay Debt other than the Notes before its regular maturity or before its regularly scheduled dates of payment in an aggregate outstanding principal amount of at least $100,000,000 or (y) after any applicable grace period, one or more Persons have the right to require the Company or any Subsidiary so to purchase or repay such Debt; or
(h) the Company, any Material Subsidiary or any Subsidiary Guarantor (i) is generally not paying, or admits in writing its inability to pay, its debts as they become due, (ii) files, or consents by answer or otherwise to the filing against it of, a petition for relief or reorganization or arrangement or any other petition in bankruptcy, for liquidation or to take advantage of any bankruptcy, insolvency, reorganization, moratorium or other similar law of any jurisdiction, (iii) makes an assignment for the benefit of its creditors, (iv) consents to the appointment of a custodian, receiver, trustee or other officer with similar powers with respect to it or with respect to any substantial part of its property, (v) is adjudicated as insolvent or to be liquidated, or (vi) takes corporate action for the purpose of any of the foregoing; or
(i) a court or other Governmental Authority of competent jurisdiction enters an order appointing, without consent by the Company, any Material Subsidiary or any Subsidiary Guarantor, a custodian, receiver, trustee or other officer with similar powers with respect to it or with respect to any substantial part of its property, or constituting an order for relief or approving a petition for relief or reorganization or any other petition in bankruptcy or for liquidation or to take advantage of any bankruptcy or insolvency law of any jurisdiction, or ordering the dissolution, winding-up or liquidation of the Company, any Material Subsidiary or any Subsidiary Guarantor, or any such petition shall be filed against the Company, any Material Subsidiary or any Subsidiary Guarantor and such petition shall not be dismissed within 60 days; or
(j) [Reserved;] or
(k) a final judgment or judgments at any one time outstanding for the payment of money aggregating in excess of $100,000,000 are rendered against one or more of the Company, any Material Subsidiary or any Subsidiary Guarantor and which judgments are not, within 60 days after entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within 60 days after the expiration of such stay; or
(l) if (i) any Plan shall fail to satisfy the minimum funding standards of ERISA or the Code for any plan year or part thereof or a waiver of such standards or extension of any amortization period is sought or granted under section 412 of the Code, (ii) a notice of intent to terminate any Plan shall have been or is reasonably expected to be filed with the PBGC or the PBGC shall have instituted proceedings under section 4042 of ERISA to terminate or appoint a trustee to administer any Plan or the PBGC shall have notified the Company or any ERISA Affiliate that a Plan may become a subject of any such proceedings, (iii) the aggregate “amount of unfunded benefit liabilities” (within the 
46

meaning of section 4001(a)(18) of ERISA) under all Plans, determined in accordance with Title IV of ERISA, shall exceed $100,000,000, (iv) the Company or any ERISA Affiliate shall have incurred or is reasonably expected to incur any liability pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans, (v) the Company or any ERISA Affiliate withdraws from any Multiemployer Plan, or (vi) the Company or any Subsidiary establishes or amends any employee welfare benefit plan that provides post-employment welfare benefits in a manner that could increase the liability of the Company or any Subsidiary thereunder; and any such event or events described in clauses (i) through (vi) above, either individually or together with any other such event or events, could reasonably be expected to have a Material Adverse Effect.
As used in Section 11(l), the terms “employee benefit plan” and “employee welfare benefit plan” shall have the respective meanings assigned to such terms in Section 3 of ERISA.

12. REMEDIES ON DEFAULT, ETC.

12.1. Acceleration.
(a) If an Event of Default with respect to the Company described in paragraph (h) or (i) of Section 11 (other than an Event of Default described in clause (i) of paragraph (h) or described in clause (vi) of paragraph (h) by virtue of the fact that such clause encompasses clause (i) of paragraph (h)) has occurred, all Notes then outstanding shall automatically become immediately due and payable.
(b) If any other Event of Default has occurred and is continuing, any holder or holders of more than 50% in aggregate principal amount of the Notes at the time outstanding may at any time at its or their option, by notice or notices to the Company, declare all Notes then outstanding to be immediately due and payable.
(c) If any Event of Default described in paragraph (a) or (b) of Section 11 has occurred and is continuing with respect to any Notes, any holder or holders of Notes at the time outstanding affected by such Event of Default may at any time, at its or their option, by notice or notices to the Company, declare all the Notes held by such holder or holders to be immediately due and payable.
Upon any Notes becoming due and payable under this Section 12.1, whether automatically or by declaration, such Notes will forthwith mature and the entire unpaid principal amount of such Notes, plus (i) all accrued and unpaid interest thereon (including, but not limited to, interest accrued thereon at the Default Rate) plus (ii) the Make-Whole Amount, if any, determined in respect of such principal amount (to the full extent permitted by applicable law) plus (iii) any Net Loss with respect to any Swapped Note, shall all be immediately due and payable, in each and every case without presentment, demand, protest or further notice, all of 
47

which are hereby waived.  The Company acknowledges, and the parties hereto agree, that each holder of a Note has the right to maintain its investment in the Notes free from repayment by the Company (except as herein specifically provided for) and that the provision for payment of a Make-Whole Amount by the Company in the event that the Notes are prepaid or are accelerated as a result of an Event of Default, is intended to provide compensation for the deprivation of such right under such circumstances.

12.2. Other Remedies.
If any Default or Event of Default has occurred and is continuing, and irrespective of whether any Notes have become or have been declared immediately due and payable under Section 12.1, the holder of any Note at the time outstanding may proceed to protect and enforce the rights of such holder by an action at law, suit in equity or other appropriate proceeding, whether for the specific performance of any agreement contained herein or in any Note or Subsidiary Guaranty, or for an injunction against a violation of any of the terms hereof or thereof, or in aid of the exercise of any power granted hereby or thereby or by law or otherwise.

12.3. Rescission.
At any time after any Notes have been declared due and payable pursuant to clause (b) or (c) of Section 12.1, the Required Holders, by written notice to the Company, may rescind and annul any such declaration and its consequences if (a) the Company has paid all overdue interest on the Notes, all principal of and Make-Whole Amount, if any, and Net Loss, if any, on such Notes that are due and payable and are unpaid other than by reason of such declaration, and all interest on such overdue principal and Make-Whole Amount and Net Loss, if any, and (to the extent permitted by applicable law) any overdue interest in respect of such Notes, at the Default Rate, (b) neither the Company nor any other Person shall have paid any amounts which have become due solely by reason of such declaration, (c) all Events of Default and Defaults, other than non-payment of amounts that have become due solely by reason of such declaration, have been cured or have been waived pursuant to Section 18, and (d) no judgment or decree has been entered for the payment of any monies due pursuant hereto or to any Notes.  No rescission and annulment under this Section 12.3 will extend to or affect any subsequent Event of Default or Default or impair any right consequent thereon.

12.4. No Waivers or Election of Remedies, Expenses, Etc.
No course of dealing and no delay on the part of any holder of any Note in exercising any right, power or remedy shall operate as a waiver thereof or otherwise prejudice such holder’s rights, powers or remedies.  No right, power or remedy conferred by this Agreement, any Subsidiary Guaranty or by any Note upon any holder thereof shall be exclusive of any other right, power or remedy referred to herein or therein or now or hereafter available at law, in equity, by statute or otherwise.  Without limiting its obligations under Section 16, the Company will pay to the holder of each Note on demand such further amount as shall be sufficient to cover 
48

all costs and expenses of such holder incurred in any enforcement or collection under this Section 12, including, without limitation, reasonable attorneys’ fees, expenses and disbursements.

13. RESERVED.

14. REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES.

14.1. Registration of Notes.
The Company shall keep at its principal executive office a register for the registration and registration of transfers of all Notes.  The name and address of each holder of one or more Notes, each transfer thereof and the name and address of each transferee of one or more Notes shall be registered in such register.  Prior to due presentment for registration of transfer, the Person in whose name any Note shall be registered shall be deemed and treated as the owner and holder thereof for all purposes hereof, and the Company shall not be affected by any notice or knowledge to the contrary.  The Company shall give to any holder of a Note that is an Institutional Investor promptly upon request therefor, a complete and correct copy of the names and addresses of all registered holders of the Notes.

14.2. Transfer and Exchange of Notes.
Upon surrender of any Note to the Company at the address and to the attention of the designated officer (all as specified in Section 19(iii)), for registration of transfer or exchange (and in the case of a surrender for registration of transfer accompanied by a written instrument of transfer duly executed by the registered holder of such Note or such holder’s attorney duly authorized in writing and accompanied by the relevant name, address and other information for notices of each transferee of such Note or part thereof), within ten Business Days thereafter, the Company shall execute and deliver, at the Company’s expense (except as provided below), one or more new Notes (as requested by the holder thereof) in exchange therefor, in an aggregate principal amount equal to the unpaid principal amount of the surrendered Note.  Each such new Note shall be payable to such Person as such holder may request in accordance with this Agreement, and shall be substantially in the form of the Note originally issued hereunder.  Each such new Note shall be dated and bear interest from the date to which interest shall have been paid on the surrendered Note or dated the date of the surrendered Note if no interest shall have been paid thereon.  The Company may require payment of a sum sufficient to cover any stamp tax or governmental charge imposed in respect of any such transfer of Notes.  Notes shall not be transferred in denominations of less than ¥100,000,000, provided that if necessary to enable the registration of transfer by a holder of its entire holding of Notes, one Note may be in a denomination of less than ¥100,000,000.  Any transferee, by its acceptance of a Note registered in its name (or the name of its nominee), shall be deemed to have made the representation set forth in Section 6.3, provided, that in lieu thereof such holder may (in reliance upon information provided by the Company, which shall not be unreasonably withheld) make a representation to 
49

the effect that the purchase by any holder of any Note will not constitute a non-exempt prohibited transaction under section 406(a) of ERISA.
The Notes have not been registered under the Securities Act (or, to the extent applicable, the Financial Instruments and Exchange Act) or under the securities laws of any state and may not be transferred or resold unless registered under the Securities Act (or, to the extent applicable, the Financial Instruments and Exchange Act) and all applicable state securities laws or unless an exemption from the requirement for such registration is available.

14.3. Replacement of Notes.
Upon receipt by the Company at the address and to the attention of the designated officer (all as specified in Section 19(iii)) of evidence reasonably satisfactory to it of the ownership of and the loss, theft, destruction or mutilation of any Note (which evidence shall be, in the case of an Institutional Investor, notice from such Institutional Investor of such ownership and such loss, theft, destruction or mutilation), and
(a) in the case of loss, theft or destruction, of indemnity reasonably satisfactory to it (provided that if the holder of such Note is, or is a nominee for, an original Purchaser or another holder of a Note with a minimum net worth of at least $50,000,000 or a Qualified Institutional Buyer, such Person’s own unsecured agreement of indemnity shall be deemed to be satisfactory), or
(b) in the case of mutilation, upon surrender and cancellation thereof,
the Company at its own expense shall execute and deliver not more than five Business Days following satisfaction of such conditions, in lieu thereof, a new Note as such lost, stolen, destroyed or mutilated Notes issued by the Company, dated and bearing interest from the date to which interest shall have been paid on such lost, stolen, destroyed or mutilated Note or dated the date of such lost, stolen, destroyed or mutilated Note if no interest shall have been paid thereon.

15. PAYMENTS ON NOTES.

15.1. Place of Payment.
Subject to Section 15.2, payments of principal, Make-Whole Amount, if any, Net Loss, if any, and interest becoming due and payable on the Notes shall be made in New York, New York at the principal office of Bank of America, N.A. in such jurisdiction.  The Company may at any time, by notice to each holder of a Note, change the place of payment of such Notes so long as such place of payment shall be either the principal office of the Company in such jurisdiction or the principal office of a bank or trust company in such jurisdiction.

50

15.2. Home Office Payment.
So long as any Purchaser or such Purchaser’s nominee shall be the holder of any Note, and notwithstanding anything contained in Section 15.1 or in such Note to the contrary, the Company will pay all sums becoming due on such Note for principal, Make-Whole Amount, if any, Net Loss, if any, interest and all other amounts becoming due hereunder by the method and at the address specified for such purpose for such Purchaser on Schedule A hereto, or by such other method or at such other address as such Purchaser shall have from time to time specified to the Company in writing for such purpose, without the presentation or surrender of such Note or the making of any notation thereon, except that upon written request of the Company made concurrently with or reasonably promptly after payment or prepayment in full of any Note issued by the Company, such Purchaser shall surrender such Note for cancellation, reasonably promptly after any such request, to the Company at its principal executive office or at the place of payment most recently designated by the Company pursuant to Section 15.1.  Prior to any sale or other disposition of any Note held by any Purchaser or its nominee, such Purchaser will, at its election, either endorse thereon the amount of principal paid thereon and the last date to which interest has been paid thereon or surrender such Note to the Company in exchange for a new Note or Notes pursuant to Section 14.2.  The Company will afford the benefits of this Section 15.2 to any Institutional Investor that is the direct or indirect transferee of any Note issued by the Company and purchased by a Purchaser under this Agreement that has made the same agreement relating to such Note as the Purchasers have made in this Section 15.2.

16. EXPENSES, ETC.

16.1. Transaction Expenses.
Whether or not the transactions contemplated hereby are consummated, the Company will pay all out-of-pocket costs and expenses (including reasonable and documented attorneys’ fees of a special counsel for the Purchasers and, if reasonably required by the Required Holders, local or other counsel) reasonably incurred by each Purchaser and each other holder of a Note in connection with such transactions and in connection with any amendments, waivers or consents under or in respect of this Agreement, the Notes and any Subsidiary Guaranty (whether or not such amendment, waiver or consent becomes effective) including, without limitation: (a) the costs and expenses incurred in enforcing or defending (or determining whether or how to enforce or defend) any rights under this Agreement, the Notes or any Subsidiary Guaranty or in responding to any subpoena or other legal process or informal investigative demand issued in connection with this Agreement, the Notes or any Subsidiary Guaranty, or by reason of being a holder of any Note, (b) the costs and expenses, including financial advisors’ fees, incurred in connection with the insolvency or bankruptcy of the Company or any Subsidiary or in connection with any work-out or restructuring of the transactions contemplated hereby, by the Notes and any Subsidiary Guaranty and (c) the costs and expenses incurred in connection with the initial filing of this Agreement and all related documents and financial information with the 
51

SVO provided that such costs and expenses under this clause (c) shall not exceed $30,500.  The Company will pay, and will save each Purchaser and each other holder of a Note harmless from, (i) all claims in respect of any fees, costs or expenses if any, of brokers and finders (other than those, if any, retained by a Purchaser or other holder in connection with its purchase of the Notes) and (ii) any and all wire transfer fees that any bank deducts from any payment under such Note to such holder or otherwise charges to a holder of a Note with respect to a payment under such Note.

16.2. Survival.
The obligations of the Company under this Section 16 will survive the payment or transfer of any Note, the enforcement, amendment or waiver of any provision of this Agreement, the Notes or any Subsidiary Guaranty, and the termination of this Agreement.

17. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT.
All representations and warranties contained herein or in any certificate or other instrument delivered by or on behalf of the Company pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Notes, the purchase or transfer by any Purchaser of any such Note or portion thereof or interest therein and the payment of any Note and may be relied upon by any subsequent holder of any such Note, regardless of any investigation made at any time by or on behalf of any Purchaser or any other holder of any such Note.  Subject to the preceding sentence, this Agreement, the Notes and any Subsidiary Guaranty embody the entire agreement and understanding between the Purchasers and the Company and supersede all prior agreements and understandings relating to the subject matter hereof (other than the Company’s undertakings with respect to any swap indemnity letter, in each case issued on or about May 30, 2019, which shall survive).

18. AMENDMENT AND WAIVER.

18.1. Requirements.
This Agreement and the Notes may be amended, and the observance of any term hereof or of the Notes may be waived (either retroactively or prospectively), with (and only with) the written consent of the Company and the Required Holders, except that (a) no amendment or waiver of any of the provisions of Section 1, 2, 3, 4, 6 or 22 hereof, or any defined term (as it is used therein), will be effective as to any holder of Notes unless consented to by such holder of Notes in writing, and (b) no such amendment or waiver may, without the written consent of each holder of a Note at the time outstanding (exclusive of Notes then owned by the Company or any of its Affiliates and any Notes held by parties who are contractually required to abstain from voting with respect to matters affecting the holders of the Notes), (A) subject to the provisions of Section 12 relating to acceleration or rescission, change the amount or time of any prepayment or payment of principal of, or reduce the rate or change the time of payment or method of 
52

computation of interest (if such change results in a decrease in the interest rate), the Make-Whole Amount, if any, or the Net Loss, Net Gain or Swap Breakage Amount, (B) change the percentage of the principal amount of the Notes the holders of which are required to consent to any such amendment or waiver or the principal amount of the Notes that the Purchasers are to purchase pursuant to Section 2 upon the satisfaction of the conditions to Closing that appear in Section 4 or (C) amend any of Sections 8 (except as otherwise provided therein), 11(a), 11(b), 12, 18, 21 or 24.9.

18.2. Solicitation of Holders of Notes.
(a) Solicitation.  The Company will provide each Purchaser (prior to the Closing) and each holder of the Notes (irrespective of the amount of Notes then owned by it) with such information as requested, in advance of the date a decision is required, to enable such Purchaser (prior to the Closing) and such holder to make an informed and considered decision with respect to any proposed amendment, waiver or consent in respect of any of the provisions hereof or of the Notes or any Subsidiary Guaranty.  The Company will deliver executed or true and correct copies of each amendment, waiver or consent effected pursuant to the provisions of this Section 18 to each Purchaser (prior to the Closing) and each holder of outstanding Notes promptly following the date on which it is executed and delivered by, or receives the consent or approval of, the requisite Purchasers (prior to the Closing) or holders of Notes.
(b) Payment.  The Company will not directly or indirectly pay or cause to be paid any remuneration, whether by way of supplemental or additional interest, fee or otherwise, or grant any security or provide other credit support, to any Purchaser (prior to the Closing) or holder of Notes as consideration for or as an inducement to the entering into by such Purchaser (prior to the Closing) or holder of Notes of any waiver or amendment of any of the terms and provisions hereof or any Subsidiary Guaranty or any Note unless such remuneration is concurrently paid, or security is concurrently granted or other credit support is concurrently provided, on the same terms, ratably to each Purchaser (prior to the Closing) and each holder of Notes then outstanding even if such Purchaser (prior to the Closing) or holder did not consent to such waiver or amendment.
(c) Consent in Contemplation of Transfer.  Any consent made pursuant to this Section 18 or any Subsidiary Guaranty by a holder of Notes that has transferred or has agreed to transfer its Notes to the Company, or any Subsidiary or Affiliate thereof and has provided or has agreed to provide such written consent as a condition to such transfer shall be void and of no force or effect except solely as to such holder, and any amendments effected or waivers granted or to be effected or granted that would not have been or would not be so effected or granted but for such consent (and the consents of all other holders of Notes that were acquired under the same or similar conditions) shall be void and of no force or effect except solely as to such holder.

53

18.3. Binding Effect, Etc.
Any amendment or waiver consented to as provided in this Section 18 or any Subsidiary Guaranty applies equally to all Purchasers and holders of Notes and is binding upon them and upon each future holder of any Note and upon the Company without regard to whether such Note has been marked to indicate such amendment or waiver.  No such amendment or waiver will extend to or affect any obligation, covenant, agreement, Default or Event of Default not expressly amended or waived or impair any right consequent thereon.  No course of dealing between the Company and any Purchaser or holder of any Note nor any delay in exercising any rights hereunder or under any Note or Subsidiary Guaranty shall operate as a waiver of any rights of any Purchaser or holder of such Note.  As used herein, the term “this Agreement” and references thereto shall mean this Agreement as it may from time to time be amended or supplemented.

18.4. Notes Held by the Company, Etc.
Solely for the purpose of determining whether the holders of the requisite percentage of the aggregate principal amount of Notes then outstanding approved or consented to any amendment, waiver or consent to be given under this Agreement, the Notes or any Subsidiary Guaranty, or have directed the taking of any action provided herein or in the Notes or any Subsidiary Guaranty to be taken upon the direction of the holders of a specified percentage of the aggregate principal amount of Notes then outstanding, Notes directly or indirectly owned by the Company or any of its Affiliates shall be deemed not to be outstanding.

19. NOTICES. 
Except to the extent otherwise provided in Section 7.4, all notices and communications provided for hereunder shall be in writing and sent (a) by telecopy if the sender on the same day sends a confirming copy of such notice by a nationally recognized overnight delivery service (charges prepaid), (b) by registered or certified mail with return receipt requested (postage prepaid), or (c) by a nationally recognized overnight delivery service (with charges prepaid).  Any such notice must be sent:
(i) if to a Purchaser or its nominee, to such Purchaser or its nominee at the address specified for such communications in Schedule A to this Agreement, or at such other address as such Purchaser or nominee shall have specified to the Company in writing pursuant to this Section 19;
(ii) if to any other holder of any Note, to such holder at such address as such other holder shall have specified to the Company in writing pursuant to this Section 19, or
(iii) if to the Company, to the Company at the address set forth at the beginning hereof to the attention of Chief Financial Officer, with a copy to the 
54

General Counsel of the Company, or at such other address as the Company shall have specified to the holder of each Note in writing.
Notices under this Section 19 will be deemed given only when actually received.

20. REPRODUCTION OF DOCUMENTS.
This Agreement and all documents relating thereto, including, without limitation, (a) consents, waivers and modifications that may hereafter be executed, (b) documents received by any Purchaser at the Closing (except the Notes themselves), and (c) financial statements, certificates and other information previously or hereafter furnished to any Purchaser, may be reproduced by such Purchaser by any photographic, photostatic, electronic, digital, or other similar process and such Purchaser may destroy any original document so reproduced.  The Company agrees and stipulates that, to the extent permitted by applicable law, any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made by such Purchaser in the regular course of business) and any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence.  This Section 20 shall not prohibit the Company or any other holder of Notes from contesting any such reproduction to the same extent that it could contest the original, or from challenging the accuracy of any such reproduction.

21. CONFIDENTIAL INFORMATION.
For the purposes of this Section 21, “Confidential Information” means information delivered to any Purchaser by or on behalf of the Company or any Subsidiary in connection with the transactions contemplated by or otherwise pursuant to this Agreement that is proprietary in nature and that was clearly marked or labeled or otherwise adequately identified when received by such Purchaser as being confidential information of the Company or such Subsidiary, provided that such term does not include information that (a) was publicly known or otherwise known to such Purchaser prior to the time of such disclosure, (b) subsequently becomes publicly known through no act or omission by such Purchaser or any Person acting on such Purchaser’s behalf, (c) otherwise becomes known to such Purchaser other than through disclosure by the Company or any Subsidiary or (d) constitutes financial statements delivered to such Purchaser under Section 7.1 that are otherwise publicly available.  Each Purchaser will maintain the confidentiality of such Confidential Information in accordance with procedures adopted by such Purchaser in good faith to protect confidential information of third parties delivered to such Purchaser, provided that such Purchaser may deliver or disclose Confidential Information to (i) such Purchaser’s directors, trustees, officers, employees, agents, attorneys and affiliates (to the extent such disclosure reasonably relates to the administration of the investment represented by such Purchaser’s Notes), (ii) such Purchaser’s financial advisors and other professional advisors who agree to hold confidential the Confidential Information substantially in accordance with the terms of this Section 21, (iii) any other holder of any Note, (iv) any Institutional Investor to which such Purchaser sells or offers to sell such Note or any part thereof or any participation therein (if such Person has agreed in writing prior to its receipt of such Confidential Information 
55

to be bound by the provisions of this Section 21), (v) any Person from which such Purchaser offers to purchase any security of the Company (if such Person has agreed in writing prior to its receipt of such Confidential Information to be bound by the provisions of this Section 21), (vi) any federal or state regulatory authority having jurisdiction over such Purchaser, (vii) the NAIC or the SVO or, in each case, any similar organization, or any nationally recognized rating agency that requires access to information about such Purchaser’s investment portfolio, or (viii) any other Person to which such delivery or disclosure may be necessary or appropriate (w) to effect compliance with any law, rule, regulation or order applicable to such Purchaser, (x) in response to any subpoena or other legal process, (y) in connection with any litigation to which such Purchaser is a party or (z) if an Event of Default has occurred and is continuing, to the extent such Purchaser may reasonably determine such delivery and disclosure to be necessary or appropriate in the enforcement or for the protection of the rights and remedies under such Purchaser’s Notes, any Subsidiary Guaranty and this Agreement.  Each holder of a Note, by its acceptance of a Note, will be deemed to have agreed to be bound by and to be entitled to the benefits of this Section 21 as though it were a party to this Agreement.  On reasonable request by the Company in connection with the delivery to any holder of a Note of information required to be delivered to such holder under this Agreement or requested by such holder (other than a holder that is a party to this Agreement or its nominee), such holder will enter into an agreement with the Company embodying the provisions of this Section 21.
In the event that as a condition to receiving access to information relating to the Company or its Subsidiaries in connection with the transactions contemplated by or otherwise pursuant to this Agreement, any Purchaser or holder of a Note is required to agree to a confidentiality undertaking (whether through IntraLinks, another secure website, a secure virtual workspace or otherwise) which is different from this Section 21, this Section 21 shall not be amended thereby and, as between such Purchaser or such holder and the Company, this Section 21 shall supersede any such other confidentiality undertaking.

22. SUBSTITUTION OF PURCHASER.
Each Purchaser shall have the right to substitute any one of its Affiliates or another Purchaser or any one of such other Purchaser’s Affiliates (a “Substitute Purchaser”) as the purchaser of the Notes that it has agreed to purchase hereunder, by written notice to the Company, which notice shall be signed by both such Purchaser and such Substitute Purchaser, shall contain such Substitute Purchaser’s agreement to be bound by this Agreement and shall contain a confirmation by such Substitute Purchaser of the accuracy with respect to it of the representations set forth in Section 6.  Upon receipt of such notice, any reference to such Purchaser in this Agreement (other than in this Section 22), shall be deemed to refer to such Substitute Purchaser in lieu of such original Purchaser.  In the event that such Substitute Purchaser is so substituted as a Purchaser hereunder and such Substitute Purchaser thereafter transfers to such original Purchaser all of the Notes then held by such Substitute Purchaser, upon receipt by the Company of notice of such transfer, any reference to such Substitute Purchaser as a “Purchaser” in this Agreement (other than in this Section 22), shall no longer be deemed to 
56

refer to such Substitute Purchaser, but shall refer to such original Purchaser and such original Purchaser shall again have all the rights of an original holder of the Notes under this Agreement.

23. [RESERVED.]

24. MISCELLANEOUS.

24.1.         Successors and Assigns.

All covenants and other agreements contained in this Agreement by or on behalf of any of the parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Note) whether so expressed or not.

24.2. Payments Due on Non-Business Days.
Anything in this Agreement or the Notes to the contrary notwithstanding (but without limiting the requirement in Section 8.6 that the notice of any optional prepayment specify a Business Day as the date fixed for such prepayment), any payment of principal of or Make-Whole Amount, interest or Net Loss on any Note that is due on a date other than a Business Day shall be made on the next succeeding Business Day without including the additional days elapsed in the computation of the interest payable on such next succeeding Business Day.

24.3. Accounting Terms; GAAP; Pro Forma Calculations.
(a) Except as otherwise expressly provided herein, all terms of an accounting or financial nature used herein shall be construed in accordance with generally accepted accounting principles in the United States of America as in effect from time to time (“GAAP”); provided that, if the Company notifies each holder of the Notes that the Company requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Required Holders notify the Company that the Required Holders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made (a) without giving effect to any election under Accounting Standards Codification 825-10-25 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Debt or other liabilities of the Company or any Subsidiary at “fair 
57

value”, as defined therein, (b) without giving effect to any treatment of Debt in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Debt in a reduced or bifurcated manner as described therein, and such Debt shall at all times be valued at the full stated principal amount thereof, and (c) without giving effect to Accounting Standards Update No. 2016-02, Lease: Topic 842 issued by the Financial Accounting Standards Board.
(b) All pro forma computations required to be made hereunder giving effect to any acquisition, disposition or issuance, incurrence or assumption of Debt, or other transaction shall in each case be calculated after giving pro forma effect thereto (and, in the case of any pro forma computation made hereunder, to determine whether such acquisition, disposition or issuance, incurrence or assumption of Debt or other transaction is permitted to be consummated hereunder) immediately after giving effect to such acquisition, disposition or issuance, incurrence or assumption of Debt (and to any other such transaction consummated since the first day of the period for which such pro forma computation is being made and on or prior to the date of such computation) as if such transaction had occurred on the first day of the Reference Period most recently ended for which financial statements shall have been delivered pursuant to Section 7.1(a) or 7.1(b), and, to the extent applicable, the historical earnings and cash flows associated with the assets acquired or disposed of, any related incurrence or reduction of Debt and any related cost savings, operating expense reductions and synergies, all in accordance with (and, in the case of cost savings, operating expense reductions and synergies, to the extent permitted by) Article 11 of Regulation S-X under the Securities Act.  If any Debt bears a floating rate of interest and is being given pro forma effect, the interest on such Debt shall be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period for which such pro forma computation is being made (taking into account any Swap Agreement applicable to such Debt).

24.4. Severability.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall (to the full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction.

24.5. Construction.
Each covenant contained herein shall be construed (absent express provision to the contrary) as being independent of each other covenant contained herein, so that compliance with any one covenant shall not (absent such an express contrary provision) be deemed to excuse compliance with any other covenant.  Where any provision herein refers to action to be taken by 
58

any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person.
For the avoidance of doubt, all Schedules and Exhibits attached to this Agreement shall be deemed to be a part hereof.

24.6. Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original but all of which together shall constitute one instrument.  Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties hereto.

24.7. Governing Law.
This Agreement shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State.

24.8. Jurisdiction and Process; Waiver of Jury Trial.
(a) The Company irrevocably submits to the non-exclusive jurisdiction of any New York State or federal court sitting in the Borough of Manhattan, The City of New York, over any suit, action or proceeding arising out of or relating to this Agreement or the Notes.  To the fullest extent permitted by applicable law, the Company irrevocably waives and agrees not to assert, by way of motion, as a defense or otherwise, any claim that it is not subject to the jurisdiction of any such court, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.
(b) The Company consents to process being served by or on behalf of any holder of Notes in any suit, action or proceeding of the nature referred to in Section 24.8(a) by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, return receipt requested, to the Company at its address specified in Section 19 or at such other address of which such holder shall then have been notified pursuant to said Section.  The Company agrees that such service upon receipt (i) shall be deemed in every respect effective service of process upon it in any such suit, action or proceeding and (ii) shall, to the fullest extent permitted by applicable law, be taken and held to be valid personal service upon and personal delivery to it.  Notices hereunder shall be conclusively presumed received as evidenced by a delivery receipt furnished by the United States Postal Service or any reputable commercial delivery service.

59

(c) Nothing in this Section 24.8 shall affect the right of any holder of a Note to serve process in any manner permitted by law, or limit any right that the holders of any of the Notes may have to bring proceedings against the Company in the courts of any appropriate jurisdiction or to enforce in any lawful manner a judgment obtained in one jurisdiction in any other jurisdiction.
(d) The parties hereto hereby waive trial by jury in any action brought on or with respect to this Agreement, the Notes, any Subsidiary Guaranty or any other document executed in connection herewith or therewith.

24.9. Obligation to Make Payment in Yen.
Subject to Section 8.10(b) and 8.11, any payment on account of an amount that is payable hereunder or under the Notes in Yen which is made to or for the account of any holder of Notes in any other currency, whether as a result of any judgment or order or the enforcement thereof or the realization of any security or the liquidation of the Company or any Subsidiary, shall constitute a discharge of the obligation of the Company under this Agreement or the Notes only to the extent of the amount of Yen which such holder could purchase in the foreign exchange markets in London, England, with the amount of such other currency in accordance with normal banking procedures at the rate of exchange prevailing on the London Banking Day following receipt of the payment first referred to above.  If the amount of Yen that could be so purchased is less than the amount of Yen originally due to such holder, the Company agrees to the fullest extent permitted by law, to indemnify and save harmless such holder from and against all loss or damage arising out of or as a result of such deficiency.  This indemnity shall, to the fullest extent permitted by law, constitute an obligation separate and independent from the other obligations contained in this Agreement and the Notes, shall give rise to a separate and independent cause of action, shall apply irrespective of any indulgence granted by such holder from time to time and shall continue in full force and effect notwithstanding any judgment or order for a liquidated sum in respect of an amount due hereunder or under the Notes or under any judgment or order.  As used herein the term “London Banking Day” shall mean any day other than Saturday or Sunday or a day on which commercial banks are required or authorized by law to be closed in London, England.
*  *  *  *  *
The execution hereof by the Purchasers shall constitute a contract among the Company and the Purchasers for the uses and purposes hereinabove set forth.  This Agreement may be executed in any number of counterparts, each executed counterpart constituting an original but all together only one agreement.

60

Very truly yours,
DENTSPLY SIRONA INC.
By: /s/ William E. Reardon    
Name: William E. Reardon
Title:   Vice President & Treasurer
By: /s/ Andy Smith      
Name: Andy Smith
Title:   Assistant Treasurer

Accepted as of the date first written above.

[Signature Page to Note Purchase Agreement – Dentsply]

Accepted as of the date first written above.

BRIGHTHOUSE LIFE INSURANCE COMPANY
By:  MetLife Investment Advisors, LLC, Its Investment Manager

By: /s/ Judith A Gulotta   
Name: Judith A. Gulotta
Title: Managing Director

METLIFE INSURANCE K.K. 
By:  MetLife Investment Advisors, LLC, Its Investment Manager

By: /s/ John A. Wills  
Name: John A. Wills
Title:   Managing Director

[Signature Page to Note Purchase Agreement – Dentsply]

THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
By: Northwestern Mutual Investment Management Company, LLC,
its investment adviser

By: /s/ Brian P. McDonald 
Name: Brian P. McDonald
Title:   Managing Director

[Signature Page to Note Purchase Agreement – Dentsply]

HARTFORD FIRE INSURANCE COMPANY
HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
By:  Hartford Investment Management Company, 
their Investment Manager

By: /s/ Dawn Bruneau 
Name: Dawn Bruneau
Title:   Vice President

[Signature Page to Note Purchase Agreement – Dentsply]

SCHEDULE B 

DEFINED TERMS
As used herein, the following terms have the respective meanings set forth below or set forth in the Section hereof following such term:
“Affected Noteholder” is defined within the definition of “Noteholder Sanctions Event”.  
“Affected Notes” is defined in Section 8.8(a). 
“Affiliate” means, at any time, and with respect to any Person, any other Person that at such time directly or indirectly through one or more intermediaries Controls, or is Controlled by, or is under common Control with, such first Person.  As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.  Unless the context otherwise clearly requires, any reference to an “Affiliate” is a reference to an Affiliate of the Company.
“Agreement” is defined in Section 18.3.
“Anti-Corruption Laws” is defined in Section 5.16(d)(1).
“Anti-Money Laundering/Anti-Terrorism Laws” is defined in Section 5.16(c).
“Bank Credit Agreements” means (a) the RCF; (b) that certain Credit Agreement, dated as of August 26, 2013, by and among the Company, PNC Bank, National Association, as administrative agent, the lenders party thereto and the other financial institutions party thereto, as amended by that certain Amendment No. 1 dated as of November 30, 2015, as the same may be further amended, restated, amended and restated, joined, supplemented or otherwise modified from time to time, and any renewals, extensions or replacements thereof; and (c) that certain Loan Agreement, dated as of September 22, 2014 (the loans made thereunder being referred to herein as the “September 2014 Loan”), by and among the Company, the lenders party thereto, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent, as amended by that certain Amendment No. 1, dated as of December 18, 2018, by and among Dentsply International Inc., the lenders party thereto, and the Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent, as the same may be further amended, restated, amended and restated, joined, supplemented or otherwise modified from time to time, and any renewals, extensions or replacements thereof, which, collectively, constitute the primary bank credit facilities of the Company and its Subsidiaries.

Schedule B-1

“Blocked Person” is defined in Section 5.16(a).
“Business Day” means any day other than a Saturday, a Sunday or a day on which commercial banks in New York City, New York or Tokyo, Japan are required or authorized to be closed.
“Called Principal” is defined in Section 8.10. 
“Capital Lease” means any lease that has been or is required to be, in accordance with GAAP, recorded as a capitalized lease; provided that for all purposes hereunder, the amount of obligations under any Capital Lease shall be the amount thereof accounted for as a liability on a balance sheet in accordance with GAAP.
“CFC” means a Person that is a controlled foreign corporation under Section 957 of the Code.
“Change of Control” means any of the following events or circumstances: (a) any Person or related Persons constituting a “group” for purposes of Section 14(d) of the Exchange Act shall have acquired “beneficial ownership” of a majority of the Voting Stock of the Company or (b) during any period of up to 24 consecutive months commencing after the date of this Agreement, individuals who at the beginning of such 24-month period were directors of the Company shall cease for any reason (other than due to death or disability) to constitute a majority of the board of directors of the Company (except to the extent that individuals who at the beginning of such 24-month period were replaced by individuals (x) elected by a majority of the remaining members of the board of directors of the Company, (y) nominated for election by a majority of the remaining members of the board of directors of the Company and thereafter elected as directors by the shareholders of the Company or (z) whose election or nomination was approved by a majority of the remaining members of the board of directors of the Company). 
“Closing” is defined in Section 3.
“Closing Date” is defined in Section 3.
“Code” means the Internal Revenue Code of 1986, as amended from time to time, and the rules and regulations promulgated thereunder from time to time.
“Company” is defined in the introductory paragraph of this Agreement.
“Confidential Information” is defined in Section 21.

Schedule B-2

“Consignment Agreements” means, collectively, (a) that certain Consignment Agreement dated as of February 15, 2002 by and between Umicore AG & Co. KG and the Company,  (b) that certain Consignment and Forward Contracts Agreement dated as of December 20, 2001, as amended on January 30, 2002, December 10, 2003, December 26, 2007 and on July 15, 2016, by and between The Bank of Nova Scotia and the Company, (c) that certain Consignment Agreement dated as of January 30, 2002 by and between Commerzbank AG, Frankfurt and the Company, (d) that certain Consignment Agreement dated as of December 20, 2001 by and between JPMorgan Chase Bank and the Company, and (e) that certain Consignment Agreement dated as of April 29, 2013 by and between The Toronto-Dominion Bank and the Company, in each case as each may be amended, restated, supplemented or otherwise modified from time to time.
“Consolidated” means the consolidation of accounts in accordance with GAAP.
“Controlled Entity” means any of the Subsidiaries of the Company and any of their or the Company’s respective Controlled Affiliates.  As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.
“Debt” of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (other than trade payables not overdue by more than 60 days incurred in the ordinary course of such Person’s business), (c) all obligations of such Person evidenced by notes, bonds, debentures or other similar instruments, (d) all obligations of such Person created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all obligations of such Person as lessee under leases that have been or should be, in accordance with GAAP, recorded as Capital Leases, (f) all obligations, contingent or otherwise, of such Person in respect of acceptances, letters of credit or similar extensions of credit, (g) all obligations of such Person in respect of Swap Agreements, (h) all debt of others referred to in clauses (a) through (g) above or clause (i) below (collectively, “Guaranteed Debt”) guaranteed directly or indirectly in any manner by such Person, or in effect guaranteed directly or indirectly by such Person through an agreement (1) to pay or purchase such Guaranteed Debt or to advance or supply funds for the payment or purchase of such Guaranteed Debt, (2) to purchase or lease property or services, primarily for the purpose of enabling the debtor to make payment of such Guaranteed Debt or to assure the holder of such Guaranteed Debt against loss, (3) to supply funds to or in any other manner invest in the debtor (including any agreement to pay for property or services irrespective 
Schedule B-3

of whether such property is received or such services are rendered) or (4) otherwise to assure a creditor against loss, and (i) all Debt referred to in clauses (a) through (h) above (including Guaranteed Debt) secured by (or for which the holder of such Debt has an existing right, contingent or otherwise, to be secured by) any Lien on property (including, without limitation, accounts and contract rights) owned by such Person, even though such Person has not assumed or become liable for the payment of such Debt (and if such Person has not assumed or become liable for such Debt of others, then the amount of Debt of such Person shall be the lesser of (A) the amount of such Debt of others and (B) the fair market value of such property, as determined by such Person in good faith); provided that, Debt of the Company and its Subsidiaries shall not include (i) Debt incurred in connection with the Consignment Agreements relating to the consignment of precious metals between the Company and certain counterparties or (ii) unfunded pension obligations.
“Default” means an event or condition the occurrence or existence of which would, with the lapse of time or the giving of notice or both, become an Event of Default.
“Default Rate” means, with respect to the Notes, the rate of interest that is the greater of (a) 2% per annum above the rate of interest then in effect pursuant to clause (a) of the first paragraph of such Notes or (b) 2% over the rate or interest publicly announced by JPMorgan Chase Bank in New York, New York as its “base” or “prime” rate.
“Disclosure Documents” is defined in Section 5.3.
“Discounted Value” is defined in Section 8.10(a).
“Dollars” or “$” means the lawful currency of the United States of America.
“Domestic Subsidiary” means any Subsidiary that is not a Foreign Subsidiary.
“EBITDA” means, for any period, net income (or net loss) plus the sum of (a) interest expense, (b) income tax expense, (c) depreciation expense, (d) amortization expense, (e) other non-cash charges (less unusual or non-recurring non-cash income or gains), (f) any extraordinary, non-recurring or unusual fees, expenses or other charges incurred in connection with any acquisition or merger consummated by the Company or a Subsidiary (including the issuance or repayment of Debt related to such acquisition or merger), and any corporate reorganization and integration activities which are related to such acquisition or merger, in each case determined in accordance with GAAP for such period and (g) charges and expenses incurred prior to December 31, 2018 in connection with the Company’s publicly announced efficiency initiatives, which includes, but is not limited to, costs and expenses in connection with discontinued operations, retention, severance and related employee benefits, systems 
Schedule B-4

establishment costs, excess pension charges, contract termination costs, costs to close and/or consolidate facilities and relocate employees, integration costs, other business optimization costs and costs associated with establishing new facilities or reserves deducted (and not added back) in such period not exceeding $200,000,000 in the aggregate for such period, provided that the aggregate amount available to be added back pursuant to this clause (g) shall not exceed $200,000,000 during the term of this Agreement.  For the purposes of calculating EBITDA for any period of four (4) consecutive fiscal quarters (each such period, a “Reference Period”), (i) if at any time during such Reference Period the Company or any Subsidiary shall have made any Material Disposition, the EBITDA for such Reference Period shall be reduced by an amount equal to the EBITDA (if positive) attributable to the property that is the subject of such Material Disposition for such Reference Period or increased by an amount equal to the EBITDA (if negative) attributable thereto for such Reference Period, and (ii) if during such Reference Period the Company or any Subsidiary shall have made a Material Acquisition, EBITDA for such Reference Period shall be calculated after giving effect thereto on a Pro Forma Basis as if such Material Acquisition occurred on the first day of such Reference Period.
“Environmental Laws” means any and all federal, state, local, and foreign statutes, laws, regulations, ordinances, rules, judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of the environment or the release of any materials into the environment, including but not limited to those related to hazardous substances or wastes, air emissions and discharges to waste or public systems.
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder from time to time in effect.
“ERISA Affiliate” means any trade or business (whether or not incorporated) that is treated as a single employer together with the Company under section 414 of the Code.
“Event of Default” is defined in Section 11.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Financial Instruments and Exchange Act” or “FIEA” is defined in Section 6.4(a).
“Foreign Subsidiary” means any Subsidiary (a) that is a CFC, or (b) all or substantially all of the assets of which consist of equity interests in one or more CFCs as determined by the Company and certified to the holders of Notes from time to time.

Schedule B-5

“GAAP” is defined in Section 24.3.
“Governmental Authority” means

(a) the government of
(i) The United States of America or any state or other political subdivision thereof, or
(ii) any jurisdiction in which the Company or any Subsidiary conducts all or any part of its business, or which has jurisdiction over any properties of the Company or any Subsidiary, or
(b) any entity exercising executive, legislative, judicial, regulatory or administrative functions of, or pertaining to, any such government.
“Governmental Official” means any governmental official or employee, employee of any government-owned or government-controlled entity, political party, any official of a political party, candidate for political office, official of any public international organization or anyone else acting in an official capacity.
“Hazardous Material” means any and all pollutants, toxic or hazardous wastes or other substances that might pose a hazard to health and safety, the removal of which may be required or the generation, manufacture, refining, production, processing, treatment, storage, handling, transportation, transfer, use, disposal, release, discharge, spillage, seepage or filtration of which is or shall be restricted, prohibited or penalized by any applicable law including, but not limited to, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, petroleum, petroleum products, lead based paint, radon gas or similar restricted, prohibited or penalized substances.
“holder” means, with respect to any Note, the Person in whose name such Note is registered in the register maintained by the Company pursuant to Section 14.1.
“Implied Rate Yen Yield” is defined in Section 8.10(a).
“INHAM Exemption” is defined in Section 6.3(e).
“Initial Swap Agreement” is defined in Section 8.10(b).
“Institutional Investor” means (a) any original purchaser of a Note, (b) any holder of more than $2,000,000 of the aggregate principal amount of the Notes then outstanding, (c) any 
Schedule B-6

bank, trust company, savings and loan association or other financial institution, any pension plan, any investment company, any insurance company, any broker or dealer, or any other similar financial institution or entity, regardless of legal form, and (d) any Related Fund of any holder of any Note.
“ISDA Master Agreement” is defined in Section 8.11.
“Japan Purchaser” is defined in Section 6.4.
“Lien” means any lien, security interest or other charge or encumbrance of any kind, or any other type of preferential arrangement, including, without limitation, the lien or retained security title of a conditional vendor and any easement, right of way or other encumbrance on title to real property.
“Make-Whole Amount” is defined in Section 8.10.
“Material” means material in relation to the business, operations, affairs, financial condition, assets or properties of the Company and its Subsidiaries taken as a whole.
“Material Acquisition” means any acquisition (whether by purchase, merger, consolidation or otherwise) by the Company or any Subsidiary of property or series of related acquisitions of property that (a) constitutes (i) assets comprising all or substantially all or any significant portion of a business or operating unit of a business, or (ii) all or substantially all of the common stock or other equity interests of a Person, and (b) involves the payment of consideration by the Company and its Subsidiaries in excess of $200,000,000.
“Material Adverse Effect” means a material adverse effect on (a) the business, operations, affairs, financial condition, assets or properties of the Company and its Subsidiaries taken as a whole, (b) the ability of the Company to perform its obligations under this Agreement and the Notes, (c) the ability of any Subsidiary Guarantor that is a Material Subsidiary to perform its obligations under the Subsidiary Guaranty (if any) or (d) the validity or enforceability of this Agreement, the Notes or the Subsidiary Guaranty (if any).
“Material Disposition” means any sale, transfer or disposition of property or series of related sales, transfers, or dispositions of property (other than transactions among the Company and its Subsidiaries) that yields gross proceeds to the Company or any of its Subsidiaries in excess of $200,000,000.
“Material Subsidiary” means, at any time, any Subsidiary of the Company which, together with all other Subsidiaries of such Subsidiary, accounts for more than (a) 5% of the 
Schedule B-7

Consolidated assets of the Company and its Subsidiaries, determined as of the end of the then most recently ended fiscal quarter of the Company or (b) 5% of Consolidated revenue of the Company and its Subsidiaries, determined for the then most recently ended period of four consecutive fiscal quarters of the Company.
“Maturity Date” is defined in the first paragraph of each Note.
“Multiemployer Plan” means any Plan that is a “multiemployer plan” (as such term is defined in Section 4001(a)(3) of ERISA).
“NAIC” means the National Association of Insurance Commissioners or any successor thereto.
“NAIC Annual Statement” is defined in Section 6.3(a).
“Net Gain” is defined in Section 8.11.
“Net Loss” is defined in Section 8.11.
“Net Worth” means the consolidated stockholder’s equity of the Company and its Subsidiaries, as defined according to GAAP.
“New Swap Agreement” is defined in Section 8.10(b).
“Non-Swapped Note” is defined in Section 8.10(a).
“Non-U.S. Plan” means any plan, fund or other similar program that (a) is established or maintained outside the United States of America by the Company or any Subsidiary primarily for the benefit of employees of the Company or one or more Subsidiaries residing outside the United States of America, which plan, fund or other similar program provides, or results in, retirement income, a deferral of income in contemplation of retirement or payments to be made upon termination of employment, and (b) is not subject to ERISA or the Code.
“Note” and “Notes” is defined in Section 1.
“Noteholder Sanctions Event” means, with respect to any holder of a Note (an “Affected Noteholder”), such holder or any of its Affiliates being in violation of or the target of any U.S. Economic Sanctions as a result of the Company or any Controlled Entity becoming a Blocked Person or, directly or indirectly, having any investment in or engaging in any dealing or 
Schedule B-8

transaction (including any investment, dealing or transaction involving the proceeds of the Notes) with any Blocked Person.
 “OFAC” is defined in Section 5.16(a).
“OFAC Listed Person” is defined in Section 5.16(a).
“OFAC Sanctions Program” means any economic or trade sanction that OFAC is responsible for administering and enforcing.  A list of OFAC Sanctions Programs may be found at http://www.treasury.gov/resource-center/sanctions/Programs/Pages/Programs.aspx.
“Officer’s Certificate” means a certificate of a Senior Financial Officer or of any other officer of the Company whose responsibilities extend to the subject matter of such certificate.
“Order for Enforcement of FIEA” is defined in Section 6.4(b). 
“Original Swap Agreement” is defined in Section 8.10(b).
“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA or any successor thereto.
“Permitted Lien” means each of the following: (a) Liens for taxes, assessments and governmental charges or levies to the extent not required to be paid under Section 9.4 hereof; (b) Liens imposed by law, such as landlords’, banks’ (and rights of set-off), warehousemen’s, materialmen’s, mechanics’, carriers’, workmen’s and repairmen’s Liens and other similar Liens arising in the ordinary course of business securing obligations that are not overdue for a period of more than 30 days; (c) pledges or deposits to secure obligations under workers’ compensation laws, laws related to unemployment insurance and other types of social security or similar legislation or Liens to secure public or statutory obligations, surety and appeal bonds, bids, leases, government contracts, trade contracts, performance and return of money bonds and other similar obligations; (d) easements, rights of way, restrictions, encroachments, encumbrances and other defects or irregularities in title to real property that do not render title to the property encumbered thereby unmarketable or materially adversely affect the use of such property for its present purposes; (e) interest or title of a lessor, lessee, sublessor or sublessee under any lease or sublease permitted hereunder and any interest or title of a licensor, licensee, sublicensor or sublicensee under any license or sublicense permitted hereunder; (f) Liens solely on any cash earnest money deposits, escrow arrangements or similar arrangements made by the Company or any Subsidiary in connection with any letter of intent or purchase agreement permitted hereunder and Liens on trusts, cash or cash equivalents, or other funds in connection with defeasance, discharge or redemption of Debt, pending consummation of a strategic transaction or similar 
Schedule B-9

obligations; (g) purported Liens evidenced by the filing of precautionary Uniform Commercial Code financing statements (or any similar precautionary filings) relating solely to operating leases of personal property entered into in the ordinary course of business; (h) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with importation of goods; (i) any zoning or similar law or right reserved to or vested in any Governmental Authority to control or regulate the use of any real property; (j) Liens arising out of judgments, decrees, orders or awards that do not constitute an Event of Default under Section 11; and (k) Liens arising by reason of deposits necessary to obtain standby letters of credit in the ordinary course of business.
“Person” means an individual, partnership, corporation, limited liability company, association, trust, unincorporated organization, or a government or agency or political subdivision thereof.
“Plan” means an “employee benefit plan” (as defined in section 3(3) of ERISA) subject to Title I of ERISA that is or, within the preceding five years, has been established or maintained, or to which contributions are or, within the preceding five years, have been made or required to be made, by the Company or any ERISA Affiliate or with respect to which the Company or any ERISA Affiliate may have any liability.
“Principal Credit Facility” means (a) each Bank Credit Agreement, as the same may be amended, restated or otherwise modified from time to time, or such other principal credit facility or facilities of the Company as may from time to time refinance or replace any such facility and (b) any committed or funded debt facility of the Company with an aggregate facility size of at least $100,000,000 (or the equivalent thereof in the relevant currency), as of any date of determination.
“Pro Forma Basis” means on a basis in accordance with Section 24.3(b).
“property” or “properties” means, unless otherwise specifically limited, real or personal property of any kind, tangible or intangible, choate or inchoate.
“Proposed Prepayment Date” is defined in Section 8.3(c).
“PTE” is defined in Section 6.3(a).
“Purchaser” or “Purchasers” means each of the purchasers that has executed and delivered this Agreement to the Company and such Purchaser’s successors and assigns (so long as any such assignment complies with Section 14.2), provided, however, that any Purchaser of a Note that ceases to be the registered holder or a beneficial holder (though a nominee) of such 
Schedule B-10

Note as the result of a transfer thereof pursuant to Section 14.2 shall cease to be included within the meaning of “Purchaser” of such note for the purposes of this Agreement upon such transfer. 
“QPAM Exemption” is defined in Section 6.3(d).
“Qualified Institutional Buyer” means any Person who is a “qualified institutional buyer” within the meaning of such term as set forth in Rule 144A(a)(1) under the Securities Act.
“Qualified Institutional Investor” is defined in Section 6.4(b).
“Ratable Portion” means, with respect to any Note, an amount equal to the product of (x) the amount equal to the net proceeds being so applied to the prepayment of Senior Debt in accordance with Section 10.4(2), multiplied by (y) a fraction the numerator of which is the outstanding principal amount of such Note and the denominator of which is the aggregate outstanding principal amount of Senior Debt of the Company and its Subsidiaries.
“RCF” means that certain Credit Agreement, dated as of July 27, 2018, by and among the Company, certain Subsidiaries of the Company named therein, JPMorgan Chase Bank, N.A., as administrative agent, the lenders party thereto and other financial institutions party thereto, as the same may be further amended, restated, amended and restated, joined, supplemented or otherwise modified from time to time, and any renewals, extensions or replacements thereof.
“Recognized Yen Market Makers” is defined in Section 8.10(a).
“Reference Period” has the meaning assigned to such term in the definition of “EBITDA”.
“Reinvestment Yield” is defined in Section 8.10. 
“Related Fund” means, with respect to any holder of any Note, any fund or entity that (a) invests in Securities or bank loans, and (b) is advised or managed by such holder, the same investment advisor as such holder or by an affiliate of such holder or such investment advisor.
“Remaining Average Life” is defined in Section 8.10(a).
“Remaining Scheduled Payments” is defined in Section 8.10(a).
“Replacement Swap Agreement” is defined in Section 8.10(b).
“Reported” is defined in Section 8.10(b).

Schedule B-11

“Required Holders” means (a) prior to the Closing, the Purchasers and (b) on or after the Closing, the holders of not less than 50.1% in principal amount of the Notes at the time outstanding (exclusive of Notes then owned by the Company or any of their Affiliates and any Notes held by parties who are contractually required to abstain from voting with respect to matters affecting the holders of the Notes).
“Responsible Officer” means any Senior Financial Officer and any other officer of the Company with responsibility for the administration of the relevant portion of this Agreement.
“Sanctions Prepayment Date” is defined in Section 8.8(a). 
“Sanctions Prepayment Offer” is defined in Section 8.8(a). 
“Sanctions Prepayment Response Date” is defined in Section 8.8(a). 
“SEC” means the Securities and Exchange Commission of the United States, or any successor thereto.
“Securities” or “Security” shall have the meaning specified in Section 2(1) of the Securities Act.
“Securities Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations promulgated thereunder from time to time in effect.
“Senior Debt” means, as of the date of any determination thereof, all Debt, other than Subordinated Debt.
“Senior Financial Officer” means the chief financial officer, principal accounting officer, treasurer or comptroller of the Company.
“September 2014 Loan” has the meaning assigned to such term in the definition of “Bank Credit Agreements”. 
“Settlement Date” is defined in Section 8.10(a).
“Source” is defined in Section 6.3.
“Subordinated Debt” means all unsecured Debt of any Person which shall contain or have applicable thereto subordination provisions providing for the subordination thereof to other Debt of such Person (including for purposes of the Company, the obligations of the Company under this Agreement and the Notes). 

Schedule B-12

“Subsidiary” means, as to any Person, any corporation, partnership, joint venture, limited liability company, trust or estate of which (or in which) more than 50% (directly or indirectly) of (a) the issued and outstanding capital stock having ordinary voting power to elect a majority of the Board of Directors of such corporation (irrespective of whether at the time capital stock of any other class or classes of such corporation shall or might have voting power upon the occurrence of any contingency), (b) the interest in the capital or profits of such limited liability company, partnership or joint venture or (c) the beneficial interest in such trust or estate is at the time directly or indirectly owned or controlled by such Person, by such Person and one or more of its other Subsidiaries or by one or more of such Person’s other Subsidiaries.  Unless the context otherwise clearly requires, any reference to a “Subsidiary” is a reference to a Subsidiary of the Company.
“Subsidiary Guarantor” means each Subsidiary that is party to the Subsidiary Guaranty.
“Subsidiary Guaranty” means a subsidiary guaranty agreement executed and delivered in connection with Section 9.8(a) of the Agreement.
“Substitute Purchaser” is defined in Section 22.
“SVO” means the Securities Valuation Office of the NAIC or any successor thereto.
“Swap Agreement” means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Company or the Subsidiaries shall be a Swap Agreement.
“Swap Breakage Amount” is defined in Section 8.11.
 “Swap Note Agreement” is defined in Section 8.10(b).
 “Swapped Note” is defined in Section 8.10(b).
“Swapped Note Called Accrued Interest Amount” is defined in Section 8.10(b).
“Swapped Note Called Notional Accrued Interest Amount” is defined in Section 8.10(b).

Schedule B-13

“Swapped Note Called Notional Amount” is defined in Section 8.10(b).
“Swapped Note Called Principal” is defined in Section 8.10(b).
“Swapped Note Discounted Value” is defined in Section 8.10(b).
“Swapped Note Reinvestment Yield” is defined in Section 8.10(b).
“Swapped Note Remaining Average Life” is defined in Section 8.10(b).
“Swapped Note Remaining Scheduled Swap Payments” is defined in Section 8.10(b).
“Swapped Note Settlement Date” is defined in Section 8.10(b).
“Tax” means any tax (whether income, documentary, sales, stamp, registration, issue, capital, property, excise or otherwise) and any similar charge, levy, impost or duty.
“Total Assets” means, as of any date of determination, the total amount of all assets of the Company and its Subsidiaries.

“USA PATRIOT Act” means United States Public Law 107-56, Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, as amended from time to time, and the rules and regulations promulgated thereunder from time to time in effect.

“U.S. Economic Sanctions” is defined in Section 5.16(a).

“Voting Stock” means, with respect to any Person, any class of shares of stock or other equity interests of such Person having general voting power under ordinary circumstances to elect the board of directors or other managing entities, as appropriate, of such Person (irrespective of whether or not at the time stock of any other class or classes or other equity interests of such Person shall have or might have voting power by reason of the happening of any contingency).
“Yen” or “¥” means the lawful currency of Japan. 

Schedule B-14

EXHIBIT 1
[FORM OF SERIES W NOTE]

THIS NOTE HAS BEEN ACQUIRED WITHOUT A VIEW TO DISTRIBUTION AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”), OR UNDER STATE SECURITIES LAWS. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS NOTE MAY BE MADE UNLESS REGISTERED OR EXEMPT FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS.

NO SECURITIES REGISTRATION STATEMENT FOR A PUBLIC OFFERING PURSUANT TO ARTICLE 4, PARAGRAPH 1 OF THE FINANCIAL INSTRUMENTS AND EXCHANGE ACT OF JAPAN (INCLUDING ANY AMENDMENTS THERETO, THE “FIEA”) HAS BEEN FILED OR WILL BE FILED WITH RESPECT TO THE SOLICITATION FOR THE PURCHASE OF NOTES IN JAPAN AS THE OFFERING OF THE NOTES IN JAPAN FALLS WITHIN THE PRIVATE PLACEMENT EXCEPTION FROM THE REGISTRATION REQUIREMENTS SET FORTH IN ARTICLE 2, PARAGRAPH 3 OF THE FIEA. 

A PURCHASER WHO WAS SOLICITED TO SUBSCRIBE FOR THE NOTES IN JAPAN (A “JAPAN PURCHASER”) THAT WAS A “QUALIFIED INSTITUTIONAL INVESTOR” (TEKIKAKU KIKAN TOUSHIKA) AS DEFINED UNDER ARTICLE 2, PARAGRAPH 3, ITEM 1 OF THE FIEA AND ARTICLE 10, PARAGRAPH 1 OF THE CABINET OFFICE ORDINANCE REGARDING DEFINITIONS UNDER ARTICLE 2 OF THE FIEA (A “QUALIFIED INSTITUTIONAL INVESTOR”) AT THE TIME THAT IT SUBSCRIBED FOR OR ACQUIRED NOTES  MAY NOT TRANSFER ITS NOTES (OR ANY INTEREST THEREIN), IN WHOLE OR IN PART, TO ANY PERSON OTHER THAN A QUALIFIED INSTITUTIONAL INVESTOR.  ANY JAPAN PURCHASER THAT IS NOT A QUALIFIED INSTITUTIONAL INVESTOR OR IS A QUALIFIED INSTITUTIONAL INVESTOR THAT ELECTS TO BE COUNTED AS A NON-QUALIFIED INSTITUTIONAL INVESTOR WITHIN THE SMALL NUMBER PRIVATE PLACEMENT (SHOUNINZU SHIBO) PURSUANT TO ARTICLE 2, PARAGRAPH 3, ITEM 2(C) OF THE FIEA AND ARTICLE 1-7 OF THE ORDER FOR ENFORCEMENT OF THE FINANCIAL INSTRUMENTS AND EXCHANGE ACT MAY NOT TRANSFER THE NOTES TO ANYONE EXCEPT IN THE CASE SUCH JAPAN PURCHASER TRANSFERS THE NOTES HELD BY IT TO A SINGLE PARTY IN A BLOCK TRANSFER.

Exhibit 1-1

 
DENTSPLY SIRONA INC. 
 
0.99% SERIES W SENIOR NOTE DUE SEPTEMBER 25, 2031
No. RW-[_______]  [Date__] 
¥[__________] PPN: 24906P E#2
For Value Received, the undersigned, DENTSPLY SIRONA Inc. (herein called the “Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay to [_____________________] or registered assigns, the principal sum of [______________] YEN (¥[________]) (or so much thereof as shall not have been prepaid) on September 25, 2031 (the “Maturity Date”) with interest (computed on the basis of a 360 day year of twelve 30-day months) (a) on the unpaid balance thereof at the rate of 0.99% per annum from the date hereof, payable semi-annually on the 25th day of March and September in each year and at maturity, commencing with the March 25 or September 25 next succeeding the date hereof, and on the Maturity Date, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, at a rate per annum from time to time equal to the Default Rate (as defined in the Note Purchase Agreement referred to below), on any overdue payment of interest, any overdue payment of Net Loss and, during the continuance of an Event of Default, on the unpaid balance hereof and on any overdue payment of any Make-Whole Amount (as defined in the Note Purchase Agreement referred to below), payable semi-annually as aforesaid (or, at the option of the registered holder hereof, on demand).
Payments of principal of and interest on this Note are to be made in Yen.  At any time this Note is a Swapped Note (as defined in the Note Purchase Agreement referred to below), payments of any Make-Whole Amount and any Net Loss with respect to this Note are to be made in Dollars.  At any time this Note is a Non-Swapped Note (as defined in the Note Purchase Agreement referred to below), payments of any Make-Whole Amount with respect to this Note are to be made in Yen.  In each case, payments on this Note are to be made at the principal office of Bank of America, N.A. in New York, New York or at such other place as the Company shall have designated by written notice to the holder of this Note as provided in the Note Purchase Agreement referred to below.
This Note is one of a series of Senior Notes (herein called the “Notes”) issued pursuant to the Note Purchase Agreement, dated as of June 24, 2019 (as from time to time amended, restated, supplemented or modified, the “Note Purchase Agreement”), among the Company and the respective Purchasers named therein and is entitled to the benefits thereof.  Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 21 of the Note Purchase Agreement and (ii) made the 
Exhibit 1-2

representations set forth in Section 6.3 of the Note Purchase Agreement, provided, that in lieu thereof such holder may (in reliance upon information provided by the Company, which shall not be unreasonably withheld) make a representation to the effect that the purchase by any holder of any Note will not constitute a non-exempt prohibited transaction under section 406(a) of ERISA.  Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement.
This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration of transfer, duly endorsed, or accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the name of, the transferee.  Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the Company will not be affected by any notice to the contrary.
This Note is subject to optional prepayment, in whole or from time to time in part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise.
If an Event of Default, as defined in the Note Purchase Agreement, occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including the applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement.
This Note shall be construed and enforced in accordance with, and the rights of the issuer and holder hereof shall be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would require the application of the laws of a jurisdiction other than such State.
DENTSPLY SIRONA INC.
By:___________________________
Name:
Title:

By:___________________________
Name:
Title:
Exhibit 1-3Exhibit
10.1

 

CERTAIN
IDENTIFIED INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN EXCLUDED BECAUSE THE INFORMATION (I) IS NOT MATERIAL
AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.

 

Manufacturing
Supply Agreement

 

This
Manufacturing Supply Agreement (the “Agreement”), dated as of June 8, 2019 (the “Effective Date”),
is entered into by and between INTERCON CHEMICAL COMPANY, a Missouri corporation having its principal place of business at 1100
Central Industrial Drive, St. Louis, MO 63110 (“ICC”), and PURE BIOSCIENCE, INC., a Delaware corporation having
its principal place of business at 1725 Gillespie Way, El Cajon, CA 92020 (“Pure”, and together with ICC, the
“Parties”, and each, a “Party”).

 

WHEREAS,
Pure owns or controls certain intellectual property related to silver di-hydrogen citrate known as SDC and its finished form of
antimicrobial goods;

 

WHEREAS,
ICC is in the business of manufacturing, packaging, marketing and distributing services of goods for the cleaning, sanitary maintenance,
industrial, foodservice, laundry, medical and healthcare, food plant, bottling, pharmaceutical and cosmetic industries;

 

WHEREAS,
Pure wishes to have ICC manufacture certain Goods (as defined below) and to purchase these Goods from ICC; and

 

WHEREAS,
ICC desires to manufacture and sell the Goods to Pure.

 

NOW,
THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1.
Definitions. Capitalized terms have the meanings set forth or referred to in this Section.

 

“Action”
means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation,
citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other, whether at law,
in equity or otherwise.

 

“Affiliate”
of a Person means any other Person that directly or indirectly, through one or more intermediaries, Controls, is Controlled by,
or is under common Control with, such Person.

 

“Agreement”
has the meaning set forth in the preamble to this Agreement.

 

“Background
Intellectual Property Rights” means any and all Intellectual Property Rights, except for any Foreground Intellectual
Property Rights.

 

“Business
Day(s)” means the days reflected on a calendar mutually agreed upon by the Parties prior to the beginning of the calendar
year except for those the Parties designate as holidays or non-business days.

 

“Claim”
means any Action brought against a Person entitled to indemnification under Section ‎10.

 

“Confidential
Information” has the meaning set forth in Section ‎13.1.

 

“Confirmation”
has the meaning set forth in Section 3.3.

 

“Control”
(and with correlative meanings, the terms “Controlled by” and “under common Control with”) means, with
respect to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of another Person, whether through the ownership of voting securities, by contract, or otherwise.

 

    	 

    	 

    

 

“Defective”
means not conforming to the Product Warranty under Section ‎9.3.

 

“Defective
Goods” means goods shipped by ICC to Pure Parties pursuant to this Agreement that are Defective.

 

“Delivery
Date” means the confirmed delivery date (a) for Goods ordered as set forth in a Purchase Order or (b) for Goods shipped
as set forth in a Picking Order.

 

“Delivery
Location” means the ICC managed inventory location for delivery of the Goods specified in the applicable Purchase Order.
For Picking Orders, the Delivery Location is the dock awaiting pickup by the carrier.

 

“Disclosing
Party” has the meaning set forth in Section ‎13.1.

 

“Dispute”
has the meaning set forth in Section ‎17.16.

 

“Dispute
Notice” has the meaning set forth in Section ‎17.16.

 

“Effective
Date” has the meaning set forth in the preamble to this Agreement.

 

“Encumbrance”
means any charge, claim, community property interest, pledge, condition, equitable interest, lien (statutory or other), option,
security interest, mortgage, easement, encroachment, right of way, right of first refusal, or restriction of any kind, including
any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.

 

“Equipment”
means, collectively, the ICC Managed Equipment and the General Production Equipment.

 

“Force
Majeure Event” has the meaning set forth in Section ‎17.21.

 

“Forecast”
means, with respect to each period of succeeding [ * ], a good faith projection or estimate of Pure’s requirements for Goods
during the period. The Forecast based on information reasonably available at the time to Pure. The Forecast will allow ICC to
calculate and purchase the necessary components and raw materials for the Goods recognizing that those materials typically have
longer lead times than POs for which Pure issues to ICC for Goods.

 

“Foreground
Intellectual Property Rights” means any and all of the Intellectual Property Rights developed with respect to, or for
incorporation into, the Goods, that are either developed by Pure alone, by Pure and ICC jointly, by ICC alone, or as requested
in writing by Pure in connection with this Agreement.

 

“GAAP”
means U.S. generally accepted accounting principles in effect from time to time.

 

    	 	2	 

    	 

    

 

“General
Production Equipment” means equipment that is owned by ICC, may be used exclusively by ICC in the manufacturing and/or
assembly of finished and in-process Goods governed by the Intellectual Property Rights of Pure, and is deployed by ICC to manufacture
a variety of different products at ICC. For the avoidance of doubt, ICC Managed Equipment and General Production Equipment are
mutually exclusive categories.

 

“Goods”
means the goods identified on Schedule 1 and described in the Specifications.

 

“Governmental
Authority” means any federal, state, local or foreign government or political subdivision thereof, or any agency or
instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory
authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority
have the force of Law), or any arbitrator, court or tribunal of competent jurisdiction.

 

“Governmental
Order” means any order, writ, judgment, injunction, decree, stipulation, award or determination entered by or with any
Governmental Authority.

 

“ICC”
has the meaning set forth in the preamble to this Agreement.

 

“ICC
Contracts” means all contracts or agreements to which ICC is a party or to which any of its material assets are bound.

 

“ICC
Parties” means ICC, its Affiliates, customers (other than Pure), subcontractors and successors and assigns, and each
of their respective Representatives.

 

“ICC
Indemnified Parties” has the meaning set forth in Section 10.3.

 

“ICC
Managed Equipment” means equipment that is owned by Pure but located at ICC and which is exclusively used in the manufacturing
and/or assembly of finished and in-process Goods governed by the Intellectual Property Rights of Pure. [ * ] For the avoidance
of doubt, ICC Managed Equipment and General Production Equipment are mutually exclusive categories.

 

“ICC’s
Intellectual Property” means all Intellectual Property Rights owned by or licensed to ICC, including any of ICC’s
Background Intellectual Property Rights used in the design, production, and manufacturing of the Goods.

 

“ICC’s
Property” has the meaning set forth in Section ‎14.4.

 

“Initial
Term” has the meaning set forth in Section ‎6.1.

 

“Inspection
Period” has the meaning set forth in Section ‎4.5.

 

    	 	3	 

    	 

    

 

“Intellectual
Property Rights” means all industrial and other intellectual property rights comprising or relating to: (a) Patents;
(b) Trademarks; (c) internet domain names, whether or not Trademarks, registered by any authorized private registrar or Governmental
Authority, web addresses, web pages, website, and URLs; (d) works of authorship, expressions, designs and design registrations,
whether or not copyrightable, including copyrights and copyrightable works, software and firmware, application programming interfaces,
architecture, files, records, schematics, data, data files, and databases and other specifications and documentation; (e) Trade
Secrets; (f) semiconductor chips, mask works and the like; and (g) all industrial and other intellectual property rights, and
all rights, interests and protections that are associated with, equivalent or similar to, or required for the exercise of, any
of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications
for, and renewals or extensions of, such rights or forms of protection pursuant to the Laws of any jurisdiction throughout in
any part of the world.

 

“Inventory
Bank” means a quantity of safety stock of raw materials, packaging, labels or work in progress, at the most-current
design level, sufficient to fulfill Pure’s projected requirements of the Goods as set forth in any Purchase Orders and/or
rolling Forecast issued to ICC hereunder.

 

“Law”
means any statute, law, ordinance, regulation, rule, code, constitution, treaty, common law, Governmental Order or other requirement
or rule of law of any Governmental Authority.

 

“Losses”
has the meaning set forth in Section ‎10.1.

 

“Manufacturing
Facility” means ICC’s physical location for the manufacturing of Goods located at 1100 Central Industrial Drive,
St. Louis, MO 63110.

 

“Nonconforming
Goods” means any goods received by Pure Parties from ICC that: (a) do not conform to the product item number listed
in the applicable Purchase Order / Picking Order; (b) were not manufactured by ICC to the Specifications; (c) are otherwise Defective
due to the sole action of ICC; or (d) exceed the quantity of Goods ordered by Pure pursuant to this Agreement or any Purchase
Order / Picking Order. Where the context requires, Nonconforming Goods are deemed to be Goods for purposes of this Agreement.

 

“Notice”
has the meaning set forth in Section ‎17.5.

 

“Order
Fulfillment Fees” has the meaning set forth in Section 5.5.

 

“Party”
has the meaning set forth in the preamble to this Agreement.

 

“Patents”
means all patents (including all reissues, divisionals, provisionals, continuations and continuations-in-part, re-examinations,
renewals, substitutions and extensions thereof), patent applications, and other patent rights and any other Governmental Authority-issued
indicia of invention ownership (including inventor’s certificates, petty patents, and patent utility models).

 

“Permits”
means permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained
or required to be obtained, from any Governmental Authority.

 

“Person”
means any individual, partnership, corporation, trust, limited liability entity, unincorporated organization, association, Governmental
Authority or any other entity.

 

    	 	4	 

    	 

    

 

“Personnel”
of a Party means any agents, employees, contractors or subcontractors engaged or appointed by such Party.

 

“Product
Warranty” has the meaning set forth in Section ‎9.3.

 

“Picking
Order” means Pure’s picking order issued to ICC for the shipment of Goods from Pure’s on-site ICC warehouse
inventory to Pure Parties, which may, among other things, specify items such as: (a) the Goods to be shipped, including item number;
(b) the quantity of each of the Goods; (c) the Delivery Date; (d) the billing address; and (e) the Delivery Location; in each
case, including all terms and conditions attached to, or incorporated into, such picking order issued by Pure to ICC under such
picking order.

 

“Purchase
Order “ means Pure’s purchase order issued to ICC for the manufacture of Goods, which may, among other things,
specify items such as: (a) the Goods to be purchased, including item number; (b) the quantity of each of the Goods; (c) the Delivery
Date; (d) the unit Transfer Price for each of the Goods to be purchased; (e) the billing address; and (f) the Delivery Location;
in each case, including all terms and conditions attached to, or incorporated into, such purchase order issued by Pure to ICC
under such purchase order.

 

“Pure”
has the meaning set forth in the preamble to this Agreement.

 

“Pure
Contracts” means all contracts or agreements to which Pure is a party or to which any of its material assets are bound.

 

“Pure
Indemnified Parties” has the meaning set forth in Section 10.1.

 

“Pure
Parties” means Pure, its Affiliates, customers, subcontractors and successors and assigns, and each of their respective
Representatives.

 

“Pure
Property” has the meaning set forth in Section 14.1‎(a) and includes the ICC Managed Equipment.

 

“Pure’s
Intellectual Property” means all Intellectual Property Rights owned by or licensed to Pure, including all Foreground
Intellectual Property Rights and any of Pure’s Background Intellectual Property Rights used in the design, production, and
manufacturing of the Goods.

 

“Receiving
Party” has the meaning set forth in Section ‎13.1.

 

“Renewal
Term” has the meaning set forth in Section ‎6.2.

 

“Representatives”
means a Party’s Affiliates and each of their respective Personnel, officers, directors, partners, shareholders, attorneys,
third-party advisors, successors and permitted assigns.

 

“Slow-Moving
Inventory Bank” means any unique raw materials, packaging and other components from ICC that have not moved at all or
are expected to turn at a rate less than one (1) inventory rotation per year based upon the prior [ * ] of Purchase Orders. Both
Parties may mutually agree to have certain items excluded from the Slow-Moving Inventory Bank.

 

“SDC”
means Pure’s patented antimicrobial, water soluble, silver salt of citric acid based on a stabilized silver ion complex
produced at various concentrations by a unique electrochemical process involving silver and citric acid; this substance is used
as a raw material in the production of various goods and use dilutions and distributed under multiple brand names.

 

    	 	5	 

    	 

    

 

“SOPs”
means Pure’s processes and procedures for the manufacture of Goods, [ * ]

 

“Specifications”
means the specifications for the Goods attached hereto as Exhibit A.

 

“Taxes”
means any and all present and future sales, income, stamp and other taxes, levies, imposts, duties, deductions, charges, fees
or withholdings imposed, levied, withheld or assessed by any Governmental Authority, together with any interest or penalties imposed
thereon.

 

“Term”
has the meaning set forth in Section ‎6.2.

 

“Trademarks”
means all rights in and to U.S. and foreign trademarks, service marks, trade dress, trade names, brand names, logos, symbols,
trade dress, corporate names and domain names and other similar designations of source, sponsorship, association or origin, together
with the goodwill symbolized by any of the foregoing, in each case whether registered or unregistered and including all registrations
and applications for, and renewals or extensions of, such rights and all similar or equivalent rights or forms of protection in
any part of the world.

 

“Trade
Secrets” means all inventions, discoveries, trade secrets, business and technical information and know-how, databases,
data collections, patent disclosures and other confidential and proprietary information and all rights therein.

 

“Transfer
Price” has the meaning set forth in Section ‎5.1.

 

“UCC”
means the Uniform Commercial Code, as adopted in the State of California.

 

“U.S.”
means the United States of America.

 

2.
Purchase and Sale of Goods.

 

2.1
Purchase and Sale. Subject to the terms and conditions of this Agreement, during the Term, Pure shall purchase Goods from
ICC, and ICC shall manufacture and sell Goods to Pure, from the ICC Manufacturing Facility, at the Transfer Prices and in the
quantities set forth on Schedule 1 attached hereto. Schedule 1 contains: (a) a description of the Goods to be manufactured and
sold hereunder; (b) the purchase price for each of the Goods; (c) the case quantity of the Goods; and (d) the minimum order quantity
that Pure is required to purchase on a Purchase Order for ICC to manufacture the Goods. Unless otherwise provided in Schedule
1, subject to the terms and conditions of this Agreement, Pure shall purchase from ICC, and ICC shall manufacture and sell to
Pure, 100% of Pure’s requirements of the Goods. The Parties shall, from time to time, amend Schedule 1 to reflect any agreed
upon revisions to any of the terms described in the foregoing clauses (a)-(c); provided that no such revisions will modify this
Agreement or be binding on the Parties unless such revisions have been fully approved in a signed writing by authorized Representatives
of both Parties. Notwithstanding the foregoing and in accordance with Section 5.1 herein, ICC reserves the right to change the
Transfer Price to appropriately reflect increased or decreased costs in fulfilling its obligations under this Agreement.

 

    	 	6	 

    	 

    

 

2.2
Terms of Agreement and Pure’s Purchase Order / Picking Order Prevail; Order of Precedence. The Parties intend for
the express terms and conditions contained in this Agreement (including any Schedules and Exhibits hereto) and in any Purchase
Order / Picking Order to exclusively govern and control each of the Parties’ respective rights and obligations regarding
the manufacture, purchase and sale of the Goods, and the Parties’ agreement is expressly limited to such terms and conditions.
Any additional, contrary or different terms or conditions contained in any Confirmation, Purchase Order / Picking Order or any
of ICC’s invoices or other communications will be viewed as supplemental and any such revisionary documentation shall govern
and control each Party’s rights and obligations coinciding with this Agreement (including any Schedules and Exhibits hereto).

 

2.3
Quantity. Quantity includes Pure’s production, replacement and Inventory Bank requirements of the Goods and raw materials;

 

(a)
throughout the Term, ICC and Pure shall jointly review the Forecast every [ * ]. The Parties shall agree in this review on the
amount of capacity that ICC shall maintain for expected short and long-term increases or decreases in demand;

 

(b)
throughout the Term, ICC shall maintain an Inventory Bank sufficient to build the Goods specified in the Forecast. ICC shall also
obtain additional raw materials (including chemicals and packaging components) necessary to fulfill all Confirmations of Purchase
Orders (as defined in Section 3) to the extent that such Confirmations of Purchase Orders are expected to exceed the Goods specified
in the Forecast; and

 

(c)
commencing on the Effective Date and each [ * ] thereafter, Pure
shall provide ICC with a forecast indicating good faith estimates of Goods that Pure may need for the succeeding [ * ]. These
Forecasts are for informational purposes only and do not create any binding obligations on behalf of either Party.

 

Without
limitation of the foregoing, under no circumstances will Pure be obligated to purchase any quantity of Goods in excess of its
actual requirements of the Goods.

 

2.4
No Right to Manufacture or Sell Competitive Products Containing SDC to Other Persons. To the extent permissible under applicable
Law, ICC shall not, without the prior written consent of Pure or by separate agreement with Pure, use any Pure Intellectual Property
(including Foreground Intellectual Property Rights and Background Intellectual Property Rights) to manufacture or sell to any
Person other than Pure, or enter into any agreement with any Person other than Pure to manufacture or sell, products containing
SDC (including the Goods) that are similar to or competitive with the Goods. This Section ‎2.4 shall survive expiration or
termination of this Agreement. The Parties acknowledge that ICC has been for its entire history, and remains actively engaged
in, formulating, developing and manufacturing cleaning and disinfecting products that do not contain SDC, and selling such products
to distributors and customers. The Parties further acknowledge that such products may be similar to or competitive with the Goods.

 

2.5
Retained Rights. ICC understands and agrees Pure has the right to manufacture SDC concentrate and the Goods on its own
[ * ]

 

    	 	7	 

    	 

    

 

3.
Ordering Procedure.

 

3.1
Purchase Orders. Pure shall issue Purchase Orders to ICC in written or electronic form (including e-mail). For the avoidance
of doubt, Pure shall only be obligated to purchase from ICC, and ICC shall be obligated to sell to Pure, the Goods listed on Schedule
1 hereto or otherwise specified in a Purchase Order.

 

(a)
[ * ]

 

(b)
As set forth in Section 3.3, within [ * ] of receipt of a Purchase Order from Pure, ICC will send Pure a Confirmation (as defined
below) for the Purchase Order via e-mail, which such Confirmation shall list the Goods, quantities, lead time, and transportation
details for the Purchase Order.

 

(c)
The lead time on all Purchase Orders [ * ] for the Goods. Any goods or products not listed on Schedule 1 attached hereto may be
subject to a longer lead time.

 

(d)
Once ICC has completed production of the Good(s) on the Purchase Order, ICC shall invoice Pure for the Good(s) and transfer the
Goods to the Delivery Location.

 

3.2
Picking Orders. Pure shall issue Picking Orders to ICC in written or electronic form (including e-mail). For the avoidance
of doubt, Pure shall only issue Picking Orders for Goods held in the Pure-owned inventory located at ICC.

 

(a)
[ * ]

 

(b)
The lead time on all Picking Orders [ * ] for the Goods. Any goods or products not listed on Schedule 1 attached hereto may be
subject to a longer lead time. The Goods or product requested on a Picking Order must be produced, transacted and/or expected
to be available in the Pure-owned inventory location before [ * ] lead time will begin.

 

(c)
Once ICC has completed the Picking Order, ICC shall invoice Pure for any associated fulfillment and storage charges according
to Schedule 1 attached hereto and transfer the Goods to the Delivery Location.

 

(d)
All required documentation required for a Picking Order (including bill of lading, carrier selection, special Good(s) marking
or labeling) must be included with the submission of the Picking Order by Pure. Any changes or delays in this documentation may
result in [ * ] lead time.

 

    	 	8	 

    	 

    

 

3.3
Acceptance, Rejection, and Cancellation of Purchase Orders / Picking Orders. ICC shall confirm to Pure the receipt of each
Purchase Order / Picking Order issued hereunder (each, a “Confirmation”) within [ * ] following ICC’s
receipt thereof in written or electronic form. In addition to any applicable requirements contained in this Section 3, each Confirmation
must reference (a) Pure’s Purchase Order / Picking Order number, (b) confirm acceptance of the Purchase Order / Picking
Order or advise Pure of ICC’s rejection of such Purchase Order / Picking Order, and (c) the date of acceptance or rejection
and the basis for rejection, if applicable. Pure may withdraw any Purchase Order / Picking Order prior to ICC’s acceptance
thereof. ICC may only reject a Purchase Order / Picking Order in accordance with Section 5.8 herein or if (a) ICC has sent Pure
a Notice of termination under Section ‎6.4 or (b) the applicable Purchase Order / Picking Order includes terms and conditions
that supplement or conflict with those contained in this Agreement, which ICC is unwilling to accept or (c) the order reflects
[ * ] the Forecast. ICC may not cancel any previously accepted Purchase Order / Picking Order hereunder.

 

4.
Shipment, Delivery, Acceptance, and Inspection.

 

4.1
Shipment and Delivery Requirements. Time, quantity and delivery to the Delivery Location are of the essence under this
Agreement. ICC shall procure materials for, fabricate, assemble, produce, pack, mark and deliver Goods strictly in the quantities,
by the methods, to the Delivery Locations and by the Delivery Dates, specified in this Agreement or in an applicable Purchase
Order / Picking Order. Delivery times will include the period until such time that Goods are actually received at the Delivery
Location. If ICC does not comply with any of its delivery obligations under this Section ‎4 for a reason other than an event
provided for in Section 17.21 (Force Majeure), Pure may, in coordination with ICC, (a) approve a revised Delivery Date, or (b)
cancel the applicable Purchase Order / Picking Order. Unless otherwise expressly agreed to by the Parties in writing, ICC may
not make partial shipments of Goods to Pure Parties.

 

4.2
Transfer of Title and Risk of Loss.

 

(a)
Title to Goods shipped under any Purchase Order passes to Pure upon the earliest to occur of (i) delivery of the Goods to Pure
Delivery Location, (ii) payment of any portion of the Transfer Price for the Goods by Pure, (iii) Pure’s acceptance of the
Goods and (iv) ICC’s tender of the Goods to a carrier. For the avoidance of doubt, in the event title passes pursuant to
clauses (i), (iii) or (iv) of the foregoing, title will still transfer to Pure even if ICC has not been paid for such Goods, provided
that Pure will not be relieved of its obligation to pay for such Goods in accordance with the terms hereof.

 

(b)
Notwithstanding any agreement between Pure and ICC concerning transfer of title or responsibility for shipping costs, risk of
loss to Goods delivered under any Purchase Order passes to Pure upon receipt and acceptance by Pure at the Delivery Location,
and ICC will bear all risk of loss or damage with respect to Goods until Pure’s receipt and acceptance of such Goods in
accordance with the terms hereof.

 

    	 	9	 

    	 

    

 

(c)
ICC shall ship all Goods in accordance with the Picking Order. All Goods per the Picking Order shall be available for pickup by
the assigned carrier at the time specified by ICC on the applicable shipment date. All Goods shall be delivered and shipped Ex
Works place of manufacture (Incoterms 2010). Title and risk of loss and damages to Goods shall pass from Pure to Pure Parties
upon delivery by ICC to the designated carrier.

 

4.3
Packaging and Labeling. ICC shall properly pack, mark and ship Goods as reasonably instructed by Pure and otherwise in
accordance with applicable Law and industry standards, and shall provide Pure with shipment documentation showing the Purchase
Order / Picking Order number, ICC’s identification number for the subject Goods, the quantity of pieces in shipment, the
number of cartons or containers in shipment, ICC’s name, and the bill of lading number.

 

4.4
Ingredients and Materials Disclosure. Upon Pure’s written request, ICC shall promptly provide to Pure, in such form
and detail (including the brand or supplier) as Pure requests, a list of all ingredients and materials incorporated in the Goods,
the amount of such ingredients and materials, and information concerning any changes in or additions to such ingredients and materials.
ICC shall not make any changes in or additions to such ingredients and materials without the written consent of Pure.

 

(a)
Without limitation of the foregoing, upon a Party’s written request, the other Party shall provide all information (in sufficient
detail), as applicable with written certifications thereof, to enable the requesting Party to reasonably comply with all of its
due diligence, disclosure and audit requirements.

 

4.5
Inspection. Goods are subject to Pure Parties’ inspection and approval or rejection notwithstanding Pure Parties’
prior receipt of or payment for the Goods. Pure Parties shall have a reasonable period of time, not to be more than [ * ] following
receipt of the Goods at the Delivery Location (“Inspection Period”), to inspect all Goods received under this
Agreement and to inform ICC, in writing, of Pure Parties’ rejection of any Nonconforming Goods. Pure will coordinate with
ICC and may return to ICC any or all units of rejected Goods that constitute Nonconforming Goods. For Nonconforming Goods, Pure
may elect to (a) require ICC, at ICC’s sole cost, to repair or replace the rejected Goods at the Pure Parties’ location,
(b) produce similar goods itself (and apply such production quantities against Pure’s quantity requirements hereunder),
(c) repair the Goods itself or have a third party repair the Goods, or (d) retain the rejected Goods; in each case without limiting
the exercise by Pure of any other rights available to Pure under this Agreement or pursuant to applicable Law. All returns of
Nonconforming Goods to ICC are at ICC’s sole risk and expense. Goods that are not rejected within the Inspection Period
will be deemed to have been accepted by Pure Parties; provided, however, that Pure Parties’ acceptance of any Goods will
not be deemed to be a waiver or limitation of ICC’s obligations pursuant to this Agreement (or any breach thereof), including
those obligations with respect to ICC’s Product Warranty and ICC’s duty to indemnify Pure Parties.

 

    	 	10	 

    	 

    

 

5.
Transfer Price and Payment.

 

5.1
Transfer Price and Taxes. Unless otherwise mutually agreed upon in a Purchase Order / Picking Order, Pure shall purchase
the Goods from ICC at the prices set forth on Schedule 1 attached hereto (“Transfer Prices”). All Transfer
Prices include, and ICC is solely responsible for, all costs and expenses relating to the making of SDC, blending, filling, bottling,
packing, and any other similar financial contributions or obligations relating to procuring the raw materials and components for
the production, manufacture, and delivery of the Goods. ICC is responsible for the manufacturing tax and insurance on the General
Production Equipment and/or property. For the avoidance of doubt, Pure is solely responsible for any personal property tax and
related taxes from the City of St. Louis on the ICC Managed Equipment, Pure Property and inventory; any sales or use tax due on
Pure’s purchase of the Goods or sales of the Goods to Pure’s customers; and California Mills tax on Pure’s sale
or shipment of applicable Goods or products into the State of California. Pure is responsible for the manufacturing tax and insurance
on the ICC Managed Equipment, Pure Property, inventory or equipment located at ICC. The Parties must agree in writing to any additions
to or changes in Transfer Prices, or Order Fulfillment Fees applied to Purchase Orders / Picking Orders. Notwithstanding the foregoing,
any price change will go into effect [ * ] review of Transfer Prices set forth in Section 7.4.

 

5.2
Invoices. ICC shall issue invoices to Pure for all Goods manufactured to orders. Each invoice for Goods must set forth
in reasonable detail the amounts payable by Pure under this Agreement and contain the following information, as applicable: ICC’s
name; invoice number; date; Purchase Order / Picking Order number; terms; ship-to address; quantity of Goods delivered; ICC item
number; Pure item number; lot number of Goods; and any other information necessary for identification and control of the Goods.
Pure reserves the right to return and withhold payment due to any invoices or related documents that are inaccurate or incorrectly
submitted to Pure. The Parties shall seek to resolve any invoice disputes expeditiously and in good faith in accordance with the
dispute resolution provisions set forth in Section ‎17.16. Any payment by Pure of an invoice prior to the end of the Inspection
Period is not an acceptance of any nonconforming element or terms on such invoice or the related Goods.

 

5.3
Payment. Except for any amounts disputed by Pure in good faith, ICC’s accurate and correctly submitted invoices will
be payable [ * ] following ICC’s invoice date. Pure may withhold payment pending receipt of evidence, in such form and detail
as Pure may reasonably direct, of the absence of any Encumbrances on the Goods. Any payment by Pure prior to the end of the Inspection
Period for Goods will not be deemed acceptance of the Goods or waive Pure’s right to inspect. Pure will be entitled to any
discounts allowable by ICC for prompt payment even though Pure is unable to make payment within the time limits set by ICC if
such failure is due to ICC’s actions. Pure shall make all payments in U.S. dollars by wire transfer or automated clearing
house. ICC shall have the right to withhold Goods with past due invoices that are [ * ] after ICC’s invoice date that Pure
has not disputed in good faith. If such past due invoices are outstanding for [ * ] after ICC’s invoice date and ICC elects
to withhold the Goods, ICC shall have the right to refrain from starting the lead time on additional Purchase Orders / Picking
Orders and/or the next Forecast until such past due invoices have been paid in full.

 

5.4
Setoff; Contingent or Disputed Claims. Except as mutually agreed upon by the Parties or otherwise contemplated by this
Agreement, each Party shall perform its obligations under this Agreement without setoff, deduction or recoupment of any kinds
for amounts owed or payable by the other Party whether under this Agreement, applicable Law, or otherwise and whether relating
to the other Party’s breach, bankruptcy, or otherwise. If an obligation of a Party is disputed, contingent or unliquidated,
the Parties shall mutually agree upon a deferral, if any, of such obligation until such dispute or contingency is resolved or
the obligation is liquidated.

 

5.5
Bankruptcy. In the event of a bankruptcy of either Party, the Party not in bankruptcy may withhold its obligations under
this Agreement until the potential for losses is eliminated. ICC shall have a lien on unpaid Goods in the event Pure petitions
for relief in bankruptcy.

 

    	 	11	 

    	 

    

 

5.6
Warehouse Storage Fees. Pure shall pay ICC a storage cost for Pure-owned inventory and the Slow-Moving Inventory Bank at
the rate reflected on Schedule 1 attached hereto.

 

5.7
Order Fulfillment Fees. Pure shall pay ICC for costs associated with the servicing and fulfillment by ICC to ship certain
Goods to Pure Parties on Pure’s behalf as set forth on Schedule 1 attached hereto (“Order Fulfillment Fees”).

 

5.8
Credit Limit. Pursuant to ICC’s
normal business practices, Pure shall apply for an aggregate credit limit from ICC (the “Credit Limit”), which ICC
will assign based on Pure’s current credit profile and subject to ICC’s approval and periodic review. ICC will provide
Pure with a [ * ] notice of any decrease in the Credit Limit, unless within the [ * ], Pure has had past due invoices that are
[ * ] after ICC’s invoice date that Pure has not disputed in good faith, in which case, ICC may decrease the Credit Limit
without such [ * ] notice. In the event the aggregate amount outstanding by Pure at any time under ICC’s invoices exceeds
the amount of the Credit Limit, ICC shall have the right to withhold Goods from Pure or reject a Purchase Order / Picking Order
from Pure until such time as: (i) the aggregate amount outstanding under ICC’s invoices no longer exceeds the amount of
the Credit Limit; (ii) Pure’s Credit Limit is reviewed by ICC and ICC determines, in its sole discretion, to increase the
Credit Limit or (iii) Pure prepays for Picking Order Fulfillment Fees. ICC’s rights in this Section 5.8 are in addition
to ICC’s rights in Section 3.3 to reject a Purchase Order / Picking Order.

 

6.
Term; Termination.

 

6.1
Initial Term. The term of this Agreement commences on the Effective Date and continues for a period [ * ] unless it is
earlier terminated pursuant to the terms of this Agreement or applicable Law (the “Initial Term”).

 

6.2
Renewal Term. Upon expiration of the Initial Term, the term of this Agreement will automatically renew for [ * ] (the “Renewal
Term”) unless either Party provides written Notice of non-renewal [ * ] prior to the end of the Initial Term (the Initial
Term and the Renewal Term, collectively, the “Term”). If the Initial Term is renewed pursuant to this Section
‎6.2, the terms and conditions of this Agreement during the Renewal Term will be the same as the terms in effect immediately
prior to such renewal. In the event either Party provides timely Notice of its intent not to renew this Agreement, this Agreement
shall terminate on the expiration of the Initial Term.

 

6.3
Pure’s Right to Terminate for Cause. Pure may terminate this Agreement, by providing written Notice to ICC:

 

(a)
if ICC denies any of its obligations under this Agreement;

 

 

(b)
except as otherwise specifically provided under this Section, if ICC is in material breach of any representation, warranty or
covenant of ICC under this Agreement, and either the breach cannot be cured or, if the breach can be cured, it is not cured by
ICC within a commercially reasonable period of time under the circumstances but in no case [ * ] following ICC’s receipt
of written Notice of such breach;

 

    	 	12	 

    	 

    

 

(c)
notwithstanding the generality of Section 6.3 ‎(b), if ICC fails to timely deliver Goods within [ * ] from the Delivery Date
in conformity with the requirements of, and otherwise in accordance with, the terms and conditions of this Agreement;

 

(d)
if ICC (i) becomes insolvent or is generally unable to pay, or fails to pay, its debts as they become due, (ii) files or has filed
against it, a petition for voluntary or involuntary bankruptcy or otherwise becomes subject, voluntarily or involuntarily, to
any proceeding under any domestic or foreign bankruptcy or insolvency Law, (iii) makes or seeks to make a general assignment for
the benefit of its creditors, or (iv) applies for or has appointed a receiver, trustee, custodian or similar agent appointed by
order of any court of competent jurisdiction to take charge of or sell any material portion of its property or business;

 

(e)
if ICC fails to provide Pure, within a commercially reasonable period of time after Pure’s request (but in no case [ * ]
after such request) with adequate and reasonable assurance of ICC’s financial and operational capability to perform timely
any of ICC’s obligations under this Agreement;

 

(f)
if, as a result of any breach by ICC of any of its obligations under this Agreement, Pure’s customer requires that Pure
obtain another supplier of Goods;

 

(g)
if ICC takes any action, or fails to take any action, required under this Agreement or any other agreement between Pure and ICC,
or as reasonably requested by Pure, the result of which is any imminent interruption or delay, or the threat of an imminent interruption
or delay, in any production at any of Pure’s or its customer’s manufacturing facilities;

 

(h)
if, without obtaining Pure’s prior written consent, such written consent not to be unreasonably withheld, (i) ICC sells,
leases or exchanges a material portion of Equipment for the manufacture of Goods, (ii) [ * ];

 

(i)
upon the occurrence of any other event constituting grounds for termination set forth in any other sections of this Agreement
and Section 17.21;

 

(j)
if ICC repudiates any of its obligations under this Agreement; or

 

(k)
if ICC fails to provide Pure, within a commercially reasonable period of time after Pure’s request (but in no case [ * ]
after such request) with adequate and reasonable assurance of ICC’s ability to perform its obligations under this Agreement.

 

    	 	13	 

    	 

    

 

Any
termination under this Section will be effective upon ICC’s receipt of Pure’s written Notice of termination or such
later date (if any) set forth in such Notice of termination. Upon the occurrence of any of the events described under this Section,
Pure may, in addition to any of its other rights under this Agreement or applicable Law, immediately suspend its performance under
all or any part of this Agreement, without any liability of Pure to ICC, and, notwithstanding anything to the contrary contained
in this Agreement (including the limitations set forth in Section ‎11) Pure may, at its election, recover any and all damages
(including direct, indirect, incidental and consequential damages), costs (including attorneys’ and other professionals’
fees and costs), expenses and losses incurred by Pure as a result of any event described under this Section or any breach of this
Agreement by ICC.

 

6.4
ICC’s Right to Terminate for Cause. ICC may terminate this Agreement, by providing written Notice to Pure:

 

(a)
except as otherwise specifically provided under this Section, if Pure is in material breach of any representation, warranty or
covenant of Pure under this Agreement, and either the breach cannot be cured or, if the breach can be cured, it is not cured by
Pure within a commercially reasonable period of time (but in no case [ * ]) following Pure’s receipt of written Notice of
such breach;

 

(b)
if Pure (i) becomes insolvent or is generally unable to pay, or fails to pay, its debts to ICC within [ * ] after the invoice
date, (ii) files or has filed against it, a petition for voluntary or involuntary bankruptcy or otherwise becomes subject, voluntarily
or involuntarily, to any proceeding under any domestic or foreign bankruptcy or insolvency Law, (iii) makes or seeks to make a
general assignment for the benefit of its creditors, or (iv) applies for or has appointed a receiver, trustee, custodian or similar
agent appointed by order of any court of competent jurisdiction to take charge of or sell any material portion of its property
or business;

 

(c)
if Pure takes any action, or fails to take any action, required under this Agreement or any other agreement between Pure and ICC,
the result of which is any imminent interruption or delay, in any production of Goods;

 

(d)
upon the occurrence of any other event constituting grounds for termination set forth in any other sections of this Agreement
and Section ‎17.21;

 

(e)
if Pure repudiates any of its obligations under this Agreement; or

 

(f)
if Pure fails to provide ICC, within a commercially reasonable period of time after ICC’s request (but in no case [ * ]
after such request) with adequate and reasonable assurance of Pure’s ability to perform its obligations under this Agreement.

 

    	 	14	 

    	 

    

 

Any
termination under this Section will be effective upon Pure’s receipt of ICC’s written Notice of termination or such
later date (if any) set forth in such Notice of termination. Upon the occurrence of any of the events described under this Section,
ICC may, in addition to any of its other rights under this Agreement or applicable Law, immediately suspend its performance under
all or any part of this Agreement, without any liability of ICC to Pure, and, notwithstanding anything to the contrary contained
in this Agreement (including the limitations set forth in Section ‎11) ICC may, at its election, recover any and all damages
(including direct, indirect, incidental and consequential damages), costs (including attorneys’ and other professionals’
fees and costs), expenses and losses incurred by ICC as a result of any event described under this Section or any breach of this
Agreement by Pure.

 

6.5
Effect of Expiration or Termination.

 

(a)
Immediately upon the effectiveness of a Notice of termination delivered by a Party to the other Party hereunder (as stated in
such Notice), ICC shall, unless otherwise mutually agreed upon by the Parties, and subject to ICC’s obligation provide resourcing
cooperation under Section ‎6.6:

 

(i)
promptly terminate all performance under this Agreement and under any outstanding Purchase Orders / Picking Orders;

 

(ii)
transfer title and deliver to Pure all finished Goods completed prior to effectiveness of the Notice of termination and for which
Pure has made payment; and

 

(iii)
return to Pure all Pure Property and any other property furnished by or belonging to Pure or any of Pure’s customers, or
dispose of such Pure Property or other property in accordance with Pure’s instructions (provided that Pure will reimburse
ICC for the actual, reasonable costs associated with such disposal).

 

(b)
Expiration or termination of the Term will not affect any rights or obligations of the Parties that:

 

(i)
come into effect upon or after termination or expiration of this Agreement; or

 

(ii)
otherwise survive the expiration or earlier termination of this Agreement pursuant to Section ‎17.4 and were incurred by the
Parties prior to such expiration or earlier termination.

 

(c)
Upon the expiration or earlier termination of this Agreement, each Party shall:

 

(i)
return to the other Party all documents and tangible materials (and any copies) containing, reflecting, incorporating or based
on the other Party’s Confidential Information;

 

(ii)
permanently erase all of the other Party’s Confidential Information from its computer systems, except where prohibited by
applicable Law; and

 

(iii)
upon the other Party’s written request, certify in writing to such other Party that it has complied with the requirements
of this Clause 6.5‎(c).

 

(d)
Subject to Section 6.5‎(b), neither Party will be liable to the other Party for any damage of any kind (whether direct or
indirect) incurred by the other Party by reason of the expiration or termination of this Agreement. Termination of this Agreement
will not constitute a waiver of any of the terminating Party’s rights, remedies, or defenses under this Agreement, at law,
in equity or otherwise.

 

    	 	15	 

    	 

    

 

6.6
Resourcing Cooperation. Upon the expiration or earlier termination of this Agreement for any reason, Pure will purchase
from ICC any or all work-in-process and any unique raw materials inventory relating to this Agreement, the production of the Goods,
and the Goods produced to the Forecast, including all unique packaging materials and labels. In addition, upon the expiration
or earlier termination of this Agreement for any reason except non-payment by Pure, to the extent requested by Pure in writing,
ICC shall take the following actions and such other actions as may be reasonably requested by Pure in an accepted Purchase Order
to transition production of Goods from ICC to an alternative seller without production disruptions:

 

(a)
manufacture, deliver and sell to Pure a sufficient quantity of Goods (including any or all finished Goods) to ensure that the
transition will proceed smoothly and without interruption or delay to Pure’s or Pure’s customers’ production
of products incorporating the Goods, with pricing equivalent to the pricing in effect immediately before expiration or termination;

 

(b)
ICC shall share the supplier contact information for any raw materials, components and other items included as part of the Goods;

 

(c)
sell to Pure, at ICC’s actual cost, any or all work-in-process and any raw-materials inventory relating to this Agreement
and any outstanding Purchase Orders; and

 

(d)
Pure shall have first rights of refusal to purchase any or all of ICC’s Property used by ICC to manufacture the Goods.

 

6.7
Termination by Mutual Agreement. This Agreement may be terminated as mutually agreed upon by the Parties in writing.

 

7.
Certain Obligations of ICC and Pure.

 

7.1
Quality Standards.

 

(a)
ICC shall meet or exceed Pure’s Specifications for the Goods as adopted by Pure from time to time, and which are provided
by Pure to ICC in writing and accepted by ICC. At Pure’s request, ICC shall furnish to Pure test samples of Goods as reasonably
required by Pure to determine if their manufacture is in accordance with the Specifications furnished by Pure. ICC shall perform
quality inspections of Goods before delivery and shall certify inspection results in the manner reasonably requested by Pure.
To the extent that ICC meets or exceeds Pure’s Specifications for the Goods, ICC shall not be liable or have any responsibility
for the finished Goods. If ICC did not meet or exceed Pure’s Specifications for the Goods, ICC shall be responsible for
replacement of the finished Goods. ICC shall work together with Pure to achieve global process improvements in the manufacture
of the Goods, including in the areas of technology, quality, service, responsiveness, delivery, and cost. At Pure’s request,
ICC’s representatives shall meet with Pure to review the progress made on these objectives.

 

(b)
ICC shall provide reasonable support as requested by Pure to address and correct quality concerns. In addition to its other rights
and remedies, Pure may hold ICC responsible for reasonable, actual costs associated with quality-issue investigation and containment
to the extent the Parties agree that such costs were caused by ICC’s acts or omissions. ICC may hold Pure liable and responsible
for reasonable, actual costs associated with a formula quality investigation, rectification and containment to the extent such
investigation, rectification and containment is requested by Pure. If Pure requests ICC to run any tests on Pure formulas, it
must request so in writing. ICC does not warrant product formulation for fitness for use. Pure shall communicate in writing to
ICC any changes requested by Pure to the product formulation, manufacture, packaging, decoration, labeling or classification of
the Goods. Upon receipt of such a request, ICC shall initiate the requisite change events within the framework of ICC’s
Quality Management System.

 

    	 	16	 

    	 

    

 

(c)
ICC shall, as mutually agreed upon with Pure, work to identify ways to improve the quality, performance standards and technology
of the Goods, including through participation in Pure’s quality improvement initiatives.

 

(d)
ICC shall not be liable for claims resulting from the Goods failing to be (i) fully developed in terms of stability, (ii) compliant
with regulatory requirements, including occupational safety and environmental regulations or (iii) fit for their intended use.

 

7.2
Protection Against Supply Interruptions. For the amount of Goods and raw materials or component parts included in the Forecast
and any mutually agreed upon raw material stocking quantitates, ICC shall, at ICC’s sole cost and expense, take such actions
as are necessary or appropriate to ensure the uninterrupted supply of Goods to Pure for [ * ] during any foreseeable or anticipated
event or circumstance that could interrupt or delay ICC’s performance under this Agreement, including any labor disruption,
whether or not resulting from the expiration of ICC’s labor contracts (and whether or not such occurrence constitutes a
Force Majeure Event hereunder).

 

7.3
Duty to Inform. A Party shall promptly provide written Notice to the other Party of any of the following events or occurrences,
or any facts or circumstances that may give rise to any of the following events or occurrences: (a) any failure by the notifying
Party to perform any of its obligations under this Agreement; (b) any delay in delivery of Goods; (c) any defects or quality problems
relating to Goods; (d) any deficiency in Pure specifications, samples, prototypes or test results relating to this Agreement;
(e) any failure by the notifying Party, or its subcontractors, to comply with Law; (f) any material adverse effect on the notifying
Party’s business or financial condition, including any going concern, change in management, sale, lease or exchange of a
material portion assets, a change in Control, or the breach of any loan covenants or other material obligations of the notifying
Party to its creditors; and (g) any change in the notifying Party’s authorized Representatives, insurance coverage or professional
certifications. ICC also shall promptly notify Pure of the [ * ] purchased by ICC.

 

    	 	17	 

    	 

    

 

7.4
Certain Changes Affecting Transfer Price.

 

(a)
Upon the mutual agreement of the Parties to a change, ICC shall promptly make any changes Pure directs in writing with respect
to the Goods or new Goods, which may include changes in the design, drawings, specifications, processing, inspection, testing,
quality control, methods of packing and shipping or the date or place of delivery. After Pure’s notice to ICC of the change
and prior to implementation of the change, ICC will send Pure a written Notice of a claim for adjustment with all sufficient information
and documentation regarding ICC’s costs and production timing resulting from such changes to allow Pure to perform an audit
and verify such claim. ICC may increase or decrease the Transfer Prices hereunder in a per-unit amount solely to the extent necessary
to compensate ICC for such commercially reasonable cost increases. If Pure’s audit and verification results indicate that
ICC’s costs have or should have actually decreased, the Transfer Prices hereunder shall be deemed decreased on a per-unit
basis to reflect the amount of any such cost savings. Nothing in this Section 7.4‎(a), including any disagreement with Pure
as to any adjustment in price or time for performance, will excuse ICC from proceeding with this Agreement as changed. In the
event of a change, Pure will be responsible, at Pure’s sole cost and expense, for any raw materials that will no longer
be used with respect to the Goods as a result of the change. 

 

(b)
ICC may not make any changes with respect to the Goods or scope of this Agreement without Pure’s prior written consent,
which shall not be unreasonably withheld and otherwise which may be given or withheld in Pure’s sole discretion, including
(i) the location at which Goods are manufactured and stored, (ii) any subcontractors of ICC with respect to Goods, (iii) the processes
or procedures used by ICC in the manufacture of Goods, (iv) the composition, fit, form, function or appearance of Goods, or (v)
chemicals, raw materials or any components or ingredients used in production of Goods. If ICC learns of a possible change to the
Goods that may reduce costs, improve quality, or otherwise be beneficial to Pure, ICC shall promptly notify Pure of the possible
change.

 

(c)
The Parties will adjust pricing on a [ * ] to reflect actual changes in material costs. ICC will provide Pure in advance of the
price change detailed material cost and conversion templates to validate those material cost changes. Conversion costs will be
evaluated between the Parties annually. The conversion cost per SKU will be either a percentage (%) or set dollar amount.

 

    	 	18	 

    	 

    

 

7.5
Pure Product Development. If Pure requests that ICC develop a product for Pure that is not listed on Schedule 1 hereto,
the Parties shall mutually agree upon the terms and fees associated with development, manufacturing, and production of any such
product, which may require a separate agreement. In response to a request by Pure for ICC to develop a new product, Pure shall
provide appropriate purchase price targets, performance characteristics and other characteristics sufficiently documented in design
specifications at the time of initiation of development. Any alterations to Pure formulas made by Pure need to be communicated
to ICC in writing within a reasonable period. Any joint product designs shall be processed through mutually agreed upon design
control parameters to include, but not limited to, raw materials, raw materials suppliers, SKU definition, packaging, packaging
suppliers, DOT/IATA/IMDG classification, exposure/toxicity/disposal classification and testing, anticipated production volumes
and risk management. Any and all Product development by ICC as set forth in this Section 7.5 will be deemed Pure’s Intellectual
Property and owned by Pure unless agreed to by the Parties in a separate agreement.

 

8.
Compliance with Laws.

 

8.1
Compliance. Each Party shall at all times comply with all Laws applicable to this Agreement, the operation of its business
and the exercise of its rights and performance of its obligations hereunder. Without limitation of the foregoing, ICC shall ensure
the Goods and any related packaging conform fully to any applicable Law. Upon Pure’s reasonable request, ICC shall provide
Pure with (a) written certification of ICC’s compliance with applicable Laws; (b) written certification of the origin of
any ingredients or materials in the Goods; and (c) any additional information regarding the Goods requested by Pure required so
that Pure may comply in a timely manner with its obligations under applicable Laws.

 

8.2
Permits, Licenses, and Authorizations. Each Party shall obtain and maintain all Permits necessary for the exercise of its
rights and performance of its obligations under this Agreement, including any Permits required for the import of Goods or any
raw materials and other manufacturing parts used in the production and manufacture of the Goods, and the shipment of hazardous
materials, as applicable.

 

9.
Representations and Warranties; Product Warranty.

 

9.1
ICC’s Representations and Warranties. ICC represents and warrants to Pure that:

 

(a)
it is a corporation duly organized, validly existing and in good standing under the laws of the state of Missouri;

 

(b)
it is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required for
purposes of this Agreement;

 

(c)
it has the full right, corporate power and authority to enter into this Agreement and to perform its obligations hereunder;

 

(d)
the execution of this Agreement by its Representative whose signature is set forth at the end of this Agreement, and the delivery
of this Agreement by ICC, have been duly authorized by all necessary corporate action on the part of ICC;

 

(e)
the execution, delivery, and performance of this Agreement by ICC will not violate, conflict with, require consent under or result
in any breach or default under (i) any of ICC’s organizational documents, (ii) any applicable Law or (iii) with or without
notice or lapse of time or both, the provisions of any material ICC Contract;

 

    	 	19	 

    	 

    

 

(f)
this Agreement has been executed and delivered by ICC and (assuming due authorization, execution and delivery by Pure) constitutes
the legal, valid and binding obligation of ICC, enforceable against ICC in accordance with its terms;

 

(g)
it is in compliance with all applicable Laws and ICC Contracts relating to this Agreement, the Goods and the operation of its
business (including all loan covenants and other financing obligations to which it is subject);

 

(h)
it has obtained all licenses, authorizations, approvals, consents or permits required by applicable Laws to conduct its business
generally and to exercise its rights and perform its obligations under this Agreement;

 

(i)
it is not insolvent and is paying all of its debts as they become due; and

 

(j)
all financial information that it has provided to Pure is true and accurate and fairly represents ICC’s financial condition,
and has been prepared in accordance with GAAP, uniformly and consistently applied.

 

9.2
Pure’s Representations and Warranties. Pure represents and warrants to ICC that:

 

(a)
it is a corporation duly organized, validly existing and in good standing under the laws of the state of Delaware and California;

 

(b)
it is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required for
purposes of this Agreement;

 

(c)
it has the full right, corporate power and authority to enter into this Agreement and to perform its obligations hereunder;

 

(d)
the execution of this Agreement by its Representative whose signature is set forth at the end of this Agreement, and the delivery
of this Agreement by Pure, have been duly authorized by all necessary corporate action on the part of Pure; and

 

(e)
the execution, delivery, and performance of this Agreement by Pure will not violate, conflict with, require consent under or result
in any breach or default under (i) any of Pure’s organizational documents, (ii) any applicable Law or (iii) with or without
notice or lapse of time or both, the provisions of any material Pure Contract; and

 

(f)
this Agreement has been executed and delivered by Pure and (assuming due authorization, execution, and delivery by ICC) constitutes
the legal, valid and binding obligation of Pure, enforceable against Pure in accordance with its terms.

 

(g)
it is in compliance with all applicable Laws and Pure Contracts relating to this Agreement, the Goods and the operation of its
business (including all loan covenants and other financing obligations to which it is subject);

 

(h)
it has obtained all licenses, authorizations, approvals, consents or permits required by applicable Laws to conduct its business
generally and to exercise its rights and perform its obligations under this Agreement;

 

(i)
it is not insolvent and is paying all of its debts as they become due;

 

    	 	20	 

    	 

    

 

(j)
all financial information that it has provided to ICC is true and accurate and fairly represents Pure’s financial condition,
and has been prepared in accordance with GAAP, uniformly and consistently applied;

 

(k)
to its knowledge (with no obligation of inquiry), as of the Effective Date, the Goods and their sale, distribution and use do
not violate any applicable Laws, and do not infringe or violate the privacy rights, intellectual property rights, trade secret
rights, or other proprietary rights of any third party; and

 

(l)
to its knowledge (with no obligation of inquiry), as of the Effective Date, there are no pending lawsuits, governmental investigations
or inquiries, indictments, prosecutions or regulatory actions concerning the Goods, including, but not limited to, any claim by
any third party which, if true, would involve a breach by Pure of any warranty given above.

 

9.3
Product Warranty. ICC warrants to the Pure Parties and any end users of the Goods that (the “Product Warranty”):

 

(a)
for [ * ], the Goods will:

 

(i)
conform, in all respects, to the Specifications, standards, drawings, samples, descriptions, quality requirements, performance
requirements, statements of work, and fit, form and function requirements furnished, specified or approved by Pure for the Goods;

 

(ii)
conform with Pure’s quality standards; and

 

(iii)
be merchantable, free from contamination, and not be precluded from any indicated use provided in the Specifications (as such
term is defined in the UCC) and free from defects, latent or otherwise, in design, materials, and workmanship;

 

(iv)
be fit and sufficient for the particular purpose intended by Pure and its customers, of which ICC has been made aware by Pure
in writing (and ICC acknowledges that it knows of Pure’s intended use of the Goods and that such Goods have been selected,
designed, manufactured or assembled by ICC based upon Pure’s stated use and are sufficient for the particular purposes intended
by Pure); however, for the avoidance of doubt, ICC is not responsible for manufacturing to any marketing or other suitability
for intended use claims made by Pure to its customers; and

 

(v)
comply with all applicable Laws.

 

(b)
each of the Goods will be new and conveyed by ICC to Pure with good title, free and clear of all Encumbrances.

 

9.4
Additional Terms. The Product Warranty (a) is in addition to all other warranties (whether express or implied or arising
from statute or common law) and (b) survives ICC’s delivery of the Goods. ICC shall transfer and assign to Pure all of its
rights (but not any obligations) under all warranties from equipment or material manufacturers or suppliers, permitted subcontractors
or other third parties. Any applicable statute of limitations on Pure’s claims for breach of warranty will commence no earlier
than the date on which Pure discovers the breach.

 

    	 	21	 

    	 

    

 

9.5
Withdrawal or Recall of Goods. If Pure, and/or any of Pure’s customers or any Governmental Authority determines that
any Goods sold to Pure are Defective and a recall campaign is necessary, Pure will have the right to implement such recall campaign
and return Defective Goods to ICC or destroy such Goods, as determined by Pure in its sole discretion. If a recall campaign is
implemented, at Pure’s sole option and ICC’s sole cost, ICC shall promptly replace any Defective Goods and provide
such replacement Goods to Pure or Pure’s designee. The foregoing will apply even if the Product Warranty and any other product
warranty applicable to the Goods have expired. ICC will be liable for all of Pure’s costs associated with any recall campaign
if such recall campaign is based upon a mutual, reasonable determination that the Goods failed to conform to the warranties set
forth in this Agreement. Where applicable, ICC shall pay an equal share of all reasonable expenses associated with determining
whether a recall campaign is necessary.

 

10.
Indemnification.

 

10.1
ICC Indemnification. Subject to the terms and conditions of this Agreement, ICC shall indemnify, defend and hold harmless
the Pure Parties and their Representatives, officers, directors, employees, agents, Affiliates, successors and permitted assigns
(the “Pure Indemnified Parties”) against any and all losses, damages, liabilities, deficiencies, claims, actions,
judgments, settlements, interest, awards, penalties, fines, costs, or expenses of whatever kind, including reasonable attorneys’
fees, fees and the costs of enforcing any right to indemnification under this Agreement and the cost of pursuing any insurance
providers (collectively, “Losses”) relating to or resulting from any third-party Claim or any direct Claim
against any Pure Indemnifying Party alleging:

 

(a)
a breach or non-fulfillment of any of ICC’s representations, warranties, or covenants set forth in this Agreement;

 

(b)
any negligent or more culpable act or omission of ICC or any of its Representatives (including any recklessness or willful misconduct)
in connection with ICC’s performance under this Agreement;

 

(c)
any bodily injury, death of any Person or damage to real or tangible personal property caused by the negligent acts or omissions
of ICC or any of its Representatives;

 

(d)
any failure by ICC or its Personnel to comply with any applicable Laws; or

 

(e)
that any of ICC’s Intellectual Property used in the design or production of the Goods, or that is embodied in the Goods,
infringes any Intellectual Property Right of a third party; provided, however, that, without limitation of anything contained
in Section ‎10.2, ICC has no obligations under this Section 10.1‎(e) with respect to Claims to the extent arising out
of:

 

(i)
any Specifications, raw materials, manufacturing parts or other materials provided by any Pure Indemnified Party;

 

(ii)
any Pure Indemnified Party’s marketing, advertising, promotion or sale of any product containing the Goods;

 

(iii)
use of the Goods, including use of the Goods in combination with any products, materials or equipment supplied to Pure by a Person
other than ICC or its authorized Representatives, if the infringement would have been avoided by not using the Goods or using
the Goods not so combined;

 

    	 	22	 

    	 

    

 

(iv)
any modifications or changes made to the Goods by or on behalf of any Person other than ICC or its Representatives, if the infringement
would have been avoided without such modification or change; or

 

(v)
goods (including Goods), products or assemblies manufactured or designed by any Pure Indemnified Party.

 

10.2
Exceptions and Limitations on ICC Indemnification. Notwithstanding anything to the contrary in this Agreement, ICC is not
obligated to indemnify or defend any Pure Indemnified Party against any Claim or corresponding Losses resulting directly from,
in whole or in part, any Pure Indemnified Party’s or its Personnel’s:

 

(a)
gross negligence or more culpable act or omission (including recklessness or willful misconduct); or

 

(b)
bad faith failure to comply with any of its obligations set forth in this Agreement.

 

10.3
Pure Indemnification. Subject to the terms and conditions of this Agreement, Pure shall indemnify, defend and hold harmless
the ICC Parties and their Representatives, officers, directors, employees, agents, Affiliates, successors and permitted assigns
(the “ICC Indemnified Parties”) against any and all Losses relating to or resulting from any third-party Claim
or any direct Claim against any ICC Indemnifying Party alleging:

 

(a)
a breach or non-fulfillment of any of Pure’s representations, warranties, or covenants set forth in this Agreement;

 

(b)
any negligent or more culpable act or omission of Pure or any of its Representatives (including any recklessness or willful misconduct)
in connection with Pure’s performance under this Agreement;

 

(c)
any bodily injury, death of any Person or damage to real or tangible personal property caused by the negligent acts or omissions
of Pure or any of its Representatives;

 

(d)
any failure by Pure or its Personnel to comply with any applicable Laws; or

 

(e)
that any of Pure’s Intellectual Property used in the design or production of the Goods, or that is embodied in the Goods,
infringes any Intellectual Property Right of a third party; provided, however, that, without limitation of anything contained
in Section 4, Pure has no obligations under this Section 10.3(c) with respect to Claims to the extent arising out of:

 

(i)
any Specifications, raw materials, manufacturing parts or other materials provided by any ICC Indemnified Party;

 

(ii)
any ICC Indemnified Party’s marketing, advertising, promotion or sale of any product containing the Goods;

 

(iii)
use of the Goods, including use of the Goods in combination with any products, materials or equipment supplied to ICC by a Person
other than Pure or its authorized Representatives, if the infringement would have been avoided by not using the Goods or using
the Goods not so combined;

 

    	 	23	 

    	 

    

 

(iv)
any modifications or changes made to the Goods by or on behalf of any Person other than Pure or its Representatives, if the infringement
would have been avoided without such modification or change; or

 

(v)
goods (including Goods), products or assemblies manufactured or designed by any ICC Indemnified Party.

 

10.4
Exceptions and Limitations on Pure Indemnification. Notwithstanding anything to the contrary in this Agreement, Pure is
not obligated to indemnify or defend any ICC Indemnified Party against any Claim or corresponding Losses resulting directly from,
in whole or in part, any ICC Indemnified Party’s or its Personnel’s:

 

(a)
gross negligence or more culpable act or omission (including recklessness or willful misconduct); or

 

(b)
bad faith failure to comply with any of its obligations set forth in this Agreement.

 

11.
NO LIABILITY FOR CONSEQUENTIAL OR INDIRECT DAMAGES. EXCEPT FOR A PARTY’S (1) UNLAWFUL ACTS, FRAUD, GROSS NEGLIGENCE
OR WILLFUL MISCONDUCT, (2) BREACH OF ITS CONFIDENTIALITY OBLIGATIONS UNDER SECTION 13, (3) INFRINGEMENT OF INTELLECTUAL PROPERTY
RIGHTS OR (4) INDEMNIFICATION OBLIGATIONS UNDER SECTION 10, IN NO EVENT SHALL THE PARTIES OR ITS REPRESENTATIVES BE LIABLE FOR
CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS OR REVENUES OR DIMINUTION
IN VALUE, ARISING OUT OF OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF (A) WHETHER SUCH DAMAGES WERE FORESEEABLE,
(B) WHETHER OR NOT SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT,
TORT OR OTHERWISE) UPON WHICH THE CLAIM IS BASED, AND NOTWITHSTANDING THE FAILURE OF ANY AGREED OR OTHER REMEDY OF ITS ESSENTIAL
PURPOSE.

 

12.
Intellectual Property.

 

12.1
Ownership and Use. Unless mutually agreed upon by the Parties in a separate written agreement, each of the Parties acknowledges
and agrees that:

 

(a)
each Party retains exclusive ownership of its Background Intellectual Property Rights;

 

(b)
Pure does not transfer to ICC any of its Background Intellectual Property Rights, and ICC may not use any of Pure’s Background
Intellectual Property Rights other than to produce and supply Goods to Pure hereunder;

 

(c)
ICC does not transfer to Pure any of ICC’s Background Intellectual Property Rights;

 

(d)
all Foreground Intellectual Property Rights will be owned by Pure;

 

(e)
ICC assigns to Pure all of ICC’s right, title and interest in and to all Foreground Intellectual Property Rights, and, to
the extent that any Foreground Intellectual Property Rights are copyrightable works or works of authorship (including computer
programs, technical specifications, documentation, and manuals), the Parties agree that such works are “works made for hire”
for Pure under the U.S. Copyright Act;

 

    	 	24	 

    	 

    

 

(f)
ICC shall only use the Foreground Intellectual Property Rights to produce and supply Goods to Pure; and

 

(g)
ICC waives any claim against Pure, including any hold-harmless or similar claim, whether known or unknown, contingent or latent,
in any way related to a claim asserted against ICC or Pure for infringement of any Intellectual Property Rights.

 

12.2
Prohibited Acts. Each of the Parties shall not:

 

(a)
take any action that may interfere with the other Party’s Intellectual Property Rights, including such other Party’s
ownership or exercise thereof;

 

(b)
challenge any right, title or interest of the other Party in such other Party’s Intellectual Property Rights;

 

(c)
make any claim or take any action adverse to such other Party’s ownership of its Intellectual Property Rights;

 

(d)
register or apply for registrations, anywhere in the world, of the other Party’s Trademarks or any other Trademark that
is similar to such other Party’s Trademarks or that incorporates such Trademarks in whole or in confusingly similar part;

 

(e)
use any mark, anywhere, that is confusingly similar to the other Party’s Trademarks;

 

(f)
misappropriate any of the other Party’s Trademarks for use as a domain name without such other Party’s prior written
consent; or

 

(g)
alter, obscure or remove any of the other Party’s Trademarks or trademark or copyright notices or any other proprietary
rights notices placed on the products purchased under this Agreement (including Goods), marketing materials or other materials.

 

12.3
License of ICC’s Background Intellectual Property Rights. [ * ].

 

13.
Confidentiality.

 

13.1
Scope of Confidential Information. From time to time during the Term, either Party (as the “Disclosing Party”)
may disclose or make available to the other Party (as the “Receiving Party”) information about its business
affairs, goods and services (including any Forecasts), confidential information and materials comprising or relating to Intellectual
Property Rights, trade secrets, third-party confidential information and other sensitive or proprietary information. Such information,
as well as the terms of this Agreement and other information that by its nature can reasonably be expected to be considered confidential,
whether orally or in written, electronic or other form or media, and whether or not marked, designated or otherwise identified
as “confidential” constitutes “Confidential Information” hereunder. Confidential Information does
not include information that at the time of disclosure:

 

    	 	25	 

    	 

    

 

(a)
is or becomes generally available to and known by the public other than as a result of, directly or indirectly, any breach of
this Section ‎13 by the Receiving Party or any of its Representatives;

 

(b)
is or becomes available to the Receiving Party on a non-confidential basis from a third-party source, provided that such third
party is not and was not prohibited from disclosing such Confidential Information;

 

(c)
was known by or in the possession of the Receiving Party or its Representatives prior to being disclosed by or on behalf of the
Disclosing Party;

 

(d)
was or is independently developed by the Receiving Party without reference to or use of, in whole or in part, any of the Disclosing
Party’s Confidential Information; or

 

(e)
is required to be disclosed pursuant to applicable Law; provided, that the Receiving Party (i) provide prompt written notice thereof
to the Disclosing Party to enable the Disclosing Party to seek a protective order or otherwise prevent such disclosure and (ii)
disclose only that portion of the Confidential Information required to comply with such requirement.

 

13.2
Protection of Confidential Information. The Receiving Party shall, for [ * ] from disclosure of such Confidential Information:

 

(a)
protect and safeguard the confidentiality of the Disclosing Party’s Confidential Information with at least the same degree
of care as the Receiving Party would protect its own Confidential Information, but in no event with less than a commercially reasonable
degree of care;

 

(b)
not use the Disclosing Party’s Confidential Information, or permit it to be accessed or used, for any purpose other than
to exercise its rights or perform its obligations under this Agreement; and

 

(c)
not disclose any such Confidential Information to any Person, except to the Receiving Party’s Representatives who need to
know the Confidential Information to assist the Receiving Party, or act on its behalf, to exercise its rights or perform its obligations
under this Agreement.

 

The
Receiving Party shall be responsible for any breach of this Section ‎13 caused by any of its Representatives. On the expiration
or earlier termination of this Agreement or at any time during or after the Term, at the Disclosing Party’s written request,
the Receiving Party and its Representatives shall, pursuant to Section 6.6‎(c), promptly return or permanently destroy all
Confidential Information and copies thereof that it has received under this Agreement, except where prohibited by applicable Law.

 

    	 	26	 

    	 

    

 

14.
Tangible Property.

 

14.1
Bailment.

 

(a)
All Equipment and other tangible property of every description, including supplies, materials, machinery, equipment, drawings,
photographic negatives and positives, artwork, copy layout, electronic data and other items, furnished by Pure (or Pure’s
customers), either directly or indirectly, to ICC or to any supplier to ICC in connection with or related to this Agreement, or
for which ICC has been at least partially reimbursed by Pure (collectively, “Pure Property”) is the property
of Pure (or Pure’s customer(s)), as applicable) and is held by ICC on a bailment-at-will basis. Pure Property includes,
but is not limited to, the Equipment and tangibles listed on Schedule 2 attached hereto.

 

(b)
Only Pure has any right, title or interest in and to Pure Property, except for ICC’s limited right, subject to Pure’s
sole discretion, to use the Pure Property in the performance of ICC’s obligations under this Agreement. ICC shall not use
the Pure Property for any other purpose. ICC shall not commingle Pure Property with the property of ICC or with that of a Person
other than Pure or ICC and shall not move any Pure Property from ICC’s premises without the prior written consent of Pure.
Pure may, at any time, for any reason and without payment of any kind, retake possession of any Pure Property without the necessity
of payment or notice to ICC, or a hearing or a court order, which rights, if any, are waived by ICC. Upon Pure’s request,
Pure Property will be immediately released to Pure or delivered to Pure by ICC. ICC’s continued holding of Pure Property
after demand has been made by Pure for delivery will substantially impair the value thereof, and, accordingly, Pure will be entitled
to a court order of possession without any need of proving damages or providing a bond. To the fullest extent permitted by law,
ICC shall not allow any Encumbrance to be imposed on or attach to the Pure Property through ICC or as a result of ICC’s
action or inaction, and ICC hereby waives any Encumbrance that it may have or acquire in the Pure Property.

 

(c)
ICC acknowledges and agrees that (a) Pure is neither the manufacturer of the Pure Property nor the manufacturer’s agent,
(b) Pure is bailing Pure Property to ICC for ICC’s benefit, (c) ICC has inspected the Pure Property other than [ * ] and
is satisfied that such Pure Property is suitable and fit for its intended purposes, of which ICC is aware, and (d) PURE HAS NOT
MADE AND DOES NOT MAKE ANY REPRESENTATION OR WARRANTY WHATSOEVER, EITHER EXPRESS OR IMPLIED, AS TO THE FITNESS, CONDITION, MERCHANTABILITY,
DESIGN OR OPERATION OF THE PURE PROPERTY OR ITS FITNESS FOR ANY PARTICULAR PURPOSE.

 

14.2
Maintenance; Risk of Loss. Pure shall bear all risk of loss of and damage to Pure Property unless such loss or damage is
due to ICC’s negligence, in which case, ICC shall bear the risk of loss and damage to Pure Property. ICC shall, at its own
expense, for the benefit of Pure, insure all ICC-owned inventory. Pure shall, at its own expense, for the benefit of ICC, insure
all Pure Property with full and extended coverage for all losses, for its full replacement value, in accordance with the terms
of Section ‎16. ICC shall not attempt to disassemble, maintain, repair, refurbish or replace any Pure Property. All replacement
parts, additions, improvements, and accessories for such Pure Property will automatically become Pure Property upon their incorporation
into or attachment to the Pure Property. All replacements of Pure Property will also be Pure Property. Pure shall solely bear
the expense for any routine maintenance to the Pure Property.

 

    	 	27	 

    	 

    

 

14.3
Inventory. ICC shall mark all Pure Property permanently and conspicuously to identify it as the property of Pure, and indicate
Pure’s name and address. ICC shall immediately sign any documents reasonably requested by Pure to evidence all of Pure’s
rights to and interests in Pure Property. As mutually agreed upon by the Parties, ICC will provide notice to Pure of the existence
of any Slow-Moving Inventory Bank after it determines the existence of such Slow-Moving Inventory Bank. As long as such notice
has been provided, the Parties shall agree to a final disposition of such Slow-Moving Inventory Bank in no [ * ] after such notice
has been provided. Pure will commit to reimbursing such Slow-Moving Inventory Bank. Total costs paid by Pure on such Slow-Moving
Inventory Bank shall be no less than ICC’s actual acquisition cost and cost to dispose of said Slow-Moving Inventory Bank.

 

14.4
ICC’s Property. Unless otherwise agreed to by Pure in writing, ICC, at its sole expense, shall furnish, keep in good
condition, and replace when necessary all General Production Equipment and other items necessary or helpful for the production
of the Goods (excluding Pure Property, “ICC’s Property”). ICC shall insure ICC’s Property with
full and extended coverage for all losses, for its full replacement value, in accordance with the terms of Section ‎16.

 

15.
Inspection and Audit Rights. ICC hereby grants to Pure, and each of its authorized Representatives, access to ICC’s
premises (including ICC’s manufacturing operations used in production of the Goods) at a reasonable and mutually agreed-upon
time and all pertinent documents and other information, whether stored in tangible or intangible form, including any books, records
and accounts, in any way related to ICC’s performance under this Agreement (including ICCs’ processes and procedures),
Goods, Pure Property or any payment or other transaction occurring in connection with this Agreement, for the purpose of auditing
ICC’s compliance with the terms of this Agreement and any other agreements between Pure and ICC, or inspecting or conducting
an inventory of finished Goods, work-in-process or raw-material inventory or Pure Property. ICC agrees to cooperate fully with
Pure in connection with any such audit or inspection. ICC shall maintain complete and accurate books and records and any other
financial information in accordance with GAAP, in accordance with ICC’s record retention policy and 21 C.F.R, unless a longer
period is required under applicable Law. ICC shall segregate its records and otherwise cooperate with Pure so as to facilitate
any audit by Pure. ICC shall reimburse Pure for all amounts associated with errors discovered during an audit. In addition, ICC
shall reimburse Pure for the amount of the discrepancy if the results of such audit indicate that such discrepancy is [ * ] of
the total amount actually payable by Pure for the period examined. Pure and ICC shall jointly take a physical count of the Pure-owned
inventory. Each Party shall make reasonable allowances for inventory discrepancies, waste or damaged Goods [ * ]. ICC shall reimburse
Pure for all amounts associated with errors discovered during an audit that are above the reasonable allowances agreed to for
inventory discrepancies, waste or damaged Goods. Notwithstanding the foregoing, if such audit shows a discrepancy in ICC’s
favor, then ICC may credit the amount of such discrepancy against subsequent amounts owed to Pure, or if no further amounts are
owed to Pure under this Agreement, then Pure shall pay ICC the amount of the discrepancy within [ * ] after being notified thereof.
If requested by Pure, ICC shall use its best efforts to permit Pure and its Representatives to obtain from subcontractors or other
suppliers to ICC the information and permission to conduct the reviews specified with respect to ICC in this Section ‎15.
Any audit pursuant to this Section 15 shall be conducted no more frequently than [ * ], with the exception of Pure inspecting
Pure Property and/or Pure’s on-site ICC warehouse inventory.

 

    	 	28	 

    	 

    

 

16.
Insurance. During the Term and for a period of [ * ] after expiration or earlier termination of this Agreement, each Party
shall obtain and maintain, at its sole cost and expense, insurance policies adequate to cover its obligations hereunder and which
are consistent with normal business practices of prudent companies similarly situated, including:

 

(a)
Commercial general liability insurance written on an occurrence basis with combined bodily injury, property damage and personal
injury liability limits of not less than [ * ] per occurrence and [ * ] annual aggregate;

 

(b)
Goods and/or excess liability insurance with a limit of not less than [ * ] per occurrence and [ * ] annual aggregate; and

 

(c)
Each Party shall obtain and maintain an “all risk”, “replacement cost” and “agreed amount”
form of property insurance covering its assets and in particular any property, equipment, machinery or like kind property used
in the manufacture of the Goods. The property insurance shall include but not be limited to additional coverage commonly purchased
for business interruption, extra expense and contingent business interruption in limits sufficient to satisfy the other Party’s
reliance on the Party for uninterrupted product production and supply.

 

(d)
Upon a Party’s reasonable request, the other Party’s shall provide the requesting Party with a certificate of insurance
evidencing the insurance coverage specified in this Section. The certificate of insurance shall name the requesting Party as an
additional insured and loss payee. A Party shall provide the other Party with [ * ] advance written notice in the event of a cancellation
or material change in such insurance policy. Each party waives and shall cause its insurers to waive, any right of subrogation
or other recovery against the other Party, its Affiliates, and their insurers.

 

17.
Miscellaneous.

 

17.1
Further Assurances. Upon a Party’s reasonable request, the other Party shall, at its sole cost and expense, execute
and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this
Agreement.

 

17.2
Relationship of the Parties. The relationship between ICC and Pure is solely that of vendor and vendee and they are independent
contracting parties. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise,
employment or fiduciary relationship between the Parties. Except as otherwise expressly set forth in this Agreement, neither Party
has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other Party
or to bind the other Party to any contract, agreement or undertaking with any third party.

 

17.3
Entire Agreement. This Agreement, including and together with any related exhibits, schedules and the applicable terms
of any Purchase Orders / Picking Orders, constitutes the sole and entire agreement of the Parties with respect to the subject
matter contained herein and therein, and supersedes all prior and contemporaneous understandings, agreements, representations
and warranties, both written and oral, with respect to such subject matter.

 

    	 	29	 

    	 

    

 

17.4
Survival. Subject to the limitations and other provisions of this Agreement: (a) the representations and warranties of
the Parties contained herein will survive the expiration or earlier termination of this Agreement; and (b) Sections 2.4, 5.4,
9.1, 9.2, 9.3, 9.4, 9.5, 10, 11, 12, 13, 16, 17.22 of this Agreement, as well as any other provision that, in order to give proper
effect to its intent, should survive such expiration or termination, will survive the expiration or earlier termination of this
Agreement.

 

17.5
Notices. All notices, requests, consents, claims, demands, waivers and other communications under this Agreement (each,
a “Notice”) must be in writing and addressed to the other Party at its address set forth below (or to such
other address that the receiving Party may designate from time to time in accordance with this Section). All Notices must be delivered
by personal delivery, nationally recognized overnight courier or certified or registered mail (in each case, return receipt requested,
postage prepaid). Except as otherwise provided in this Agreement, a Notice is effective only (a) on receipt by the receiving Party,
and (b) if the Party giving the Notice has complied with the requirements of this Section.

 

	 	Notice
    to ICC:	 	1100
    Central Industrial Drive
	 	 	 	St.
    Louis, MO 63110
	 	 	 	Attn:
    Chief Executive Officer and President
	 	 	 	 
	 	Notice
    to Pure:	 	1725
    Gillespie Way
	 	 	 	El
    Cajon, CA 92020
	 	 	 	Attn:
    Chief Executive Officer and President

 

17.6
Interpretation. For purposes of this Agreement: (a) the words “include,” “includes” and “including”
is deemed to be followed by the words “without limitation”; (b) the word “or” is not exclusive; (c) the
words “herein,” “hereof,” “hereby,” “hereto” and “hereunder” refer
to this Agreement as a whole; (d) words denoting the singular have a comparable meaning when used in the plural, and vice-versa;
and (e) words denoting any gender include all genders. Unless the context otherwise requires, references in this Agreement: (x)
to sections, exhibits, schedules, attachments, and appendices mean the sections of, and exhibits, schedules, attachments and appendices
attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or other document
as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (z) to a statute
means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated
thereunder. The Parties drafted this Agreement without regard to any presumption or rule requiring construction or interpretation
against the Party drafting an instrument or causing any instrument to be drafted. The exhibits, schedules, attachments, and appendices
referred to herein are an integral part of this Agreement to the same extent as if they were set forth verbatim herein.

 

17.7
Headings. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

 

17.8
Severability. If any term or provision of this Agreement is determined by a court of competent jurisdiction to be invalid,
illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability does not affect any other term or
provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon a determination
that any term or provision is invalid, illegal or unenforceable, the Parties shall negotiate in good faith to modify this Agreement
to effect the original intent of the Parties as closely as possible in order that the transactions contemplated hereby be consummated
as originally contemplated to the greatest extent possible. Further, the court of competent jurisdiction making such determination
shall have the power to limit, construe or reduce the duration, scope, activity or area of such provision, or delete specific
words or phrases as necessary to render such provision enforceable in such jurisdiction.

 

    	 	30	 

    	 

    

 

17.9
Amendment and Modification. No amendment to or rescission, termination or discharge of this Agreement is effective unless
it is in writing, identified as an amendment to or rescission, termination or discharge of this Agreement and signed by an authorized
Representative of each Party.

 

17.10
Waiver.

 

(a)
No waiver under this Agreement is effective unless it is in writing, identified as a waiver to this Agreement and signed by an
authorized representative of the Party waiving its right.

 

(b)
Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated, and does not operate
as a waiver on any future occasion.

 

(c)
None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement:

 

(i)
any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or

 

(ii)
any act, omission or course of dealing between the Parties.

 

17.11
Cumulative Remedies. All rights and remedies provided in this Agreement are cumulative and not exclusive, and the exercise
by either Party of any right or remedy does not preclude the exercise of any other rights or remedies that may now or subsequently
be available at law, in equity, by statute, in any other agreement between the Parties or otherwise.

 

17.12
Equitable Remedies. The Parties acknowledge and agree that (a) a breach or threatened breach by a Party of any of its obligations
under Section ‎13 (Confidentiality) would give rise to irreparable harm to the other Party for which monetary damages would
not be an adequate remedy and (b) in the event of a breach or a threatened breach by a Party of any such obligations, the Parties
shall, in addition to any and all other rights and remedies that may be available to a Party at law, at equity or otherwise in
respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance
and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other
security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. The
Parties agree that the other Party will not oppose or otherwise challenge the appropriateness of equitable relief or the entry
by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this
Section ‎17.12.

 

17.13
Assignment. ICC may not assign any of its rights or delegate any of its obligations under this Agreement without the prior
written consent of Pure. Pure may assign any of its rights or delegate any of its obligations to any Affiliate or to any Person
acquiring all or substantially all of Pure’s assets. Any purported assignment or delegation in violation of this Section
is null and void. No assignment or delegation relieves the assigning or delegating Party of any of its obligations under this
Agreement.

 

    	 	31	 

    	 

    

 

17.14
Successors and Assigns. This Agreement is binding on and inures to the benefit of the Parties and their respective permitted
successors and permitted assigns.

 

17.15
No Third-Party Beneficiaries. Except as expressly set forth in the second sentence of this Section ‎17.15, this Agreement
benefits solely the parties to this Agreement and their respective permitted successors and permitted assigns and nothing in this
Agreement, express or implied, confers on any other Person any legal or equitable right, benefit or remedy of any nature whatsoever
under or by reason of this Agreement. The Parties hereby designate (a) the Pure Indemnified Parties and the ICC Indemnified Parties,
as applicable, as third-party beneficiaries of Sections ‎10.1 (ICC Indemnification), 10.2 (Exceptions and Limitations on ICC
Indemnification), 10.3 (Pure Indemnification) and 10.4 (Exceptions and Limitations on Pure Indemnification), (b) each Pure Party
and any end users of the Goods as third-party beneficiaries of Section ‎9.3 (Product Warranty), and (c) each Pure Party and
ICC Party as a third-party beneficiary of Section ‎5.4 (Setoff; Contingent or Disputed Claims). Each third-party beneficiary
designated in the foregoing sentence shall have the right to enforce the Sections under which it is a designated beneficiary.

 

17.16
Dispute Resolution. Any dispute, controversy or claim arising out of or relating to this Agreement, or the breach, termination
or invalidity hereof (each, a “Dispute”), shall be submitted for negotiation and resolution to the President
of ICC (or to such other person of equivalent or superior position designated by ICC in a written Notice to Pure) and the President
of Pure (or to such other person of equivalent or superior position designated by Pure in a written Notice to ICC), by delivery
of written Notice (each, a “Dispute Notice”) from either of the Parties to the other Party. Such persons shall
negotiate in good faith to resolve the Dispute in a face to face meeting at the place of business for Pure, or as mutually agreed-upon
by the Parties. If the Parties are unable to resolve any Dispute within [ * ] after a face to face meeting, either Party may file
suit in a court of competent jurisdiction in accordance with the provisions of Section ‎17.18 and Section ‎17.19 hereunder.
Except where clearly prevented by a Dispute, each Party agrees to continue performing its obligations under this Agreement while
the Dispute is being resolved, subject to continued performance by the other Party of its obligations unless and until the Dispute
is resolved or until this Agreement is terminated in accordance with the terms of this Agreement. The time frame for a Party to
cure any breach of the terms of this Agreement shall not be tolled by the pendency of any dispute resolution procedures.

 

17.17
Governing Law. This Agreement, including all exhibits, schedules, attachments and appendices attached hereto, and all matters
arising out of or relating to this Agreement, are governed by, and construed in accordance with, the Laws of the State of California,
United States of America, without regard to the conflict of laws provisions thereof. The Parties agree that the United Nations
Convention on Contracts for the International Sale of Goods does not apply to this Agreement.

 

    	 	32	 

    	 

    

 

17.18
Choice of Forum. Each Party irrevocably and unconditionally agrees that it shall not commence any action, litigation or
proceeding of any kind whatsoever against the other Party in any way arising from or relating to this Agreement, including all
exhibits, schedules, attachments and appendices attached hereto, and all contemplated transactions, including contract, equity,
tort, fraud and statutory claims, in any forum other than the UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA or
if such court does not have subject-matter jurisdiction, the courts of the State of CALIFORNIA sitting in SAN DIEGO COUNTY, and
any appellate court from any thereof. Each Party irrevocably and unconditionally submits to the exclusive jurisdiction of such
courts and agrees to bring any such action, litigation or proceeding only in UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF
CALIFORNIA or if such court does not have subject-matter jurisdiction, the courts of the State of CALIFORNIA sitting in SAN DIEGO
COUNTY. Each Party agrees that a final judgment in any such action, litigation or proceeding is conclusive and may be enforced
in other jurisdictions by suit on the judgment or in any other manner provided by Law.

 

17.19
Waiver of Jury Trial. Each Party acknowledges and agrees that any controversy that may arise under this Agreement, including
any exhibits, schedules, attachments, and appendices attached to this Agreement, is likely to involve complicated and difficult
issues and, therefore, each such Party irrevocably and unconditionally waives any right it may have to a trial by jury in respect
of any legal action arising out of or relating to this Agreement, including any exhibits, schedules, attachments, and appendices
attached to this Agreement, or the transactions contemplated hereby. Each Party certifies and acknowledges that (a) no Representative
of the other Party has represented, expressly or otherwise, that such other Party would not seek to enforce the foregoing waiver
in the event of a legal action, (b) such Party has considered the implications of this waiver, (c) such Party makes this waiver
voluntarily, and (d) such Party has been induced to enter into this Agreement by, among other things, the mutual waivers and certifications
in this Section.

 

17.20
Counterparts. This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together
is deemed to be one and the same agreement. A signed copy of this Agreement delivered by e-mail or other means of electronic transmission
is deemed to have the same legal effect as delivery of an original signed copy of this Agreement, if the Party sending such e-mail
or other means of electronic transmission has received express confirmation that the recipient Party received the Agreement (not
merely an electronic automatic e-mail reply).

 

    	 	33	 

    	 

    

 

17.21
Force Majeure. Any delay or failure of either Party to perform its obligations under this Agreement will be excused to
the extent that the delay or failure was caused directly by an event beyond such Party’s reasonable control, without such
Party’s fault or negligence and that by its nature could not have been foreseen by such Party or, if it could have been
foreseen, was unavoidable (which events may include natural disasters, embargoes, explosions, riots, wars or acts of terrorism)
(each, a “Force Majeure Event”). A Party’s financial inability to perform will not excuse performance
by that Party under this Section ‎17.21. In addition, changes in cost of materials, components or services, or contract disputes
in which ICC is a party will not excuse performance by ICC under this Section ‎17.21. Each Party shall give the other Party
prompt written notice of any event or circumstance that is reasonably likely to result in a Force Majeure Event and the anticipated
duration of such Force Majeure Event. Each Party shall use all diligent efforts to end the Force Majeure Event, ensure that the
effects of any Force Majeure Event are minimized and resume full performance under this Agreement. During any Force Majeure Event,
Pure may, at its option (a) purchase Goods from other sources and reduce the quantities hereunder by such quantities or (b) require
ICC to deliver to Pure all finished Goods, work-in-process or parts and materials produced or acquired for work under this Agreement.
If requested by a Party, the other Party shall, within [ * ] of such request, provide adequate assurances that a Force Majeure
Event will not exceed [ * ], except, in the case of ICC, if a Force Majeure Event breaks or destroys the ICC Managed Equipment.
If the delay lasts [ * ] period, or if a Party does not provide such adequate assurances, the other Party may immediately terminate
this Agreement without any liability to the Party that fails to perform its obligations or that does not provide such adequate
assurances. The rights granted to ICC with respect to excused delays under this Section ‎17.21 are intended to limit ICC’s
rights under theories of force majeure, commercial impracticability, impracticability or impossibility of performance, or failure
of presupposed conditions or otherwise, including any rights arising under Section 2-615 or 2-616 of the UCC.

 

17.22
No Public Announcements or Trademark Use. Unless expressly permitted under this Agreement, neither Party shall either:

 

(a)
make any statement (whether oral or in writing) in any press release, external advertising, marketing or promotion materials regarding
the subject matter of this Agreement, or the Parties’ business unless:

 

(i)
it has received the express written consent of the other Party, or

 

(ii)
it is required to do so by Law or under the rules of any stock exchange to which it is subject;

 

(b)
use any of the other Party’s Trademarks without the prior written consent of such other Party.

 

[Remainder
of page intentionally left blank.]

 

    	 	34	 

    	 

    

 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the Effective Date.

 

	 	INTERCON
    CHEMICAL COMPANY
	 	 	 
	 	By:	/s/
    Jim Epstein
	 	Name: 
    	Jim
    Epstein
	 	Title:
    	Chief
    Executive Officer and President

 

	 	PURE
    BIOSCIENCE, INC.
	 	 	 
	 	By:	/s/
    Hank Lambert
	 	Name: 
    	Hank
    Lambert
	 	Title:
    	Chief
    Executive Officer and President

 

    	 	35	 

    	 

    

 

Schedule
1

 

GOODS
/ TRANSFER PRICE / FULFILLMENT FEES

 

[
* ]

 

    	Sch.1

    	 

    

 

SCHEDULE
2

 

PURE
PROPERTY

 

[
* ]

 

    	Sch.2

    	 

    

 

Exhibit
A

 

SPECIFICATIONS

 

This
Exhibit A has been provided under separate cover and is hereby incorporated by reference hereto.

 

    	 	 	 

    	 

    

 

Exhibit
B

 

SOP

 

This
Exhibit B has been provided under separate cover and is hereby incorporated by reference hereto.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]